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Abstract
Helicases unwind duplex DNA and are required for a multitude o f  cellular activities. 
The majority o f Superfamily one (SF1) helicases unwind duplex DNA with 3’ -  5 ’ 
directionality and have been studied in depth. However, there is a set o f SF1 
helicases with 5’ -  3 ’ directionality, the mechanism o f  which is yet to be understood.
The initial research o f this thesis was to determine the role o f  the 2B domain o f the 
SF1 3 ’ -5 ’ helicase, Bacillus stearothermophilus PcrA using modified inteins. 
However, this work, and work attempting to use the same modified inteins to study 
the Replication Factor C dependent loading o f Proliferating Cell Nuclear Antigen 
onto DNA, proved unsuccessful.
The crystal structure o f the E.coli RecBCD complex has been solved previously and 
gives some insights into the 5 ’- 3 ’ helicase mechanism o f the SF1 helicase RecD. 
Due to stability problems, isolated E.coli RecD protein is an unsuitable target for 
characterisation; therefore RecD homologues from other species were examined. 
The RecD homologue from Deinococcus radiodurans (drRecD2) was found to be 
soluble and was chosen for biochemical and structural characterisation.
Mutational studies were carried out to investigate the molecular mechanism by 
which drR ecD l unwinds duplex DNA. A molecular pin has been identified and is 
implicated in splitting open duplex DNA as part o f  the helicase mechanism. In 
addition to biochemical characterisation, drRecD2 was crystallised with a 5 ’-tailed 
duplex DNA substrate. The crystalisation conditions were optimised leading to 
diffraction data o f 3.5A resolution.
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Abbreviations
Standard abbreviations are used for amino acids, elements, nucleotides, protein 
names and units.
[] concentration (molar)
a alpha
P beta
Y gamma
8 extinction coefficient
Ax absorbance o f  light o f  x nM
aa amino acid
ADP adenosine diphosphate
AMPPNP 5'-adenylyl-beta,gamma-imi
AU absorbance units
ATP adenosine triphosphate
b base
bp base pair
BSA Bovine serum albumin
BME p mecaptoethanol
C-terminus/terminal carboxyl terminus/terminal
Da Dalton
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
dsDNA double stranded DNA
ssDNA single stranded DNA
DTT di-thiothreitol
E.coli Escheria coli 
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EDTA ethylenediaminetetraacetic acid
HEPES N-2-hydroxyethylpiperzine-N’-2-ethanesulphonic acid
IPTG isopropyl-p-D-thiogalctopyranoside
KDa kilo Dalton
Ka association constant
IQ dissociation constant
LB Luria broth
M molar
MES 2-(N-morpholino)-ethane sulfonic acid
MESNA 2-mercaptoethanesulfonic acid
MPD 2-methyl-2,4-pentanediol
Mw molecular weight
N-terminus/terminal amino terminus/terminal
NAD+ nicotinamide adenine dinucleotide (oxidised form)
NADH nicotinamide adenine dinucleotide (reduced form)
nt nucleotide
OD600 optical density at 600 nM
PCR polymerase chain reaction
PEG polyethylene glycol
PIPES piperazine-1,4-bis(2-ethanesulfonic acid)
rpm revolutions per minute
SDS sodium dodecyl sulphate
PAGE polyacrylamide gel electrophoresis
Tris tris-(hydroxymethyl)-aminomethane
U units o f protein
UV ultra violet
13
volume per volume 
weight per volume
1 Introduction
The aim o f this thesis is to further the understanding o f how Superfamily 1 (SF1) 
helicases unwind duplex nucleic acid, with particular attention to the Superfamily IB 
(SF1B) helicases.
1.1 Helicases
A helicase is an enzyme that couples ATP hydrolysis to the unwinding o f  double­
stranded nucleic acid into its component strands. All helicases share fundamental 
biochemical activities, including non-sequence-specific nucleic acid binding, nucleic 
acid-dependent NTP hydrolysis (usually o f ATP), and duplex nucleic acid separation
(see Figure 1.1).
A) B)
Figure 1.1. A generic helicase reaction
A) The DNA helicase (grey) binds to the DNA substrate (red and blue).
B) DNA translocation and DNA unwinding powered by ATP hydrolysis separates the strands of the 
duplex DNA.
The first in vitro experiments showing a protein to have helicase activity were 
published in 1976 (Abdel-Monem and Hoffmann-Berling 1976) and the details o f  
the helicase mechanism are still to be fully understood. The ability to unwind DNA  
means helicases have a significant role to play in almost every cellular process 
involving nucleic acids. These processes include DNA replication and repair, 
transcription, translation, ribosome synthesis, RNA maturation and splicing, nuclear
Q DNA binding
DNA transolcation 
ar '
nATP
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export and conjugal DNA transfer (Tuteja and Tuteja 2004). Helicases are also 
targets for anti-cancer therapies (Gupta and Brosh 2007) and anti-viral therapies (Xi 
2007).
Helicases are a sub-group o f translocases, which are enzymes that couple ATP 
hydrolysis to directional movement on single or double-stranded nucleic acid. A 
helicase is a translocase with the ability to unwind double-stranded nucleic acid. 
There are several different ways in which the ability to unwind duplex nucleic acid is 
conferred to a translocase and these are discussed later.
Helicase activity combines the activities o f  nucleic acid translocation with double­
stranded nucleic acid destabilisation. Both o f  these activities depend upon other sub­
activities. Translocation o f single stranded nucleic acid by a helicase depends upon 
non-sequence-specific nucleic acid binding and ATP hydrolysis activities o f  the 
helicase (Lohman and Bjomson 1996).
1.2 Biochemical properties of helicases
There are several biochemical properties o f  helicases to consider concerning how 
helicases unwind DNA.
1.2.1 DNA binding
If a helicase either binds nucleic acid too tightly or not at all, translocation cannot 
occur, i.e. the helicase cannot bind to a substrate or it gets stuck in one place. 
However, if  the nucleic acid binding activity can be modulated between a weak and 
tight hold on the nucleic acid then this provides an opportunity for single-stranded 
translocation. The modulation o f just one binding site would not be enough to
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provide a mechanism o f helicase translocation; two DNA binding sites are required 
(Lohman and Bjomson 1996).
1.2.2 NTP hydrolysis
Energy is required 1) in order to modulate the changing affinity o f the helicase for 
nucleic acid, 2) to overcome the thermodynamically unfavourable reaction o f  
splitting duplex DNA and 3) to confer other structural conformational changes 
specific to individual helicases. This energy is provided by the nucleic acid- 
dependent hydrolysis o f NTPs by the helicase (Hall and Matson 1999).
1.2.3 Rate of translocation
The rate o f  translocation is the rate at which a helicase translocates along nucleic 
acid. This varies immensely from a few base pairs per second as demonstrated by the 
Escheria coli {E.coli) Rep helicase (Bjomson et al. 1994) to approximately a 
thousand base pairs per second as demonstrated by the E.coli RecBCD complex 
(Bianco and Kowalczykowski 2000; Roman and Kowalczykowski 1989b). The rate 
of translocation is usually proportional to the rate o f ATP hydrolysis by the helicase.
1.2.4 Directionality
The directionality o f  a helicase is the direction the helicase translocates along nucleic 
acid in terms o f  the asymmetric properties o f  nucleic acid. Nucleic acid is an 
asymmetric molecule with a 3 ’ end and a 5 ’ end; helicases that translocate along 
single-stranded nucleic acid possess a directionality, in that they either move toward 
the 5 ’ end (a 3 ’ -  5 ’ translocase), or toward the 3 ’ end (a 5 ’ -  3 ’ translocase) 
(Lohman and Bjomson 1996) (see Figure 1.2).
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Figure 1.2. Helicase directionality
A schematic showing the direction of translocation along single-stranded nucleic acid by a 5’ -  3’ 
helicase (grey) and by a 3’ -  5’ helicase (brown).
Single-stranded nucleic acid translocases tend to posses an intrinsic directionality 
regardless o f how they are loaded onto the substrate. The situation is more complex 
for helicases that translocate duplex nucleic acid. Duplex nucleic acid is a bipolar 
molecule with two strands running anti parallel to one another, which confers the 
duplex with an intrinsic symmetry. The helicase will translocate along one o f the 
strands with a directionality, which means the directionality is determined by the 
way the helicase is loaded onto the substrate (Singleton et al. 2007).
1.2.5 Processivity
The processivity o f a helicase is the number o f  base pairs unwound before the 
helicase dissociates from the nucleic acid substrate. Helicases are not distributive 
enzymes, meaning they do not undergo one round o f catalysis and then release the 
products before rebinding new substrates for the next reaction. Helicases are 
processive enzymes, meaning they catalyze multiple cycles before releasing the 
products, i.e. multiple productive cycles o f DNA separation and translocation occur 
for a single nucleic acid binding event before the nucleic acid is released. The 
processivity o f  a helicase is dependent on the rate o f  translocation along, and the rate 
of dissociation from, the nucleic acid substrate. The E.coli RecBCD complex is the 
most processive helicase unwinding up to 42 kilo bases without dissociating from 
the DNA substrate (Bianco et al. 2001).
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1.2.6 Step size
There are various different ideas as to what a step size o f  a helicase is. The step size 
is defined here as the number o f base pairs that are translocated or unwound in one 
catalytic cycle (i.e. per ATP hydrolysis reaction). The free energy o f ATP hydrolysis 
(AG = -13 kcal/mol (Simmons and Hill 1976)) and an average free energy for base 
pair separation (AG = 1 - 1 . 5  kcal/mol/bp (Record et al. 1981)) should allow the 
calculation o f  a theoretical maximum step size. However, these values are highly 
variable and depend on many factors, for example, the DNA topology. Estimates for 
a theoretical limit range from 2-4 bp/ATP to 9-12 bp/ATP (Lohman and Bjomson 
1996; Roman and Kowalczykowski 1989a). However, these limits assume all the 
energy from hydrolysis is used to unwind DNA and only a thermodynamically 
perfect helicase could reach the theoretical limit.
It is very hard to measure a step size defined as the number o f  bases 
translocated/unwound per ATP hydrolysised experimentally. The obvious way o f  
measuring a step size is to measure the amount o f  ATP required to unwind a known 
number o f base pairs. This is appears simple, but there are problems. Uncoupled 
ATP hydrolysis can occur during nucleic acid dependent ATP hydrolysis, and an 
unprocessive helicases may dissociate from the nucleic acid allowing strand re­
annealing and therefore unproductive helicase activity occurs. These cannot be 
quantified in the calculation used to analyse the results, and so the step sizes 
determined will be lower then the true value.
Ali and Lohman were the first to use the approach o f  investigating pre-steady state 
kinetics o f  strand displacement by a helicase using quenched flow apparatus and
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applied it to the study o f the E.coli UvrD helicase (Ali and Lohman 1997). They 
used 3 ’-tailed duplex DNA o f varying duplex DNA lengths and observed a lag phase 
before the DNA was unwound suggesting the presence o f intermediates on the way 
to unwinding the all o f  the DNA. This is thought be an indication o f  a series o f  
kinetic steps o f  equal rate, which unwind the substrates. It is important to note that 
this does not give information relating to the number o f  ATP hydrolysis events 
required for each kinetic step. Instead it gives a kinetic step size, which is related to 
the rate-limiting step o f  DNA unwinding. The kinetic step could be related to the 
ATP hydrolysis, but not necessarily.
The structures o f  SF1 helicases show a clear indication that the step size w ill be one 
base pair per ATP hydrolysed, foPcrA and E.coli UvrD are the best examples o f  this 
(Lee and Yang 2006; Velankar et al. 1999). The largest experimentally determined 
step size in terms o f  single stranded gaps in duplex DNA that can be passed over 
with out dissociation o f the helicase is 23 nucleotides E.coli RecBCD (Bianco and 
Kowalczykowski 2000). However, the same study estimates that only around 1 base 
pair is unwound per ATP hydrolysed (Bianco and Kowalczykowski 2000). The next 
largest example comes from the E.coli Tral helicase, which is shown to have a 
kinetic step size o f  around 6 to 8 bp (Sikora et al. 2006).
1.2.7 Oligomeric state
The oligomeric state o f a helicase refers to the number o f  identical monomers within 
one active helicase complex. The Superfamily 3, Superfamily 4, Superfamily 5 and 
Superfamily 6 (SF6) helicases form hexameric rings complexes (Singleton et al. 
2007). Superfamily 1 and Superfamily 2 helicases can work as monomers in vitro 
(Cheng et al. 2007, Singleton, 2006; Morris et al. 2001; Nanduri et al. 2002;
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Velankar et al. 1999), but the oligomeric state in vivo is unclear and they could form 
dimers (see section 1.8.4).
1.3 Classification
The classification o f  helicases was, until recently, based entirely on primary 
structure analysis as described by Gorbalenya and Koonin (Gorbalenya and Koonin 
1993). Gorbalenya and Koonin describe three Superfamilies o f  helicases, 
Superfamily 1 (SF1), Superfamily 2 (SF2) and Superfamily 3 (SF3), and two 
families of, what were then, ‘putative helicases’ that are now referred to as 
Superfamily 4 (SF4) (DnaB-like helicases) and Superfamily 5 (SF5) (Rho/V- F- 
ATPase-like helicases) (Gorbalenya and Koonin 1993). The helicase Superfamily 6 
(SF6) has recently been added (Singleton et al. 2007) and contains AAA+ (ATPases 
Associated with various cellular Activities (Erzberger and Berger 2006))-like 
helicases. The classification o f helicases allowed the identification o f  seven 
conserved sequence motifs, which are described later (Gorbalenya and Koonin 1993; 
Gorbalenya et al. 1989; Gorbalenya et al. 1990). Several new motifs have been 
identified some o f which are only found in the helicases o f  one Superfamily or a 
subset o f helicases within a Superfamily, for example m otif 4a, Q-motif, TRG, and 
TxGx (Korolev et al. 1998; Mahdi et al. 2003; Pause and Sonenberg 1992; Tanner et 
a l  2003).
Some proteins do not unwind duplex DNA in vitro , but could be classified as 
helicases based upon primary structure analysis. For example, the Saccharomyces 
cerevisiae (sc) PRP2 protein (Kim et al. 1992) and the scRAD5 protein (Johnson et 
al. 1994) do not possess helicase activity despite containing the seven helicase 
motifs and displaying nucleic acid-dependent NTP hydrolysis activity. Indeed, the
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helicase motifs may not necessarily be indicative o f  helicase activity, for example 
the hsdR subunit o f type I restriction endonucleases contains all the motifs 
characteristic o f a Superfamily 2 helicase (Gorbalenya and Koonin 1991). The best 
characterised set o f  proteins with the helicase motifs that are not helicases are the 
chromatin remodelling enzymes. These proteins are part o f the Snf2-like family and 
can be placed with the Superfamily 2 helicases (Lusser and Kadonaga 2003).
The idea o f these motifs being ‘helicase motifs’ may therefore be restrictive as well 
as being somewhat misleading to those not familiar with the field. However, in all 
cases to date the helicase motifs are indicative o f  the structural RecA-like fold ‘core 
domains’ o f helicases/translocases.
1.4 The RecA-like fold core domains
Helicases o f all Superfamilies contain RecA-like fold structural core domains, also 
referred to as the motor domains (see Figure 1.3).
22
Figure 1.3. The RecA-like fold core domains common to all helicase Superfamilies
A) i) The E.coli RecA fold, ii) A schematic of the fold (based upon a figure by Caruthers et al. (Caruthers 
and McKay 2002). B) Examples of the RecA-like fold core domains of different Superfamily helicases. 
Where the helicase contains two core domains in the same polypeptide one is coloured red the other 
green. Two of the six core domains are shown for the ring helicases, except for 7/wRuvB because the 
structure of the biological ring has yet to be determined, i) Bacillus stearothermophilus PcrA (Velankar et 
al. 1999). ii) Thermatoga maritima RecG (Singleton et al. 2001). iii) Bovine papillomavirus El (Enemark 
and Joshua-Tor 2006). iv) Thermus aquaticus DnaB (Bailey et al. 2007). v) E.coli Rho (Skordalakes and 
Berger 2003). vi) Thermotoga maritima RuvB (Putnam et al. 2001).
These core domains couple NTP binding and hydrolysis to conformational changes 
within the protein associated with translocation (Ye et al. 2004).
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1.5 The helicase motifs
For the SF1 helicases, which contain the two core RecA-like domains in one 
polypeptide, seven helicase motifs were originally described (Gorbalenya and 
Koonin 1993). For the purposes o f this thesis, the two core domains are classified as 
1A and 2A, after Bacillus stearothermophilus (bs) PcrA (Subramanya et al. 1996), 
depending on which helicase motifs they contain (see Figure 1.4). Domain 1A 
contains motifs 1, la, 2, and 3 and is N-terminal to domain 2A, which contains 
motifs 4, 5 and 6 and is C-terminal to domain 1 A.
C)
Figure 1.4. The Superfamily 1 helicase motifs
A) A schematic of the bs?cxK gene that encodes for the RecA-like core domains with the locations of the 
helicase motifs indicated. B) The structure of the RecA-like fold core domains of bs?cxK and the 
locations of the helicase motifs. C) The conserved amino acid sequence of helicase motifs of Superfamily 
1 helicases (Gorbalenya et al. 1989). Capital letters are the single letter abbreviation and for amino acids 
present in at least 75% of known sequences. + represents a hydrophobic residue, o represents a 
hydrophilic residue, and x is any residue.
Motifs common to all helicases of all Superfamilies are coloured yellow, motifs coloured blue are specific 
to SF1 (and SF2) helicases. The 1A domain is coloured green and the 2A domain is coloured red (this 
colour scheme is the same in all subsequent figures). The IB and 2B domains of foPcrA are omitted for 
clarity.
The SF2 helicases also contain the seven helicase motifs found in SF1 helicases, but 
motif 3 is different and the locations o f all the motifs differ: Domain 1A contains 
motifs 1,1a, and 2; Domain 2A contains motifs 3, 4, 5, and 6.
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Helicase motifs 1, 2 and 6 are common to helicases o f  all Superfamilies and contain 
conserved residues that are involved in the binding and hydrolysis o f  NTPs. Helicase 
motifs 1 and 2 are closely related to Walker A and B boxes associated with NTP 
hydrolysis (Walker et al. 1982). M otif 6, referred to as m otif R in SF3, SF4, SF5 and 
SF6 helicases, contains an arginine finger that is involved in energy coupling 
(Scheffzek et al. 1997).
The foPcrA helicase is well characterised and the roles o f  some individual amino 
acids o f the helicase motifs have been uncovered. The crystal structures o f  ZwPcrA 
show that Q254 o f m otif 3, R287 o f motif 4 and R610 o f  motif 6 all contact the y 
phosphate o f AMPPNP. E571 o f motif 5 interacts with the ribose o f the AMPPNP 
and D233 and E224 o f  m otif 2 and T38 o f m otif 1 contact the magnesium ion. The 
position o f this magnesium ion is filled by K37 o f  m otif 1 in the apo and ADP bound 
foPcrA structures. When AMPPNP is bound K37 moves out o f this position to a 
position where it can stabilise ATP-hydrolysis intermediates (Subramanya et al. 
1996; Velankar et al. 1999). The crystal structures also show that F64 o f  m otif la, 
Y257 and W259 o f  m otif 3, R359 and N361 o f m otif 4 and H565 o f m otif 5 interact 
with DNA. M otif 3 acts as bridge between the ATP binding site and the DNA  
binding sites, Q254 interacts with the ATP while Y257 and W259 interact with the 
DNA (Subramanya et al. 1996; Velankar et al. 1999). Mutating the DNA interacting 
amino acids to alanine reduces the helicase activity o f  ZwPcrA dramatically, but ATP 
hydrolysis activity is unaffected (Dillingham et a l  1999).
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1.6 Further classification
An extension to the classification o f helicases by Gorbalenya and Koonin was 
recently published (Singleton et al. 2007), which further classifies helicases by 
biochemical and mechanistic properties. The consequence o f  this is that a ‘putative 
helicase’ cannot be fully classified until it has been biochemically characterised. 
Where directionality o f translocation can be determined, a 3 ’ -  5 ’ helicase is type A 
and a 5’ -  3 ’ helicase is type B. The SF1, SF2 and SF6 helicases contain both types 
A and B whereas at present all characterised SF3 helicases are type A and all SF4 
and SF5 helicases are type B. Further to this, helicases that translocate along single­
stranded nucleic acid are classified as type a  and those that translocate along double­
stranded nucleic acid as type (3 (see Figure 1.5).
Figure 1.5. Further classification of helicases based upon biochemical properties
A) Type Aa (brown) and Ba (grey) helicases
B) Type A(3 (brown) and Bp (grey) helicases
Figure based upon a figure by Singleton et al. (Singleton et al. 2007).
For example, foPcrA is a Superfamily 1 type A a  (S F lA a) helicase because it 
translocates in a 3 ’ -  5’ direction along single-stranded DNA.
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1.7 Accessory domains and proteins
The core domains o f  helicases do not necessarily provide the means to disrupt 
duplex DNA, but rather they translocate nucleic acid. Other accessory domains can 
provide the means to disrupt the duplex nucleic acid ahead o f  the translocating ‘core 
domains’. For example the IB and 2B domains o f  foPcrA has been shown to be 
important for disrupting duplex DNA (Soultanas et al. 2000; Velankar et al. 1999) 
(see Chapter 3 for further details). The accessory domains do not need to be 
contained within the same polypeptide. In the case o f  E.coli RecBCD, two helicases, 
RecB and RecD, translocate along opposite strands o f  the duplex DNA being 
unwound, while RecC splits open the duplex DNA using a molecular pin and binds 
to the RecB and RecD subunits (Singleton et al. 2004).
There are also a wide variety o f other accessory domains and partner proteins that 
are involved in targeting the activity o f the helicase to a specific substrate or in 
providing further catalytic activities (Singleton and W igley 2002). For example the 
Bacteriophage T7 gene 4 helicase-primase monomer comprises a helicase domain 
and a primase domain (Donmez and Patel 2006), and the helicase activity o f  Bacillus 
stearothermophilus DnaB protein is stimulated by the DnaG primase (Bird et a l  
2000).
1.8 Models of helicase activity
1.8.1 Active and passive mechanisms
An active helicase is conventionally one that participates in the unwinding o f duplex
nucleic acid ahead of, or at, the fork o f duplex DNA and the separated DNA strands
(Lohman and Bjomson 1996). A passive helicase does not participate in the
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unwinding o f duplex nucleic acid but instead waits for thermal fraying at the fork 
and then traps the single-stranded nucleic acid thus preventing reannealing o f the 
strands (Lohman and Bjomson 1996). All o f the helicases characterised to date 
appear to actively participate in unwinding DNA (Singleton et a l  2007).
There are two reports contrary to this that describe the Hepatitis C virus NS3 
helicase, and the Bacteriophage T7 gene product 4 (T7 gp4) helicase as passive 
helicases that translocate DNA in a random Brownian motion fashion (Levin et al. 
2005; Stano et al. 2005). The NS3 helicase is a Superfamily 2 helicase, a non 
hexameric ring helicase, and it is hard to imagine how a random Brownian motion 
can occur with out dissociation o f the helicase from the nucleic acid substrate, in 
which case it hard to see how the helicase would then trap single-stranded DNA  
produced by thermal fraying o f duplex DNA. If the helicase is bound to nucleic acid 
it can only translocate with out dissociating from the nucleic acid, this is a highly 
regulated process dependant on the hydrolysis o f  NTPs (Lohman and Bjomson 
1996). It is easy to imagine DNA slippage, i.e. a base not being translocated upon 
NTP hydrolysis, but it not easy to see how it would reverse direction in a random 
Brownian motion. The crystal structure o f  the helicase domain o f  the NS3 helicase 
in complex with DNA shows that there are interactions o f  the phosphodiester 
backbone o f the DNA with the RecA-like fold core domains (Kim et a l  1998). The 
authors note two amino acids that act like ‘book ends’ on either side o f  the cleft 
between the 1A and 2A domains o f the helicase. The authors suggest that the cleft 
between domains 1A and 2A will open and close in an NTP dependant manor, as is 
the case for foPcrA, and will enable single-stranded nucleic acid translocation in one 
direction. It hard to see how this can fit with a random Brownian motion o f  the 
helicase. In the case o f the T7 gp4 helicase, which is a hexameric ring it is
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conceivable that the ring acts as a clamp to keep the core helicase domains in 
proximity to the DNA during a random Brownian motion, as the core domains 
would not need to stay bound to the DNA. However, a recent study that set out to 
determine kinetically whether the T7 gp5 helicase is an active or passive helicase 
concludes that enzyme must be an active helicase (Johnson et al. 2007). The 
structure o f the T7 gp4 helicase also suggests a mechanism for DNA translocation 
that requires at least two o f six the RecA-like core domains to be bound to single 
stranded DNA at anyone time (Singleton et al. 2000), making random Brownian 
motion o f the helicase unlikely.
1.8.2 Superfamily 1 helicases
There are two main models o f how SF1 helicases function: the inchworm model and 
the active rolling model. Both o f  these models were originally devised to explain 
data relating to the E.coli Rep helicase. Yarranton and Gefter proposed the 
inchworm model to explain the very first biochemical data gathered from studying 
the E.coli Rep helicase (also known as helicase III) (Yarranton et al. 1979a, b; 
Yarranton and Gefter 1979). The active rolling model was later proposed to explain 
further biochemical data relating to the E.coli Rep helicase (Wong and Lohman 
1992).
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1.8.3 The inchworm model
i)
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Figure 1.6. The inchworm model of helicase action
The helicase, bound to single stranded DNA, extends into, and unwinds, the duplex DNA before the rest 
of the helicase translocates along the DNA to catch up with the front part.
Studies o f  the SF1A bs?crA and E.coli UvrD helicases, and the SF1B E.coli Dda 
helicase have provided the best evidence for the inchworm model. The inchworm 
model for the mechanism o f the foPcrA helicase activity is described in detail in 
Chapter 4 (see section 4.4.2.1) and shows very clearly how a monomer o f foPcrA 
could unwind duplex DNA. Biochemical evidence also points to ZwPcrA working as 
a monomer. 1) no oligomeric states o f foPcrA have been observed (Bird et al. 1998). 
2) monomers o f ZwPcrA translocate single stranded DNA (Dillingham et al. 2000, 
2002). 3) amino acid mutations in the 2B domain, the domain proposed to destabilise 
duplex DNA ahead o f the ‘motor domains’, reduce helicase activity (Soultanas et al. 
2000; Velankar et al. 1999).
A recent study implies that foPcrA is only active when part o f  a higher order 
complex because monomeric 6sPcrA cannot unwind duplex DNA under single 
turnover conditions (Niedziela-Majka et al. 2007). However, the Bacillus subtilis 
YxaL protein and the Staphylococcal pC221 RepD protein both increase the 
processivity o f foPcrA in vitro, without modifying the DNA-dependent ATP 
hydrolysis or DNA binding activities o f the enzyme (Noirot-Gros et al. 2002; 
Soultanas et al. 1999). Although these observations do not reveal anything about the
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oligomeric state o f the helicase, it is possible that accessory proteins could be 
modulating the activity o f monomeric helicases.
The crystal structures o f monomeric E.coli UvrD in complex with DNA and various 
nucleotide analogues were recently determined (Lee and Yang 2006). The structure 
o f  UvrD shows structural homology to PcrA and the mechanism o f  DNA unwinding 
appears to work in a very similar fashion.
The E.coli Dda helicase is one o f the best-characterised SF1B helicases, despite the 
lack o f  structural information. Single turnover experiments show that monomers o f  
the enzyme can unwind DNA (Nanduri et al. 2002) and that the Dda protein exists as 
a monomer and does not form oligomeric states (Morris et al. 2001). However, when 
multiple monomers are bound to the tail o f  a single-stranded tailed duplex DNA  
substrate the rate o f translocation and helicase activity increases compared to a 
single monomer (Byrd and Raney 2004, 2005). Additionally, multiple bound Dda 
monomers are required to displace single-stranded binding protein from DNA (Byrd 
and Raney 2006). These data indicate that adjacent Dda monomers on the single­
stranded DNA can either replace the active DNA-unwinding monomer upon 
dissociation and prevent reannealing o f the separated strands, or that the monomers 
function cooperatively. This has led to the proposal o f  the cooperative inchworm 
model (Mackintosh and Raney 2006; Spurling et al. 2006) (see Figure 1.7).
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Figure 1.7. The cooperative inchworm model
A) The helicase monomer unwinds a few base pairs before dissociating and the separated DNA strands 
reanneal. B) More than one helicase monomer binds to the DNA and when the lead monomer unwinding 
the DNA dissociates the other monomers continue to unwind the DNA. C) More than one helicase 
monomer binds to the DNA and work in a cooperative fashion allowing the lead monomer to unwind the 
DNA. Figure based on a figure by Mackintosh etal. (Mackintosh and Raney 2006).
1.8.4 The active rolling model
The E.coli Rep helicase is monomeric in solution (Lohman et al. 1989) and binds 
one molecule o f ATP (Moore and Lohman 1994a, b). Chao et al. report that 
dimerisation o f Rep is induced upon DNA binding (Chao and Lohman 1991) and 
Rep oligomers are required to initiate DNA unwinding (Cheng et al. 2001; Ha et al.
2002). The study o f allosteric effects o f  nucleotide binding present five possible 
DNA-bound states o f a Rep dimer, three o f which are stabilised during the ATP 
hydrolysis cycle (Wong and Lohman 1993) (see Figure 1.8).
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)Figure 1.8. The DNA bound states of a Rep dimer
The five possible DNA bound states of a Rep dimer. P = protein, D = double-stranded DNA and S = 
single-stranded DNA. Stabilising co-factors are indicated, P2D and P2D2 are not stable formations. Figure 
based on figure by Lohman et al. (Lohman and Bjomson 1996).
The active rolling model is put forward to explain these data (see Figure 1.9).
Figure 1.9. The active rolling model for the E.coli Rep helicase
Both the subunits of the Rep dimer bind to single-stranded DNA in the absence of ATP and ADP. Upon 
ATP binding one of the Rep monomers binds to duplex DNA, effectively translocating DNA. Upon ATP 
hydrolysis the duplex is destabilised and the Rep monomer binds to single-stranded DNA in the absence 
of ATP and ADP. Figure based on figure by Lohman et al. (Lohman and Bjomson 1996).
The E.coli Rep, E.coli UvrD and foPcrA proteins show structural homology to one 
another (Korolev et al. 1997; Lee and Yang 2006; Subramanya et al. 1996). It seems 
unlikely that the same structural motifs work in such vastly differing models o f  
helicase action. The active rolling model makes several assumptions about helicase 
activity. Firstly, the active rolling model requires SF1 helicases to work at least as 
dimers, however the Bacteriophage T4 Dda helicase (Nanduri et al. 2002), the F 
plasmid Tral (DNA helicase I) (Sikora et a l  2006) and the E.coli RecQ (Zhang et al. 
2006b) helicase have been shown to function as monomers. Secondly, the active 
rolling model requires a step size o f at least the length o f  a Rep monomer plus the
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length o f  the extruded loop between the dimers. This exceeds both the largest 
experimental and the largest theoretical step size determined to date (see section 
1.2.6). Thirdly, there is no obvious mechanism to confer directionality o f  unwinding, 
an active rolling helicase should be able to translocate bi-directionally as no single 
monomer is constantly bound to DNA and the Rep helicase shows clear 
directionality. Finally, the suggestion that Rep dimerises upon DNA binding may not 
be true. The crystal structure o f Rep in complex with single-stranded DNA substrate, 
does not show any indication o f Rep dimerisation because there are no interactions 
between the two Rep molecules bound to the DNA. Instead the length o f  DNA used 
both in the crystal structure and by Chao et al. is long enough to bind two Rep 
molecules. In order to say definitively that Rep dimerises upon DNA binding, 
shorter DNA needs to be used in the assays. This would mean that only one Rep 
molecule could bind to one molecule o f DNA, so any apparent dimerisation o f Rep 
would be real, i.e. protein interactions between Rep molecules would have to exist.
The active rolling model can explain the experimental data gained from studying the 
Rep helicase. However, a co-operative inchworm model explains most o f the 
observations o f all SF1 helicases and would also fit with observations o f  the Rep 
helicase. The cooperative inchworm model could also explain the fact that the 2B 
domain o f  the Rep helicases inhibits the helicase activity o f a Rep monomer and the 
proposed mutual sequestering o f the 2B domains o f  a Rep dimer activates the 
helicase (Brendza et al. 2005). An important point here is that the 2B deletion 
mutant o f  Rep unwinds DNA as a monomer. This shows that although Rep may 
prefer to work as a dimer, the core domains and the IB domain are sufficient for 
monomeric helicase activity for monomeric Rep.
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1.9 Superfamily 1A
The best-characterised S F lA a  proteins are the E.coli Rep and UvrD helicases and 
foPcrA helicase. The crystal structures o f  these proteins have all been determined 
and show that they share the common RecA-like tandem folds (Korolev et al. 1997; 
Lee and Yang 2006; Subramanya et al. 1996). The mechanism for single-stranded 
DNA translocation has been studied in depth and the proposed model o f 6sPcrA 
translocation is explained in detail in Chapter 4 (see section 4.4.2.1).
The mechanism for breaking open duplex DNA is still not entirely clear. The 2B 
domain o f  6sPcrA is implicated in disruption o f  duplex DNA ahead o f  the motor 
domains, but the 2B domain o f Rep is not required for helicase activity and indeed 
inhibits it (Brendza et al. 2005; Cheng et al. 2002).
1.10 Superfamily 1B
1.10.1 E.coli RecD
The E.coli RecD helicase is a 67KDa protein that forms a complex with the E.coli 
RecB and RecC proteins to form the RecBCD complex (Singleton et al. 2004). In 
eubacteria the RecBCD complex processes potentially lethal double-strand breaks 
within the genome. The DNA is digested by RecBCD using a combination o f  
helicase and endonuclease activity. RecBCD then loads RecA onto to the DNA in 
order to initiate DNA repair by homologous recombination.
The E.coli RecD and RecB subunits o f  RecBCD are ssDNA-dependent ATPases
(Chen et al. 1997; Hickson et al. 1985). In addition, RecB is a S F lA a  helicase
(Boehmer and Emmerson 1992) and RecD is a S IB a  helicase (Dillingham et al.
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2003). These observations fit the model o f  RecBCD being a ‘bipolar’ helicase with 
RecB and RecD translocating opposite strands o f the duplex DNA being unwound in 
an inchworm helicase mechanism. This model is supported by the structure o f E.coli 
RecBCD in complex with duplex DNA (Singleton et a l  2004)(see Figure 1.10). The 
RecB and RecD helicases are bound to opposite strands o f the DNA, and will both 
translocate in opposite polarities along the opposite DNA strands and hence travel in 
the same overall direction.
Figure 1.10. The structure of E.coli RecBCD complex
A) The structure of the E.coli RecBCD complex. B) A model of single-stranded DNA translocation by 
the RecB and RecD subunits; the RecC subunit splits open the duplex DNA.
The RecB subunit is coloured orange, the RecC subunit blue, and the RecD subunit green.
As described earlier there are two modes o f  helicase action, active and passive. The 
structure o f  the E.coli RecBCD complex reveals a pin in RecC that is positioned at 
the base o f  the duplex. Although the structure is by nature static, it is easy to imagine 
the RecB and RecD helicases translocating the opposite single-stranded DNA
A)
Rec
3 ’ 5’
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strands using the pin as a mechanical device over which the duplex DNA could be 
split open, suggesting an active DNA unwinding mechanism.
All o f the three subunits o f the E.coli RecBCD complex contain the tandem RecA- 
like fold core domains (Singleton et al. 2004). In the case o f  RecC this is surprising 
as RecC does not contain any o f the helicase motifs indicative o f  the RecA-like fold 
core domains. The 1A and 2A domains o f  both the RecB and RecD subunits are 
easily identifiable.
1.10.2 Opposite directionality of SuperfamilylBa 
helicases compared SuperfamilylAa helicases
There are two simple models that could explain the difference o f the 3 ’ -  5 ’ 
directionality o f a S F lA a  helicase compared to 5 ’ -  3 ’ directionality o f  S F lB a  
helicase. Either the helicase binds the DNA in the opposite orientation or it 
translocates DNA in the opposite direction (see Figure 1.11).
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Figure 1.11. Models of how the 3’ -  5’ directionality of a Superfamily lA a  helicase could be 
reversed to 5’ -  3 ’
direction of translocation. B) The translocation of a SF1A helicase could be reversed in a SF1B helicase 
by i) binding the DNA in the opposite orientation and keeping the same translocation mechanism, or ii) 
by binding the DNA in the same orientation and changing the mechanism of translocation.
The structure o f the E.coli RecBCD complex suggests that the change in 
directionality is not due to S F lB a helicases binding DNA in the opposite orientation 
to S F lA a  helicases (Singleton et al. 2004). The 5’ tail o f the unwound single­
stranded DNA binds firstly to the 1A domain o f the RecDl helicase then to the 2A 
domain, which is analogous to the binding o f  the 3 ’ tail o f  single-stranded DNA to 
the 2A domain o f  the S F lA a helicase 6sPcrA and then to the 1A domain. In both 
cases the polarity o f the bound DNA is the same across the 1A and 2A domains o f  
E.coli RecD and foPcrA (see Figure 1.12).
A) Translocation of a SF1A helicase showing the orientation of the 1A and 2A domains relative to the
38
A) BsPcrA B) E.coli RecD1
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Figure 1.12. The orientation of DNA binding by Superfamily lA a  and Superfamily IB a  
helicases
A) i) The structure and, ii) a schematic, of the binding of single stranded DNA to the 1A and 2A domains 
of foPcrA. B) i) The structure and ii) a schematic of the binding of single-stranded DNA to the 1A and 
2A domains of E.coli RecD. The 1A and 2A  domains of the resulting bound DNA states have the same 
orientation relative to the asymmetric single-stranded DNA.
The shared orientation o f the single-stranded DNA binding to the motor domains by 
E.coli RecDl and foPcrA is highly significant as it suggests the mechanism o f  RecD 
translocation is reversed and that the molecular details o f the helicase mechanism o f  
S F lA a  and S F lB a  helicases are not the same.
Sequence comparisons o f helicase motifs la  and 3 between S F lA a  and S F lB a  
helicases reveal a clue into how the helicase mechanisms differ. This is discussed in
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detail in Chapter 4 (see section 4.4.2) along with a newly identified motif common to 
S F lB a  helicases, motif A.
1.10.3 Type 1 and 2 RecD helicases
Usually a bacterial genome contains either the RecBCD set o f genes or the AddAB 
set o f  genes (Rocha et al. 2005). The AddAB and RecBCD protein complexes both 
work to repair double-strand DNA breaks in a similar reaction pathways (Chedin and 
Kowalczykowski 2002). The AddA protein is similar to the RecB protein, but the 
AddB protein is not similar to the RecC or RecD proteins (Wang and Julin 2004). 
However, some bacterial genomes that contain the AddAB genes and not the RecBC 
genes appear to have a RecD-like gene (Rocha et al. 2005). It has become apparent 
that there are RecD-like proteins that cannot be part o f  RecBCD complex because 
these RecD-like proteins exist in organisms that do not possess the RecB or RecC 
genes. The RecD enzymes that are likely to exist as part o f the RecBCD complex are 
referred to as type 1 RecD (R ecD l) helicases and the RecD-like enzymes that are not 
part o f the RecBCD complex are referred to as type 2 RecD (RecD2) helicases 
(Rocha et al. 2005). Table 1.1 summarises the types o f  bacteria that contain the 
AddAB or RecBCD genes and the RecD-like (RecD2) genes (Rocha et al. 2005).
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Table 1.1. Summary of the presence of the Add AB, RecBCDl and RecD2 genes in bacterial 
genomes
Type of bacteria Add AB RecBCDl RecD2
y-proteobacteria - + -
/3- proteobacteria 
a-proteobacteria
+
6- proteobacteria,
Cyanobacteria,
Acinobacteria
-/+ -/+
e- proteobacteria - - -
Firmicutes + - +
Spirochetes - -/+ -
Chlamydiae - + +
The Chlamydiae species and Deinococcus radiodurans are significant when looking 
at the presence or absence o f the AddAB, RecBCDl and RecD2 genes. The 
Chlamydiae are unusual in the fact that they contain the RecBCDl genes as well as a 
RecD2 gene. Deinococcus radiodurans is unusual because it does not contain either 
the Add AB or RecBCDl set o f genes and most bacteria appear to have either one 
set or the other (Rocha et al. 2005). Rocha et al. have carried out a phylogenetic 
analysis o f  the RecDl and RecD2 proteins (see Figure 1.13). It shows that the 
RecDl family is not only distinguished from the RecD2 family by the presence or 
absence o f the RecBC genes within the genome o f  an organism, but also by the 
sequence o f  the RecD gene, furthering the argument that there are two distinct types 
o f RecD proteins.
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Figure 1.13. An un-rooted phylogenetic tree of the R ecD l and RecD2 proteins
The dotted line splits the genomes containing RecBCDl from those containing only RecD2.
C. acetobutylicum, Clostridium acetobutylicum; C. tepidum, Chlorobium tepidum; C.violaceum, 
Chromobacterium violaceum; D. vulgaris, Desulfovibrio vulgaris; E. carotovora, Erwinia carotovora; E. 
faecalis, Enterococcus faecalis; G.sulfurreducens Geobacter, sulfurreducnes; Lplantarum, Lactobacillus 
plantarum; L. lactis, Lactococcus lactis; P.multocida, Pasteurella multocida; M. mobile, Mycoplasma 
mobile; M. florum, Mesoplasma florum; M. mycoides, Mycoplasma mycoides; M.pulmonis, Mycoplasma 
pulmonis; N.meningitidis, Neisseria meningitides; P. maritima, Prochlorococcus maritima; S. enterica, 
Salmonella enterica; S.oneidensis, Shewanella oneidensis; X.fastidiosa, Xylella fastidiosa. Figure based 
upon a figure by Rocha et al. (Rocha et al. 2005).
The E.coli RecDl helicase does not interact with the duplex portion o f  the DNA  
being unwound by the RecBCD complex (Singleton et al. 2004). The N-terminal 
domain o f the E.coli RecDl helicase interacts with RecC. This domain is not 
conserved in RecD2 helicases, probably because RecD2 helicases do not interact 
with a RecC protein. The role o f the N-terminal region o f  RecD2 helicases, which 
tend to be larger than the N-terminal domain o f R ecD l helicases, is yet to be fully 
understood. It may be involved in interacting with the duplex region o f  DNA.
1.10.4 Deinococcus radiodurans RecD2
As mentioned earlier, Deinococcus radiodurans is unusual because its genome does 
not contain either the AddAB or RecBCDl genes, although it does contain a RecD2 
gene that encodes for a 77 KDa protein (White et al. 1999). The AddAB and 
RecBCDl pathways are involved in DNA repair and so the absence o f  the these 
genes is even more odd when coupled with the fact that Deinococcus radiodurans is 
one o f the most DNA damage resistant organisms characterised to date (Battista 
1997; Battista et al. 1999; Minton 1994). The Deinococcus radiodurans genome 
does contain a RecA gene (Gutman et a l  1994; Kim et al. 2002) despite not having 
the AddAB or RecBCDl complexes to target loading RecA onto areas o f  DNA  
damage.
The precise in vivo role o f the type 2 RecD proteins is not known. The Deinococcus 
radiodurans RecD2 helicase is the only type 2 RecD enzyme to have had its in vivo 
function investigated and has recently been shown to play a role in DNA repair 
and/or homologous recombination (Servinsky and Julin 2007), as well as being 
reported to be involved in an antioxidant pathway (Zhou et al. 2007).
1.10.5 Eukaryotic Superfamily 1B helicases
Several eukaryotic SF1B helicases have been studied are associated human diseases.
1.10.5.1 The Pif1 -like helicases
Four members o f  the Pifl-like helicases have been studied in detail: two budding
yeast helicases, scP ifl and scRrm3p and the P iflp  helicase from the fusion yeast
Schizosaccharomyces pom be (sp) and humans. Like the RecD helicases, the P ifl-
like proteins all display single-stranded DNA dependent ATP hydrolysis and 5 ’ -  3 ’
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helicase activities (Ivessa et al. 2002; Lahaye et al. 1993; Zhang et al. 2006a; Zhou 
et al. 2002). The fission yeast s/?Piflp helicase gene is essential, as is the helicase 
function o f the protein (Zhou et al. 2002). The spPiflp  helicase is implicated in 
telomere maintenance, but is also essential in cells with circular chromosomes, so 
this cannot be the essential function, and the helicase function o f s/?Phflp is 
implicated in Okazaki fragment maturation (Boule and Zakian 2006). The role o f  the 
human Piflp helicase is still not clear, but it seems to be involved in telomere 
regulation (Boule and Zakian 2006; Zhang et al. 2006a).
1.10.5.2 The human Upf1 helicase
The human Upfl (hU pfl) helicase is involved in nonsense-mediated mRNA decay 
(NMD), a process that recognises and destroys aberrant mRNAs to prevent the 
synthesis o f truncated proteins within the cell (Baker and Parker 2004; Conti and 
Izaurralde 2005; Lejeune and Maquat 2005). The human and budding yeast U pfl 
helicases both possess RNA binding, RNA-dependent ATP hydrolysis and 5 ’ -  3 ’ 
helicase activities, these activities are required for NMD (Bhattacharya et al. 2000; 
Czaplinski et al. 1995; Weng et al. 1996a, b).
The structure o f the hUpfl helicase was recently solved (Cheng et al. 2007) and is 
the first example o f  a human SF1 helicase structure. As expected the hUpfl structure 
shows structural homology to the prokaryotic SF1 helicases such as foPcrA, E.coli 
Rep, UvrD and RecD, and contains the RecA-like fold core domains predicted by 
the presence o f the seven Superfamily 1 helicase motifs (Cheng et al. 2007). This is 
a clear indication that the SF1 helicase structure and, therefore, the associated 
helicase mechanisms are conserved across all domains o f  life.
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The inhibition o f NMD by inhibiting hUpfl protein expression has been used to 
reverse a phenotype, the loss o f the ability to create functional extra cellular matrix, 
o f Ullrich diseased fibroblasts taken from a patient (Usuki et al. 2004; Usuki et al. 
2006). This phenotype o f  the fibroblasts contributes toward to a clinical symptom o f  
the patient: a form muscular dystrophy (Usuki et al. 2006).
1.10.5.3 The BRCA1 -associated C-terminal helicase 1 (BACH1)
The BRCA1-associated C-terminal helicase 1 (BACH1) helicase (also known as 
FancJ and Bripl) interacts with the BRCT domain o f  the Breast Cancer Associated 
Protein 1 (BRCAl)(Cantor et al. 2001). Defects in the BRCA1 gene are linked to the 
development o f  hereditary breast, ovarian, and other cancers (Alberg et al. 1999; 
Futreal et al. 1994; Miki et al. 1994; Nathanson et al. 2001). When the helicase 
function o f BACH 1 is knocked out, the double-strand break repair activity mediated 
by the BRCA1/BACH1 complex is impaired (Cantor et al. 2001; Kumaraswamy and 
Shiekhattar 2007). Further to this two germ-line mutations in the helicase domain o f  
BACH1 have been observed in patients with early onset breast cancer (Cantor et al. 
2001).
1.11 Thesis outline
This thesis is in two parts. The first part o f  the thesis (Chapter 3) describes attempts 
to utilizes the protein splicing properties o f inteins to create a full-length foPcrA 
protein from two halves in vitro. This was to be the first step in creating a ZwPcrA 
deletion mutant missing the 2B domain that could then be used to investigate the 
disputed role o f the 2B domain o f SF1 helicases.
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The second part o f  this thesis (Chapters 4 and 5) aims to further the understanding o f  
the helicase mechanism o f SF1B helicases. Chapter 4 describes the identification o f  
a type 2 RecD helicase from Deinococcus radiodurans as a suitable target for study 
and goes on to described the purification o f Deinococcus radiodurans RecD2 
(<afrRecD2). Chapter 4 also characterises the biochemical properties o f the drRecD2 
helicase and describes the study o f mutant drRecD2 helicases to examine the SF1B 
helicase mechanism. Chapter 5 describes the crystallisation o f drRecD2 in complex 
with a 5 ’-tailed duplex DNA substrate.
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2 Materials and methods
2.1 Standard materials and methods
2.1.1 Standard methods
Molecular biology techniques were carried out as described in standard laboratory 
manuals (Ausubel et al. 1988; Sambrook et al. 1989). Where enzymes were used for 
the manipulation o f DNA the supplier’s protocol was followed. Any deviation from 
the standard protocols is noted. Concentrations o f  protein and DNA were estimated 
using the theoretical extinction coefficients.
2.1.2 Standard materials
Unless otherwise stated all chemicals were obtained from VW R International, Fisher 
Scientific and Sigma-Aldrich. Adenosine [y-32P] triphosphate was obtained from GE 
Healthcare. Chromatography columns and media were obtained from GE Healthcare 
and any exceptions are noted. Oligonucleotides were synthesised by Sigma-Genosys 
and an in-house service.
2.2 Microbiological methods
2.2.1 E.coli strains
The E.coli strains used during the work described in this thesis are listed in Table 
2 . 1.
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Table 2.1. Summary of E.coli expression strains
Strain Features
E.coli XL 1-blue (Bullock et al. 
1987) (Stratagene)
Used for cloning. 
Lacks RecA.
E.coli B834 (DE3) (Studier and 
Moffatt 1986)
(Novagen)
Used for protein and seleno-methionine protein 
expression. Lacks the ability to synthesise methionine. 
Deficient in both Ion and ompT proteases.
E.coli BL21 (DE3) 
(Novagen)
Used for protein expression. 
Derived from B843 (DE3) cells.
E.coli TUNER 
(Novagen)
lacZY deletion mutants o f BL21. The lac permease 
(lacY) mutation allows uniform entry o f IPTG into all 
cells o f the culture. By adjusting the concentration of 
IPTG, protein expression can be regulated.
Rare codon plasmids (helper expression plasmids) are listed in Table 2.2. 
Table 2.2. Summary of helper expression plasmids
Rare codon plasmid Features
Codon + (pRIL, Stratagene) Supplies tRNAs for the codons AG A, AGG, AUA and 
CUA.
Chloramphenicol resistant.
Codon 2 + (Provided by Steve 
Sandler)
Supplies tRNAs for the codons AGG and AGU. 
Spectinomycin resistant.
Codon 3 + (pRP, Stratagene) Supplies tRNAs for the codons AGG, AGA and CCC. 
Chloramphenicol resistant.
Rosetta (pRARE, Novagen) 
(Novy etal. 2001)
Supplies tRNAs for the codons AGG, AGA, AUA, CUA, 
CCC, and GGA. Chloramphenicol resistant.
When expression o f a protein is referred to both the bacterial strain and the helper 
plasmid are both quoted. For example, a protein expressed in the E.coli expression
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strain BL21(DE3) with the helper plasmid codon 2+ is quoted as being expressed in 
BL21 2+.
2.3 DNA methods
2.3.1 Oligonucleotide purification
The oligonucleotide was suspended in denaturing buffer A (50 mM phosphate buffer 
pH 6.8, 10 mM sodium hydroxide) with 100 mM sodium chloride and was loaded 
onto a Source 15Q column equilibrated in denaturing buffer. After washing away 
unbound material the oligonucleotide was eluted with a 30 column-volume gradient 
from 0.1 M to 2.0 M sodium chloride in denaturing buffer A. The oligonucleotide 
was exchanged into water using a NAP25 drip column, concentrated using a 
centricon (Amicon) with an appropriate molecular weight cut o ff  and stored at -20 
°C.
2.3.2 Annealing oligonucleotides
Equimolar amounts o f complementary oligonucleotide in water were mixed in 
annealing buffer (50 mM phosphate buffer pH 6.8, 100 mM potassium chloride, 10 
mM magnesium chloride) before being heated to 95 °C in a programmable thermal 
cycler. The thermal cycler was programmed to cool the mixture from 95 °C to 4 °C 
over 18 hours. The resulting annealed oligonucleotides were stored at -20 °C.
2.3.3 Cloning
The target gene to be cloned was used as the template for a polymerase chain 
reaction (PCR). The primers were designed so that the resulting PCR product would 
contain non-complementary flanking sequences. The flanking sequences contained
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restriction sites which were also contained within an expression vector plasmid. The 
remainder o f the primer (i.e. the region complementary to the template sequence) 
was designed to have a theoretical melting point o f  65 °C . Polymerase chain 
reactions were carried out using the Expand high fidelity PCR system (Roche) 
according to the manufacturers protocol (an exception is noted later) and the product 
was purified using the QIAquick PCR purification kit (Qiagen). The purified product 
and the target expression plasmid were digested with the appropriate restriction 
enzymes and were separated by agarose gel electrophoresis and purified using the 
QIAquick gel extraction kit (Qiagen). The restriction digest results in 
complementary overhangs between the PCR product and the expression plasmid. 
The digested plasmid was mixed with an excess o f  the product (insert) in a ligation 
reaction with DNA ligase (New England Biolabs) before being transformed into 
supercompetent E.coli XL 1-Blue cells (Stratagene) via electroporation. The E.coli 
were plated on to agar with the appropriate antibiotics and incubated at 37 °C 
overnight. Up to six colonies were picked and cultured in 5 ml o f  LB with 
appropriate antibiotic cultures and incubated at 37 °C with shaking overnight. The 
plasmids were purified using the QAI plasmid mini preparation kit (Qiagen). The 
presence o f the correct insert in the plasmid was confirmed by restriction digest with 
the appropriate restriction enzymes analysed by agarose-gel electrophoresis and by 
sequencing (in-house service). An exception to this was the PCR buffer for PCR o f  
the wild type <7rRecD2 gene using the Deinococcus radiodurans genomic DNA as 
the template. The PCR also contained 2.5 % w/v DMSO; the DNA denaturing steps 
were 1 minute at 99 °C instead o f 30 seconds at 95 °C and the initial denaturing step 
was 10 minutes at 99 °C instead o f 5 minutes at 95 °C.
All the constructs used in this thesis are listed in Table 2.3.
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Table 2.3. Constructs of this thesis
Gene cloned Expression
plasmid
Restriction 
sites used
Notes
Wild-type Deinococcus radiodurans 
RecD2
pET 22b Nde 1 
XIto 1
C-terminal hexa-histidine tag
Deinococcus radiodurans RecD2„cw and 
RecD2 mutants
pET 22b Nde 1 
Xho 1
C-terminal hexa-histidine tag
E.coli RecDl pET 15b Nde 1 
Bam HI
N-terminal hexa-histidine tag
Streptococcus pneumoniae RecD 2 pET 22b Nde 1 
Bam HI
Bacillus cereus RecD2 pET 22b Nde 1 
BamW \
Lactobacillus plantarum  RecD2 pET 22b Nde 1 
Bam HI
Desulfovibrio vulgaris RecD2 pET 22b Nde 1 
Bam HI
Methanococcus jannaschii YF19 METAJ pET 22b Nde 1 
Bam HI
Haemophilus Influenzae RecD 1 pET 15b Nco 1 
Bam HI
Mycobacterium smegmatis RecDl pET 22b Nde 1 
Bam HI
Bacillus stearothermophilus PcrAl pTWIN 1 Nde 1 
Sap 1
6sPcrAl was fused to the N- 
terminus o f  MceGyrAi
Bacillus stearothermophilus PcrA 1 pTWIN2 Nde 1 
Sap 1
foPcrAl was fused to the N- 
terminus o f  M/?RIR1 i
Bacillus stearothermophilus PcrA (amino 
acids 1-302, 1-312, 1-327 and 1-359) and 
any associated mutants.
pTWIN 1 Nde 1 
Sap 1
foPcrA was fused to the N- 
terminus o f  MreGyrAi
Bacillus stearothermophilus PcrA2 pTWIN 1 Sap 1 
Pst 1
6sPcrA2 was fused to the C- 
terminus o f  SspDnaBi
Archaeoglobus fulgidus PCNA pTWIN 1 Nde 1 
Sap 1
q/PCNA was fused to the N- 
terminus o f  MteGyrAi
Archaeoglobus fulgidus PCNA pTWIN2 Nde 1 
Sap 1
q/PCNA was fused to the N- 
terminus o f  MARIR1 i
Archaeoglobus fulgidus PCNA pTWIN 1 Sap 1 
Bam HI
q/PCNA was fused to the C- 
terminus o f  .SspDnaBi via the 
p/PCNA linker
All the vectors used contained an ampicillin resistance gene as a selective marker. 
The pET vectors were obtained from Novagen and the pTWIN vectors were 
obtained from New England Biolabs.
51
2.3.4 Site-directed m utagenesis
To produce point mutants o f a protein the Quick-change kit 2.0 was used according 
to the supplier’s instructions (Qiagen).
The drRecD2Aloop was created by replacing 412-419 (inclusive) of drRecD2 with a
glycine, using a three step PCR construction of the gene as described in Figure 2.1.
A) drRecDn** gene
C terminalN terminal
1
")
4
1
D) ■   ■ -   .........
drf?ecDstoop gene
Figure 2.1. The cloning of </rRecD2A,oop
A) A schematic of the r/rRecD2ncw gene with the region that encodes amino acids 412-419 coloured grey. 
The primers to be used are also shown. The parts of the primers that are not complementary to the gene 
sequence and instead encode a glycine residue are coloured orange.
B) i) The resulting PCR product when primers 1 and 2 are used, ii) The resulting PCR product when 
primers 3 and 4 are used.
C) The PCR products from B) are mixed and i) one round of a PCR is performed in the absence of 
primers before ii) the addition of primers 1 and 4 to the PCR.
D) The resulting PCR product from C). The gene no longer encodes amino acids 412-419, but encodes a 
glycine instead.
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Primers 1 and 4 were designed so that the PCR product, the <7rRecD2Aloop gene, 
would contain two flanking restriction sites for cloning into an expression plasmid.
2.4 Protein methods
2.4.1 Protein expression
2.4.1.1 Protein expression trials
Unless otherwise stated in the text protein expression trials were carried out as 
described here. The expression plasmid undergoing the trial was transformed into 
electro-competent E.coli expression strains B834, BL21 and TUNER with the +, 2+, 
3+ and Rosetta plasmids and were grown overnight on LB agar plates with the 
appropriate antibiotic at 37 °C. Colonies were washed into 20 ml LB cultures with 
antibiotic and grown at 37, 30 or 18 °C with shaking to an O.D .600 o f  0.5-0.7 AU and 
then the culture was split into four. The cultures were induced with 1, 0.2, 0.04 mM 
IPTG and one control culture was not induced. The cultures were incubated at 37, 30 
or 18 °C for three hours before each culture was pelleted (Hyspin 16K (Anachem) 
14000 rpm, 10 minutes) and the supernatant discarded. Each pellet was resuspended 
in trial buffer (20 mM Tris/HCl pH 7.5, 500 mM sodium chloride, 1 mM EDTA, 1 
mM DTT) and sonicated. The whole cell extract, soluble and insoluble fractions 
were analysed using SDS-PAGE.
2.4.1.2 Protein expression details
Protein was routinely expressed in the E.coli expression strains described in section
2.2.1. Expression plasmids were transformed into electro-competent E.coli and
grown overnight on LB plates at 37 °C. Colonies were washed into 50 ml LB with
antibiotic starter cultures and grown at overnight at 37 °C with shaking. 5 ml o f
starter culture was used to inoculate 1 L or 200 ml cultures that were incubated with
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shaking at 37, 30, or 18 °C until the O.D6oo reached 0.5 -0.7 AU. The culture was 
then induced with 1 or 0.2 mM IPTG and incubated for a further 3, 6 or 18 hours. 
The cells were harvested by centrifugation (J-6B (Beckman), 4000 rpm, 15 minutes) 
and the cell pellets were stored at -80 °C.
Table 2.4 below lists the protein expression parameters 
Table 2.4. Protein expression parameters
Protein expressed E.coli
strain
Temperature
(°C)
[IPTG]
(mM)
Length of 
induction 
(hrs)
Size of 
culture 
(Litres)
JrRecD2 (from wild type 
drRscD l gene)
BL21
Rosetta
37 1 3 1
seleno-methionine 
d!rRecD2* (from wild type 
drRecD2 gene)
B834
Rosetta
37 1 6 1
<7rRecD2 & <7rRecD2 
mutants (from JrRecD2new 
gene)
BL21 37 1 3 1
E.coli RecDl (Dillingham et 
al. 2003)
BL21 37 1 3 1
bs PcrA 1 -MxeGyrAi TUNER
2+
18 0.2 18 1
Ss/?DnaBi-foPcrA2 BL21 37 1 3 1
a/PCNA-MreGyrAi & 
q/PCNA-M/jRIRli
B834 2+ 37 1 3 0.2
* Grown in seleno-methionine media
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2.4.2 Protein purification
The E.coli RecBC complex and the E.coli RecBCD complex were purified by Nicola 
Cook and Robert Court.
2.4.2.1 Deinococcus radiodurans RecD2 small scale purification
The cell pellet from a 1 L expression culture was resuspended in 20 ml buffer D1 
and sonicated. The soluble fraction was clarified by centrifugation (SS-34 rotor 
(Sorvall), 20 minutes, 18000 rpm) and was incubated for 1 hour at 4 °C with gentle 
agitation with nickel-agarose beads (Qiagen) equilibrated in buffer D3 with 40 mM 
imizadole. The nickel-agarose beads were pelleted (Hyspin 16K (Anachem), 1000 
rpm 2 minutes) and the supernatant discarded. The nickel-agarose beads were 
washed by being resuspended in 20 ml buffer D3 with 40 mM imizadole, then 
pelleted by centrifugation (Hyspin 16K (Anachem), 1000 rpm 2 minutes) and the 
supernatant discarded. Any drRecD2 bound to the nickel-agarose beads was eluted 
by resuspending the beads in buffer D3 with 400 mM imizadole and then pelleting 
the beads by centrifugation (Hyspin 16K (Anachem), 1000 rpm 2 minutes). All the 
steps o f the purification were analysed by SDS-PAGE.
2.4.2.2 Deinococcus radiodurans RecD2 and RecD2 mutants large 
scale purification
The cell pellet from ten 1 L cultures was resuspended in 200 ml buffer D1 and the 
cells were lysed under pressure using a homogeniser (Stansted). The soluble fraction 
was clarified by centrifugation (SS-34 rotor (Sorvall), 20 minutes, 18000 rpm). 
Ammonium sulphate was added to 65 % saturation (0.43 g/ml) and the mixture 
incubated for 20 minutes at 4 °C with stirring. The ammonium sulphate suspension 
was pelleted by centrifugation (SS-34 rotor (Sorvall), 20 minutes, 18000 rpm) and
55
the supernatant discarded. The pellet was resuspended in 200 ml buffer D2 and was 
loaded onto a nickel-chelating column (HiTrap chelating HP 5 ml) equilibrated in 
buffer D3 with 40 mM imizadole. After washing o ff unbound material drRecD2 was 
eluted with a step gradient from 40 mM to 400 mM imizadole in buffer D3. Eluted 
fractions from the column were analysed by SDS-PAGE and those containing 
JrRecD2 were pooled. The pooled fraction was diluted in buffer D4 until the 
conductivity was between 5 and 10 mS cm ' 1 and was loaded onto a heparin column 
(HiTrap heparin HP 5 ml) equilibrated in buffer D4 with 50 mM sodium chloride. 
After washing away unbound material drRecD2 was eluted with a 10 column 
volume linear gradient from 0.05 -  1.5 M sodium chloride in buffer D4. The 
fractions from the column were analysed by SDS-PAGE and those containing 
drRecD2 were pooled. The pooled fraction was diluted in buffer D4 until the 
conductivity was between 5 and 10 S cm ' 1 and was loaded onto a Mono Q column 
(HR 5/5) equilibrated in buffer D4 with 50 mM sodium chloride. After washing 
away unbound material drRecD2 was eluted with a 10 column volume linear 
gradient from 50 -  500 mM sodium chloride in buffer D4. The fractions from the 
column were analysed by SDS-PAGE and those containing pure drRecD2 were 
pooled. The pooled fraction was dialysed against 4 L o f buffer D5 over night at 4 °C. 
Aliquots o f  the drRecD2 were frozen in liquid nitrogen and stored at -80 °C.
2.4.2.3 Seleno-methionine Deinococcus radiodurans RecD2
Seleno-methionine drRecD2 was purified as described for wild-type drRecD2, but 
with 10 mM BME added to the buffers. A fast flow nickel-chelating column (FF 
chelating column 5 ml) was used instead o f the HiTrap chelating column.
2.4.2.4 E.coli RecD
E.coli RecD was purified as described by Dillingham et al. (Dillingham et al. 2003).
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2.4.2.5 Small scale purification of proteins fused to either 
MxeGryAi or MthR\RM
The pellet from a 200 ml expression culture was resuspended in 2 ml buffer 12 and 
sonicated. The soluble fraction was clarified by centrifugation (SS-34 rotor (Sorvall), 
20 minutes, 14000 rpm) and was incubated for 1 hour at room temperature with 50 
pi chitin bead slurry (New England Biolabs) equilibrated in buffer II. The chitin 
beads were pelleted (Hyspin 16K (Anachem), 1000 rpm 2 minutes) and the 
supernatant discarded. The beads were washed in buffer 11. Any intein fusion protein 
bound to the beads was induced to cleave o ff the target protein by suspending the 
beads in 100 pi buffer 12 for 1 hour at room temperature. The beads were pelleted by 
centrifugation (Hyspin 16K (Anachem), 1000 rpm 2 minutes) and the supernatant 
and all the other steps o f the purification were analysed by SDS-PAGE.
2.4.2.6 Large scale purification of proteins fused to either 
MxeGryAi or MthRlRM
These purifications were carried out as described in the IMPACT-TWIN system 
manual (New England Biolabs). The chitin column comprised a 10 ml C 10/10 
column containing chitin beads (New England Biolabs).
The cell pellets from three 1 L (or fifteen 200 ml) cultures were resuspended in 50 
ml buffer 12 and lysed under pressure using a homogeniser (Stansted). The soluble 
fraction was clarified by centrifugation (SS-34 rotor (Sorvall), 20 minutes, 18000 
rpm) and loaded onto the chitin column equilibrated in buffer II at room 
temperature. The chitin column was washed with 5 column volumes o f  buffer 11 
before being equilibrated with 5 column-volumes o f  buffer 12 and incubated 
overnight at room temperature to induce intein cleavage. The target protein cleaved
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from the intein was eluted with buffer 12 and the fractions analysed by SDS-PAGE. 
The chitin column was washed with buffer 14 to remove the intein bound to the 
chitin. The fractions containing the target protein were pooled and either aliquots 
were frozen in liquid nitrogen and stored at -80 °C or, if  the protein was to be used 
for intein-mediated protein ligation, was immediately mixed with the ligation 
partner.
2.4.2.7 Large scale purification of proteins fused to SspDNABi
Purification was carried out as described in the IMPACT-TWIN system manual 
(New England Biolabs). The chitin column comprised a 10 ml C 10/10 column 
containing chitin beads (New England Biolabs). Buffer 13 and the chitin column 
were pre-chilled to 4 °C.
The cell pellet from three 1 L cultures was resuspended in 50 ml buffer 13 and lysed 
under pressure using a homogeniser (Stansted). The soluble fraction was clarified by 
centrifugation (SS-34 rotor (Sorvall), 20 minutes, 18000 rpm) and loaded onto the 
chitin column equilibrated in buffer 13 at 4 °C. The chitin column was washed with 5 
column volumes o f  buffer 13 before being equilibrated with 5 column volumes o f  
buffer II and incubated overnight at room temperature in order to induce intein 
cleavage. The target protein cleaved o ff the intein was eluted with buffer II and the 
fractions analysed by SDS-PAGE. The chitin column was washed with buffer 14 to 
remove the intein bound to the chitin. The fractions containing the target protein 
were pooled and aliquots were frozen in liquid nitrogen and stored at -80 °C.
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2.4.3 Ligation of intein prepared polypeptides
Ligation o f intein prepared polypeptides was carried out as described in the 
IMPACT-TWIN manual (New England Biolabs). The equimolar amounts o f  protein 
were mixed and were concentrated to 80 pM in the ligation buffer (20 mM Tris/HCl 
pH 7.0, 500 mM sodium chloride, 25 mM MESNA, 1 mM EDTA). The concentrated 
protein mix was incubated overnight at 4 °C or at room temperature and analysed by 
SDS-PAGE.
2.4.4 Protein/protein complex analysis by gel-filtration 
chromatography
Purified proteins were mixed with a molar excess o f the smaller moiety, 
concentrated to less than 3 ml and purified on a Superdex S200 or S75 gel filtration 
column equilibrated in buffer GF (20 mM Tris/HCl pH 7.5, 100 mM sodium 
chloride, 1 mM EDTA, 1 mM DTT). Fractions were analysed by SDS-PAGE.
2.4.5 Dynamic light scattering
Dynamic light scattering was performed using a Zeta-sizer Nano series (Malvern) 
instrument according to the manufacturer’s instructions. 1 ml o f  protein at a 
concentration o f  1 mg/ml in DLS buffer (20 mM Tris/HCl pH 7.5, 100 mM sodium 
chloride, 1 mM EDTA, 1 mM DTT) was used. The results were analysed using the 
software supplied.
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2.4.6 Identification of proteins by mass spectrometry
Proteins were purified by SDS-PAGE and the band to be identified excised and 
suspended in 20 pi o f water. Proteins were then identified by peptide mass mapping 
at the Aberdeen Proteome Facility.
2.5 Biochemical assay methods
Each experiment was repeated at least three times and the mean value taken as the 
result. The error was taken as the standard deviation o f the mean, and where 
appropriate is plotted as error bars on graphs.
2.5.1 DNA substrates
2.5.1.1.1 The 5’-tailed duplex substrate
The 5’-tailed duplex comprised oligonucleotide 1 (0 1 ) and oligonucleotide 2 (0 2 )  
(see Figure 2.2). Unless otherwise stated this is the substrate referred to as the 5 ’- 
tailed duplex substrate. The duplex part o f the substrate is 20 bp long and the 5 ’ tail 
is 1 2  nt long.
0 1  3 '  CAGCTACACGTATGATGCCG 5 '
0 2  5 '  TACAGCTACCTAGTCGATGTGCATACTACGGC 3 '
Figure 2.2. The 5’-taiIed duplex substrate
If the text specifies a tail length, then 0 2  was modified to make the 5 ’ tail either 10 
or 8  nucleotides long.
The 40bp 5 ’-tailed duplex substrate comprises oligonucleotide 3 (0 3 ) and 
oligonucleotide 4 (0 4 ) (see Figure 2.3).
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0 3  3 '  CAGCTACACGTATGATGCCGAGTCGCTAAGCTTACGGTAC 5 '
0 4  5 ' TACAGCTACCTAGTCGATGTGCATACTACGGCTCAGCGATTCGAATGCCATG 3 '
Figure 2.3. 40bp 5’-tailed duplex substrate
2.5.1.1.2 The ssDNA substrate
The ssDNA substrate comprised a 15nt poly d-thymine substrate (pdT15).
2.5.1.1.3 The dsDNA substrate
The dsDNA substrate comprised oligonucleotide 1 (O l) and oligonucleotide 5 (0 5 )  
(see Figure 2.4). Unless otherwise specified in the text this is the substrate referred to 
as the dsDNA substrate.
0 1  3 '  CAGCTACACGTATGATGCCG 5 '
0 5  5 '  GTCGATGTGCATACTACGGC
Figure 2.4. The dsDNA substrate
2.5.2 Radio labelling of DNA
DNA was radio-labelled by the incorporation o f  adenosine [y-32P] triphosphate using 
T4 polynucleotide kinase (New England Biolabs). Labelled oligonucleotides were 
purified using a Micro Biospin P6  or P30 spin column (Biorad). The concentration 
o f radio-labelled oligonucleotide was determined, based on the counts per minute o f  
radioactivity compared to a calibration curve o f known concentrations o f  adenosine
32[y- P] triphosphate. Radio-labelled oligonucleotide was mixed with the same cold 
oligonucleotide in a 1:20 ratio to produce a stock o f  5 % labelled oligonucleotide. If 
the DNA substrate comprised two oligonucleotides, one oligonucleotide was radio­
labelled. The 5 % radio-labelled oligonucleotide was annealed with the appropriate
complementary oligonucleotide in equimolar amounts.
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2.5.3 ATP-hydrolysis assay
2.5.3.1 Experimental setup
Coupled ATP hydrolysis assays were carried out as described previously (Pullman et 
al. 1960; Tamura and Gellert 1990). The ATPase being assayed converts ATP to 
ADP and then pyruvate kinase transfers a phosphate group from 
phosphoenolpyruvate to the ADP thus regenerating the ATP making this assay 
continuous with constant ATP concentration. The resulting pyruvate is converted to 
lactate via the oxidation o f NADH to NAD+ by lactate dehydrogenase. NADH 
absorbs light o f wavelength 340 nM and so the rate o f loss o f NADH can be 
measured spectrophotometrically (see Figure 2.5).
A )
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ATP-<v >  Pyruvate
VPyruvate 
I  kinase,AC
L ac tate 
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Figure 2.5. The coupled ATP-hydrolysis assay
A) The coupling of ATP hydrolysis to the oxidation of NADH in order to measure the rate of ATP 
hydrolysis.
B) A representation of a typical spectrophotometric trace of an assay from the spectrophotometer.
The rate o f loss ofN A D H  can be calculated using Equation 2.1.
d A 3 4 o = e ( d [ N A D H ] ) l
Where dA340 = rate of change of absorbance UV light of 340 nM wavelength, e  = the absorbance 
coefficient of NADH, d[NADH] = rate of change of NADH concentration and 1 = path length of the 
spectrophotometer.
Equation 2.1.
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As the rate o f NADH oxidation to NAD+ is equal to the rate o f ATP hydrolysis to 
ADP by the ATPase, the concentration o f  ATP hydrolysed per second can be 
calculated using Equation 2.2.
dA340/6250 = d[ATP] M/sec
Where 1 = 1 cm, and e = 6250 M'1 cm'1 
Equation 2.2.
The rate o f ATP hydrolysis, (v) (the moles o f  ATP hydrolysed per mole o f  ATPase 
per second) can be calculated using Equation 2.3.
d[ATP]/[ATPase] = v (s'1)
Equation 2.3.
All the ATP hydrolysis assays in this thesis used 5 nM protein and various 
concentrations o f pdT60 or various concentrations o f ATP in ATPase buffer (50 mM 
Tris acetate pH7.5, 100 mM sodium chloride, 10 mM magnesium chloride, 0.11 
mg/ml NADH, 2 mM phosphoenolpyruvate, 20 U lactate dehydrogenase, 35 U 
pyruvate kinase). The reaction was initiated by the addition o f protein and the A 340 
was measured using a spectrophotometer (UV 1601, Shimadzu).
The rate o f ATP hydrolysis, v, was determined at various ATP concentrations ([S]) 
under saturating pdT60 concentrations. Values for kcat (the turnover number), and 
K a t p  (the concentration o f ATP when the rate o f  ATP hydrolysis, v, is equal to half 
the value o f  kcat) were determined by fitting these data to the Michaelis-Menten
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equation (Michaelis and Menten 1913) (see Equation 2.4). These data were fitted 
using Prism 4 (GraphPad software) by non-linear regression.
v = (Vmax[S])/(Km + [S])
Where Km = KATP and Vmax = kcat[ATPase]0 
Equation 2.4.
In order to determine K Dn a , the rate o f ATP hydrolysis, v, was determined at various 
DNA concentrations ([S]) under saturating ATP concentrations. Values for kcat (the 
turnover number), and K Dn a  (the concentration o f  DNA when the rate o f  ATP 
hydrolysis, v, is equal to half the value o f kcat) were determined by fitting these data 
to the Michaelis-Menten equation as done for determining K At p
2.5.4 DNA-binding assay (gel-mobility shift assay)
2.5.4.1 Experimental setup
DNA-binding assays were carried out using protein diluted in binding buffer (20 
mM Tris acetate pH7.5, 100 mM sodium chloride, 10 mM magnesium chloride, 0.1 
mg/ml BSA, 10 % v/v glycerol, 0.1 mM DTT). The protein was incubated at room 
temperature for 5 minutes, radio-labelled DNA substrate was added and the mixture 
further incubated for 10 minutes. DNA binding was analysed using native 
polyacrylamide gels run in 1 x TBE buffer at 20 mA for 15 minutes at room 
temperature. The gels were dried and exposed to phosphor-imager screens 
(Molecular Dynamics). Quantitive analysis was done using a phosphor-imager and 
ImageQuant software (Molecular Dynamics). The amounts o f  free and bound DNA  
were quantified as counts o f radioactivity for each lane. The % DNA substrate bound 
was calculated as being the number o f  counts o f  bound DNA substrate divided by
64
the total counts o f both the bound and free DNA substrate. The % DNA substrate 
bound (Y) was plotted against protein concentration (X) and a value for Kd was 
obtained by fitting the data to Equation 2.5. These data were fitted using Prism 4 
(GraphPad software) by non-linear regression.
Y = (YmaxX)/(Kd + X)
Where Ymax = 100 (% DNA bound) and Kd = X when Y =1/2 Ymax 
Equation 2.5.
For all the DNA-binding assays 1 nM DNA substrate was used. For details o f  
protein concentrations see figures in the results section.
2.5.4.2 Theory relating to the calculation of Kd
In the DNA binding assays the Kd is taken as equal to the protein concentration
required to bind 50% o f the DNA substrate. This can be equated to Kd as defined by:
[Free Protein] [Free DNA]
[Protein/DNA complex]
If the DNA concentration used in the assays is significantly lower than the Kd o f  the
protein for the DNA substrate, then the amount o f  protein in the protein/DNA
complex will be negligible compared to the amount o f free protein. Therefore [Free
Protein] s  [Total Protein] meaning the Kd can be now described as:
[Total Protein] [Free DNA]
1 \ .  j  “ “
[Protein/DNA complex]
When 50% o f  the DNA is bound in the protein/DNA complex, then:
[Free DNA]
[Protein/DNA complex]
Therefore Kd = [Total Protein] when 50% o f  the DNA is bound in the protein/DNA  
complex. This means the Kd is equivalent to the amount o f protein required to bind
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50% o f the DNA. This is not ideal and will not provide as accurate a Kd as 
isothermal calorimetry. This is because the assumption has to be made that the free 
DNA and protein/DNA complex is at equilibrium, but this equilibrium will be 
disturbed when the complex is separated from the free DNA and free protein in the 
electrophoresis gel. However, the assay is very useful to compare the relative DNA  
binding activities o f  different proteins under identical conditions.
2.5.5 Isothermal calorimetry (ITC)
In this thesis ITC was used to determine the affinity o f  protein-DNA interactions. All 
calorimetric experiments performed in this thesis were carried out using a Microcal 
VP-ITC instrument and all the experiments were performed as described in the 
manufacturers manual.
2.5.5.1 Sample preparation
The protein and DNA used in the experiment were dialysed into ITC buffer (50 mM 
Hepes pH 7.5, 100 mM sodium chloride and 10 mM magnesium chloride) overnight 
at 4°C. A change o f  buffer is necessary to remove DTT, Tris buffer and EDTA. DTT 
and Tris buffer can cause erroneous background signals due to the oxidation o f  DTT 
and the heat o f ionisation o f Tris buffer. EDTA chelates magnesium and will alter 
the magnesium concentration. Protein and DNA concentrations were determined 
spectrophotometrically and were degassed.
2.5.5.2 Experimental setup
The main part o f the ITC instrument comprises two separate identical enclosed cells. 
One is a reference cell filled with double distilled, filtered and degassed water; the 
other is a reaction cell in which the two reactants are mixed. These two cells are
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surrounded by two temperature-constant shields at the same temperature as the cells, 
in order to minimise heat exchange between the cells and the external surroundings.
In this thesis the protein was in the reaction cell and the DNA substrate was 
introduced into the reaction cell via a spinning syringe that homogenises the 
reactants. If there is an enthalpy change resulting from the interaction o f the protein 
and the DNA substrate, the change in temperature o f the reaction cell is detected, 
and energy is either supplied or removed from the reaction cell in order to take the 
temperature o f the reaction cell back to that o f  the reference cell. The amount o f  
energy that is supplied to the reaction cell is plotted against time. Further injections 
o f the DNA substrate into the reaction cell occur and the amount o f energy supplied 
to the cell measured and plotted. The integrated area under each peak is equal to the 
amount o f heat evolved or absorbed during that injection. The integrated values o f  
the peaks are plotted against time. A binding isotherm curve can be fitted by the 
least-squares method using the Origin software supplied with the ITC instrument and 
values for Ka and N are output. Ka is defined in Equation 2.6.
Ka= [protein/DNA complex]/[protein][DNA]
Equation 2.6.
The Ka can be used to calculate the inverse IQ. N can be used to calculate the 
number o f molecules o f  protein bound to one DNA molecule, N, where N=N~l. If, as 
explained in Chapter 4 (see section 4.3.2.1), two binding events with different 
equilibrium constants occur then a bipartite-isotherm binding curve is observed. The 
two parts o f the curve each gives values for Ka and N, Kai and Ni for the first 
binding event and and N2 for the second-binding event. In this case the number
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o f molecules o f protein bound to one DNA molecule o f  the first and second binding 
events are Nj and N2 respectively, where Ni = N f 1 and N2 -  (N 1+N2)’1.
2.5.5.3 Experimental parameters
The experimental parameters for all the ITC experiments are listed in Table 2.5.
Table 2.5. Experimental parameters for the ITC experiments
Parameter Value
Shield, reference cell and reaction cell 
temperature
30 °C
Number o f injections 30
Injection volume 1st = 2 pi
2nd -  30th = 10 nl
Injection spacing 300 s
Syringe mix speed 310 rpm
Protein concentration 8 pM
DNA substrate 
concentration
pdT lengths 8-15 80 pM
pdT lengths 20-30 50 pM
The first injection o f the ITC experiment is a small volume o f  2 pi to compensate for 
any losses or dilution-effects from the tip o f the syringe during loading o f the DNA  
into the syringe. Data from the first injection was removed during data analysis.
2.5.6 Helicase assay (strand-displacement assay)
Helicase assays were performed using the 5 ’-tailed duplex substrate described earlier 
in section 2.5.1.1.1. Helicase time course assays were carried out at 30 °C in helicase 
buffer (20 mM Tris acetate pH 7.5, 100 mM sodium chloride, 10 mM magnesium
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chloride, 0.1 mg/ml BSA, 0.1 mM DTT) using 1 nM protein and 1 nM DNA 
substrate unless otherwise stated. The protein and the DNA substrate were incubated 
in the helicase buffer at 30 °C for 5 minutes before adding ATP to a final 
concentration o f 1 mM to start the reaction. At each time point an aliquot was 
removed and the reaction was stopped with quenching buffer (0.2 % w/v SDS, 40 
mM EDTA, 10 % w/v glycerol, 0.1% w/v bromophenol blue). DNA unwinding was 
analysed using SDS polyacrylamide gels run in SDS-PAGE buffer at 80 V for 60 
minutes at room temperature. The gels were dried and exposed to phosphor-imager 
screens (Molecular Dynamics). Quantitive analysis was done using a phosphor- 
imager and ImageQuant software (Molecular Dynamics). The amount o f duplex 
DNA and amount o f ssDNA were determined for each lane and the % o f the DNA  
substrate unwound was calculated. For the purposes o f  this thesis Un is the time 
taken by the protein to unwind 50 % o f the DNA substrate when 1 nM protein and 1 
nM DNA substrate are used.
The % DNA substrate unwound (Y) was plotted against time (X) and a value for ti/2 
was obtained by fitting the data to Equation 2.7. These data were fitted using Prism 4 
(GraphPad software) by non-linear regression.
Y = (YmaxX)/(t1/2 + X)
Where = 100 (% DNA unwound) and t1/2= X when Y =1/2 Ymax
Equation 2.7.
2.5.7 Processivity helicase assay
Processivity assays were performed using the 5 ’-tailed duplex substrate and the 40bp 
5’-tailed duplex substrate described earlier in section 2.5.1.1.1
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The protein and DNA substrate were incubated in processivity buffer (20 mM Tris 
acetate pH7.5, 100 mM sodium chloride, 10 mM magnesium chloride, 0.1 mg/ml 
BSA, 0.1 mM DTT) using 1 pM protein and 1 nM DNA substrate. The reaction was 
started by the addition o f start buffer (1 mM ATP, 50 pM heparin (final 
concentrations)). The assays were analysed as described for the helicase assay earlier 
in section 2.5.6.
2.6 X-ray crystallography methods
2.6.1 DNA substrate S1
DNA SI comprised oligonucleotide 6 (0 6 ) and oligonucleotide 7 (0 7 ) forming a 5 ’- 
tailed duplex DNA (see Figure 2.6). The duplex DNA was 10 base pairs and the 5 ’ 
tail was pdT7.
0 6  3 '  CGTCACGAGC 5 '
0 7  5 '  TTTTTTTGCAGTGCTCG 3 '
Figure 2.6. DNA SI
DNA SI was purified, after annealing o f  0 6  and 0 7 , on a resource Q column. DNA  
SI in annealing buffer (50 mM phosphate buffer pH 6.8, 100 mM potassium 
chloride, 10 mM magnesium chloride) was loaded onto a resource Q column 
equilibrated with 50 mM phosphate buffer pH 6.8 , 100 mM potassium chloride. 
After washing away unbound material DNA SI was eluted with a 30 column-volume 
linear gradient o f 0.05 -  1 M potassium chloride. DNA SI was exchanged into water 
using a NAP25 drip column, concentrated using a centricon (Micon) with an 
appropriate molecular weight cut-off and stored at -20 °C.
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2.6.2 Crystallisation
Crystallisation trials for protein and protein/DNA complex crystals were set up using 
the high-throughput Mosquito robot (TTP Lab-Tech) using the sitting drop method 
(100 nl drop size), commercially available sparse matrix screens and 96-well sitting- 
drop high-throughput plates (Axygem). Crystallisation trials were also set up by 
hand using the hanging drop vapour diffusion method (2 pi drop size) and sparse 
matrix screens in 24 well VDX plates (Hampton Research) with plastic cover slips 
(Henleysmed). The screens used are listed below in Table 2.6.
Table 2.6. Crystallisation screens
Supplier High-throughput
screens
Screens set up by hand
Hampton Research Crystal screen HT 
Index screen HT 
Salt RX screen HT
Crystal screen 
Crystal screen 2 
Natrix
Molecular Dimensions Clear strategy screen I 
Clear strategy screen II 
Structure screen I & II 
Memsys & Memstart
Jena Biosciences JBScreen classic I 
JBScreen classic II
Emerald Biosciences Wizard screen HT
Potential crystallisation conditions were optimised using grid screens around the lead 
condition. Protein/DNA complex crystals were grown in 2 pi hanging drops using
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the vapour diffusion method in 24 well VDX plates (Hampton Research) with plastic 
cover slips (Henleysmed).
2.6.2.1 Micro-seeding
Protein/DNA complex crystals were crushed using a glass pipette, the end o f which 
had been melted into a ball shape, or by using a crystal-probe (Hampton Research). 
The resulting solution was diluted by 10, 100 and 1000 in the mother liquor and 0.5 
pi o f  a diluted stock was added to a 2 pi hanging drop.
2.6.3 Data collection
Data was collected from crystals using either the in-house copper rotating anode X- 
ray source (Rigaku) with a MAR 345 scanner (MAR Research), or at the European 
Syncotron Radiation Facility (ESRF) in Grenoble, or at the Syncotron Radiation 
Source (SRS) in Daresbury. For all data collections, 1° o f data was collected at 0°, 
45° and 90° o f phi. The images were autoindexed using MOSFLM (CCP4 suite 
(CCP4 1994)) and the space group and unit cell were determined. The strategy 
option o f MOSFLM was used to determine the degrees o f Phi to collect the dataset 
with the highest completeness.
2.6.3.1 Room temperature
Crystals were mounted in quartz capillaries between layers o f  mother liquor. The 
capillary ends were sealed with wax. The capillary was mounted onto a goniometer 
head for data collection.
2.6.3.2 100 °K
Crystals were cryoprotected using a sequential soaking method. Crystals were placed 
in 5 pi 1.1 x mother liquor. 5 pi 1.1 x mother liquor with 10% MPD was added to
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the drop and was mixed before removing 5 pi, leaving the crystal in 5 pi o f 1.1 x 
mother liquor with 5 % MPD. This was repeated by adding 5 pi 1.1 x mother liquor 
with 15 % MPD, leaving the crystal in 5 pi 1.1 x mother liquor with 10% MPD. This 
process was repeated with 5 % increments o f  MPD until the crystal was in 1.1 x 
mother liquor with 20 % MPD. Crystals were flash frozen in the cryo-stream 
(Oxford Cryosystems) o f the in-house X-ray set.
2.6.4 Data processing
All datasets were processed using default settings except where stated.
2.6.4.1 Integration and scaling
All the data sets o f the short c-axis were processed using MOSFLM. The space 
group and unit cell were determined as described earlier in this section. The unit cell 
was refined and the mosaicity determined using four 5° sections o f  data 30° apart. 
The whole dataset was then integrated as a single output reflection file. The data was 
scaled using SCALA (CCP4 suite (CCP4 1994)). Data was merged during scaling 
except for derivative datasets where Friedel pairs were kept separate.
All the datasets collected from crystals with the long c-axis were processed using 
XDS (Kabsch, W). The space group and unit cell were determined using three 10° 
sections o f  data 30° apart. The whole dataset was then integrated using these 
parameters. XDS provides an un-scaled statistical output that can be used to check 
the quality o f the processed data, as well as a refined unit cell. The refined unit cell 
was then used to reprocess the whole dataset and the process repeated until the 
refined unit cell matched the input unit cell. The data was then scaled into a single
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data file using XSCALE (Kabsch, W). Data was merged during scaling except for 
derivative datasets where Friedel pairs were kept separate.
2.6.4.2 Phase determination
Native and derivative datasets were scaled together using SCALEIT (CCP4 suite 
(CCP4 1994)).
Heavy atom positions were searched for using the automatic functions o f the 
auto. SHARP and SOLVE programmes (Bricogne et al. 2003; Terwilliger and 
Berendzen 1999). Difference Patterson maps were calculate using the FFT 
programme (CCP4 suite (CCP4 1994)) and peaks searched for manually.
Potential heavy atom positions were refined in SHARP (Bricogne et al. 2003), which 
also calculated experimental electron density maps using the resulting phasing 
information. Coherent and protein-like electron density was then looked for 
manually.
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2.7 Buffer formulations
2.7.1 Cell culture
Luria broth (LB) As described by Sambrook et al. 
(Sambrook et al. 1989). For plating 
purposes 0.01 g/ml agar was added
Seleno-methionine media (per litre) 0.5 g alanine, 0.58 g arginine HC1,
0.41 g aspartic acid, 0.03 g cystine 
0.67 g (0.75 g) glutamic acid (Na)
0.33 g glutamine, 0.54 g glycine 
0.06 g histidine 0.23 g isoleucine 
0.23 g leucine 0.23, 0.42 g lysine HC1 
0.13 g phenylalanine, 0.10 g proline
2.08 g serine, 0.24 g threonine 
0.17 g tyrosine, 0.23 g valine 
0.50 g adenine, 0.67 g guanosine 
0.17 g thymine, 0.50 g uracil
1.50 g sodium acetate, 1.50 g succinic acid 
0. 75 g ammonium chloride
1.08 g Sodium hydroxide
8.0 g (10.5 g) di-potassium hydrogen 
orthophostphate (trihydrate)
10 x seleno-methionine media supplement (per 
200 ml)
Added to sterile seleno-methionine media 
before growing culture
20g glucose
0.5g magnesium sulphate 7-hydrate
8.35mg iron sulphate
16.6ul cone sulphuric acid
10 mg thiamine
100 mg seleno-methionine
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Where appropriate 100 pg/ml ampicillin, 34 pg/ml chloramphenicol and 100 pg/ml 
spectinomycin were included (final concentrations).
2.7.2 Gel electrophoresis
2.7.2.1 Loading buffers
SDS-PAGE loading buffer (5x) 7% v/v BME 
10% w/v SDS
0.5 % w/v bromophenol blue 
20% glycerol
Agarose gel loading buffer (1 Ox) 0.25 % w/v bromophenol blue 
50% w/v sucrose 
10 mM Tris/HCl pH 8.0
2.7.2.2 Running buffers
SDS-PAGE buffer (5x stock), (per litre) 72g glycine
15 g Tris base
5.0 g SDS
TBE (5x) (per litre) 54.0 g Tris/HCl base
27.5 g boric acid
20 ml 0.5 M EDTA
2.7.2.3 Staining/destaining
Coommassie brilliant blue stain. 25 % v/v methanol 
8 % v/v acetic acid 
0.2 % w/v Coomassie brilliant blue
Destain 25 % v/v methanol 
8% v/v acetic acid
Ethidium bromide stain 0.1 mg/ml in water
76
2.7.3 Protein purification
D1 20 mM Tris/HCl pH 7.5 
500 mM sodium chloride 
100 pM phenyl methyl sulfonyl fluoride 
10 pM leupeptin 
1 pM pepstatin
D2 20 mM Tris/HCl pH 7.5 
40 mM imizadole
D3 20 mM Tris/HCl pH 7.5 
500 mM sodium chloride
D4 20 mM Tris/HCl pH 7.5 
1 mM EDTA 
1 mM DTT
D5 20 mM Tris/HCl pH 7.5 
100 mM sodium chloride 
1 mM EDTA 
1 mM DTT
11 20 mM Tris/HCl pH 7.0 
500 mM sodium chloride 
1 mM EDTA
12 20 mM Tris/HCl pH 7.0 
500 mM sodium chloride 
50 mM MESNA 
1 mM EDTA
13 20 mM Tris/HCl pH8.5 
500 mM sodium chloride 
1 mM EDTA
14 20 mM Tris/HCl pH 8.0 
500 mM sodium chloride 
1% (w/v) SDS
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3 An attempt to make Bacillus stearothermophilus 
PcrA mutants and an Archaeoglobus fulgidus 
PCNA dimer using the IMPACT-TWIN intein system 
3.1 Introduction
3.1.1 Summary
This chapter describes the attempt to create mutants o f the Bacillus 
stearothermophilus PcrA (ZwPcrA) helicase and to create a dimer o f  the 
Archaeoglobus fulgidus proliferating cell nuclear antigen (q/PCNA). For both o f  
these projects modified inteins were to be used to produce the required final protein 
products. Therefore this chapter first explains how the modified inteins work and 
then goes on to describe the work done with foPcrA and q/PCNA.
3.1.2 Inteins
Protein expression and purification can often be tricky with many problems to 
overcome. A given protein may be toxic to the host organism. At other times it may 
be desirable to make a fusion protein, but either it cannot be cloned or w ill not 
express. Inteins are proteins that have the ability to form reactive polypeptides that 
can then be ligated together. This chapter describes efforts to use inteins to express a 
toxic protein, a foPcrA mutant, and a covalently linked dimer o f q/PCNA.
Inteins are naturally occurring protein elements that have the ability to splice 
themselves out o f  proteins. The IMPACT-TWIN system is an expression kit that 
fuses a modified intein and chitin-binding domain (CBD) to a target protein (New
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England Biolabs; Watanabe et al. 1994). The resulting fusion protein can be purified 
by affinity chromatography using a chitin column. The target protein is eluted by 
inducing a specific intermolecular proteolysis by the intein that results in the target 
protein being cleaved off the column-bound intein.
The IMPACT-TWIN system can also be used to create two reactive polypeptides for 
intein-mediated protein ligation (IPL) (see Figures 1.1-1.3) (Dawson et al. 1994; 
Evans et al. 1998, 1999a, b; Evans and Xu 1999; Mathys et al. 1999; Muir et al. 
1998; Severinov and Muir 1998; Tam et al. 1995; Xu et al. 1999). This technique 
allows the ligation o f two polypeptides in vitro , which is useful for making proteins 
that cannot be made genetically. For example proteins that are toxic in vivo can be 
over expressed as two non toxic fragments and ligated together in vitro. If a protein 
comprising two domains, PI and P2, is toxic to E.coli when expressed as full length 
protein, the two domains can be prepared separately and then ligated together in 
vitro. PI is cloned into either the pTWINl or the pTWIN2 expression plasmid in 
such a way that it is fused via its C-terminus to a modified intein derived from either 
the Mycobacterium xenopi GyrA gene {MxeGyrAi) or from the Methanobacterium  
thermoautotrophicum RIR1 gene (M//zRIRli) (Evans et al. 1998, 1999b; Iwai and 
Pluckthun 1999; Telenti et al. 1997) (see Figure 3.1 A). P2 is cloned into pTW INl in 
such a way that it is fused via its N-terminus to a modified intein derived from the 
Synechocystis species DnaB gene (SspDnaBi) (Mathys et al. 1999; Wu et al. 1998) 
(see Figure 3 .IB).
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A)
SspDnaBi [M C S [ MxeGryAi/MthRIRH | 0 ^ |
MxeGryAi/MthRIRI i | g » |
[MCS I MxeGryATSspDnaBi
SspDnaBi
Figure 3.1. Cloning PI and P2 into pTW INl/pTW IN2
A) The PI gene fragment is fused via its C-terminus to the MteGyrAi mini intein (MxeGyrAi) in 
pTWIN 1, or M /jRIRI mini intein in pTWIN2 (M//?RIRli).
B) The P2 gene fragment is fused via its N-terminus to the SspDnaBi mini intein (SspDnaBi) in pTWIN 1.
The only requirement for intein mediated protein ligation is that the N-terminal 
residue o f P2, the residue to be ligated, must be a cysteine residue and the C-terminal 
residue o f PI must have a thiol group attached (Evans et al. 1998; New England 
Biolabs). PI is cleaved from the chitin-bound intein by addition of the thiol 2- 
mercaptoethanesulfonic acid (MESNA), allowing the purification o f  PI with a C- 
terminal thiol ester (see Figure 3.2). P2 is cleaved from the chitin-bound intein by 
lowering the pH and raising the temperature allowing the purification o f  P2 with an 
N-terminal cysteine (see Figure 3.2).
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N
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Figure 3.2. Strategy to purify and ligate PI and P2 protein fragments to make the P1-P2 
fusion protein
A)The Pl-MceGryAi fusion protein is loaded onto a chitin column at pH 7.0 and 4 °C. The MreGryAi is 
induced to cleave off the PI by the addition of a thiol (MESNA) and PI is eluted from the column.
B)The SspDnaBi-P2 fusion protein is loaded onto a chitin column at pH 8.5 and 4 °C. The SspDnaBi is 
induced to cleave off P2 by lowering the pH to 7.0 and raising the temperature to 22 °C and P2 is eluted 
from the column.
C) The PI and P2 fragments are concentrated and mixed allowing them to ligate together to form the final 
P1-P2 protein.
PI and P2 are concentrated and mixed allowing the thiol o f  PI to react with the 
cysteine o f  P2 to form a peptide bond between PI and P2 (see Figure 3.3A, B and C) 
(Dawson et al. 1994; Tam et al. 1995). The thiol attached to the C-terminal o f  PI 
can dissociate in a reversible fashion, but this does not effect the rate o f  formation o f  
P1:P2, which is independent o f the free thiol concentration (see Figure 3.3 D and 
Equation 3.7.).
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SH
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D) i-»>« .nm  i , n .  A .   _______* . /-»r-»i i 3^P1:SRH + P2 P1:P2* + SRH P1:P2 + SRH
k2 |k-2
P1+SRH + P2
Figure 3.3. Peptide bond formation between PI and P2
A) A reversible thiol/thiol ester exchange gives a thiolester linked intermediate. B) An irreversible 
nucleophilic rearrangement occurs resulting in C) A peptide bond between PI and P2. D) The overall 
reaction.
Parts A), B) and C) are based on a figure from (New England Biolabs)
The overall rate o f formation of PI :P2 can be expressed as:
Equation 3.1 d [ P l : P 2
dt
—  can be expressed as:
*-i
Equation 3.2
Or when re-arranged as:
k, [P\ :P2*][SRH]  
k_x ”  [P\ :SRH][P2\
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Equation 3.3 [ P 1 : P 2 * ]  =
kx[P  1 :  SRH][P  2 ]  
k, [SRH]
Substituting equation 1.3 into 1.1 gives:
Equation 3.4
d [ P l : P 2 ]  k3kx [ P I :  SRH] [P 2 ]
eft
can be expressed as
-2
Equation 3.5
Or when rearranged as
Equation 3.6
k2 [Pl :SRH][P2]  
k_2 ~ [Pl][SRH][P2]
[ P I : SRH]  =
£2 [/>!][£/?//]
-2
Substituting equation 3.6 into 3.4 gives:
Equation 3.7
4 P 1 : P 2 ]  i t 3  ^  [Pl ]k2 [ P I ]  [SRH] kxk2k 3  [ P 2 ] [ P 1 ]
dt k_x[SRH]k_ k_xk_
Equation 3.7 demonstrates that the rate o f  formation o f P1:P2 is not dependent on 
the concentration o f  the thiol SRH.
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3.2 An attempt to make full length 
stearothermophilus PcrA from two halves
3.2.1 Introduction
Bacillus stearothermophilus PcrA (ZwPcrA) is a Superfamily one (SF1) 3 ’-5’
helicase involved in DNA repair and rolling cycle plasmid replication (Petit et a l
1998; Soultanas et al. 1999). The crystal structure o f  ZwPcrA shows that it has two
domains each o f which comprises two sub domains (Velankar et al. 1999) (see
Figure 3.4). For the purposes o f this work domains 1A and IB are referred to as
foPcrAl and domains 2A and 2B are referred to as 6sPcrA2 (see Figure 3.4).
A) B)
1A 1B 1A 2A 2B 2A
Figure 3.4. The structure of AsPcrA
The domains of 6sPcrA are coloured as follows: lA-green, IB-yellow, 2B-blue, 2A-red. bsPcrAl 
comprises domains 1A and IB. &sPcrA2 comprises domains 2A and 2B.
A) The crystal structure of foPcrA. B) A schematic representation of the crystal structure of fesPcrA. C) A 
schematic of the 6sPcrA gene.
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Like all SF1 helicases, ZwPcrA has the seven classical helicase motifs (Gorbalenya 
and Koonin 1993). Crystal structures o f 6sPcrA in complex with DNA with ATP 
analogues have been used to propose an inchworm model o f  helicase activity 
(Velankar et al. 1999). Velankar et al. propose that domains 1A and 2A (the motor 
domains) translocate along ssDNA and domains IB and 2B interact with the duplex 
DNA (via amino acids K456, T426, K419 o f  2B and K137, K138 o f IB) ahead o f  
the motor domains (Velankar et al. 1999). This interaction disrupts the structure o f  
the duplex DNA allowing separation o f the two strands (Velankar et al. 1999). This 
hypothesis is supported by biochemical evidence in that helicase activity is reduced 
when the amino acids involved with duplex interaction are mutated to alanine 
(Soultanas et al. 2000). In contrast, the 2B domain is not required for helicase 
activity in the homologous SF1 helicase Rep, instead the 2B domain appears to 
inhibits the helicase activity o f monomeric Rep (Brendza et al. 2005; Cheng et al. 
2002).
3.2.2 Aims and strategy
The aim o f this part o f the thesis was to determine the roles played in helicase 
activity by domains 2B and IB o f  foPcrA by making deletion mutants. Previous 
work has shown that faPcrA missing domain(s) 2B and/or IB is toxic to E.coli and 
the protein could not be expressed (personal communication, Wigley, D.).
The IMACT-TWIN system was used to try and create the deletion mutants. Figure 
3.5 outlines the strategy used. The aim was to separately purify two halves o f  
6sPcrA, with or without domains 2B and IB, and then ligate them together in vitro 
to form full-length ZwPcrA or bsPcrA deletion mutants.
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WxeGryAi I 
MJftRIRi
SspDnaBiSspDnaBiMxeGryAi / 
MARIRi
Figure 3.5. Strategy for creating BsPcrA deletion mutants
A) Fusion proteins to be made:
i) bsPcrA 1 -MxeGryAi/MthRIR 1 i,
ii) bsPcrA 1 A-MceGryAi/Mf/jRIR 1 i,
iii) S.s/?DnaBi &sPcrA2,
iv) SspDn aB i-6sPcrA 2A.
B) AsPcrA fragments after cleavage from inteins ready for ligation:
i) 6sPcrAl,
ii) bsPcrA 1 A,
iii) 6sPcrA2,
iv) AsPcrA 2A.
C) Products of ligated foPcrA fragments:
i) AsPcrAl + foPcrA2 = bsPcrA,
ii) AsPcrAl + AsPcrA 2A = A-sPcrA A2B,
iii) bsPcrA 1A + AsPcrA 2 = AsPcrA A IB,
iv) AsPcrA 1A + AsPcrA 2A = bsPcrA A1B2B.
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The first aim was to make a positive control by ligating two halves o f  bsPcrA 
together to make full length bsPcrA and showing that it has similar activity to the 
wild-type bsPcrA. The residues chosen to fuse with the inteins were determined by 
examining the crystal structure o f bsPcrA and deciding where would be a good point 
to split bsPcrA in two (see Figure 3.6).
Serine 288 
Threonine 289
Figure 3.6. Crystal structure of AsPcrA
Serine 288 and threonine 289 are labelled in black.
The cut point decided upon was between residues serine 288 and threonine 289, the 
reason being that these residues are located in a flexible linker that connects the two 
naturally occurring halves o f bsPcrA meaning that the secondary structure would be 
left intact and allow correct folding o f the foPcrA halves when they are fused to the 
modified inteins (see Figure 3.6). In addition intein mediated protein ligation 
requires a cysteine as the N-terminal residue o f the protein and threonine was 
thought to be a suitable amino acid to be mutated to cysteine without changing any 
properties o f the foPcrA. The domains o f  foPcrA are classified as listed below in 
Table 3.1.
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Table 3.1. Definitions of AsPcrA domains
Domain of AsPcrA Amino acids
AsPcrA 1A 1-90 and 219-288
AsPcrA IB 91-218
AsPcrA 2A 289-379 and 550-724
AsPcrA 2B 380-550
AsPcrA 1 (AsPcrA 1A and IB) 1-288
AsPcrA2 (AsPcrA 2A and 2B) T289C-724
Domains 1A and IB o f AsPcrA, (AsPcrA 1), were to be fused via its C-terminus to 
MreGyrAi or the Mf/zRIRli. Domains 2A and 2B o f  AsPcrA, (AsPcrA2), were to be 
fused via its N-terminus to 5s/?DnaBi (see Figure 3.5 A). These constructs would 
enable the purification o f two AsPcrA halves that can be ligated together to create 
AsPcrA (see Figure 3.5 B and C). Making the following additional constructs would 
allow the creation o f deletion mutants: AsPcrA domain 1A (AsPcrA 1A) fused to 
MxeGyvAil M ARIRli intein and AsPcrA domain 2A (AsPcrA 2A) fused to the 
SspDnaBi intein (see Figure 3.5 A). This would allow the following ligations: i) 
AsPcrA 1A and AsPcrA2 can create AsPcrA missing domain IB (AsPcrA A IB), ii) 
AsPcrA 1 and AsPcrA 2A can create AsPcrA missing domain 2B (AsPcrA A2B), iii) 
AsPcrA 1A and AsPcrA 2A can create AsPcrA missing domains IB and 2B (AsPcrA 
A1B2B) (see Figure 3.5 B and C).
3.2.3 Cloning and expression of frsPcrAI-MxeGyrAi and 
/>sPcrA1-MtfiRIR1i
The AsPcrA 1 encoding sequence was cloned into both pTWINl and pTWIN2 to
produce a construct with AsPcrA amino acids 1-288 cloned directly next to the
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MreGyrAi or the Mf/zRIRli intein respectively. Both the AsPcrA 1-MceGyrAi and 
AsPcrA 1 -MthRlRli fusion proteins expressed in BL21 codon 2+ E.coli, but were 
insoluble. Expression trials were carried out, to try and reduce the level of  
expression to see if  any soluble protein could be made. The expression strains BL21 
codon 2+, Tuner codon 2+, BL21 codon 2+ pLysS, and were tested at either 3 hours 
for 37 °C or overnight at 18 °C with varying amounts of IPTG. The expression trials 
revealed that the AsPcrA 1-MreGyrAi fusion protein was soluble when expressed in 
Tuner codon 2+ E.coli cells when induced with 0.2 mM IPTG for 18 hours at 18 °C, 
however this condition did not produce soluble AsPcrA 1-M/jRIRli fusion protein 
(see Figure 3.7).
A) bsPcrA 1 -MxeGryAi B) bsPcrA 1 -MthR\R\
Figure 3.7. Expression of AsPcrA 1-A/jteGryAi and AsPcrA l-A//ARIRli
A) Expression of soluble AsPcrA 1 -A/jceGyrAi fusion protein showing the whole cell extract and insoluble 
and soluble fractions. * indicates soluble AsPcrA- AfxeGyrAi protein.
B) Expression of insoluble AsPcrA l-A//ARIRli fusion protein showing the whole cell extract, and 
insoluble and soluble fractions.
89
3.2.4 Purification of bsPcrA 1 from f>sPcrA1-/WxeGyrAi
Small-scale purification tests were carried out in which the expressed AsPcrA 1- 
MxeGryAi fusion product was incubated with chitin beads. The beads were then 
pelleted, pulling down the protein-intein fusion and the supernatant discarded. The 
chitin beads were then re-suspended in a buffer designed to induce intein cleavage 
after which the chitin beads were pelleted to leave the purified protein in the 
supernatant. However, no AsPcrA 1 was purified from AsPcrA 1 -MxeGyvAi (see 
Figure 3.8 A). The chitin beads were then washed in an SDS solution to dissociate 
anything bound to the chitin beads and the full length AsPcrA 1-MreGryAi fusion 
protein was eluted showing that no intein cleavage had occurred.
In order to stimulate intein cleavage activity serine 288 o f AsPcrA 1 was mutated to 
methionine because it has been shown that the intein cleaves more readily with a 
methionine at the fusion point (New England Biolabs). In the small-scale 
purification tests a protein o f approximately 27 KDa was eluted after intein cleavage 
(see Figure 3.8 B). The eluted protein was identified as AsPcrAl by peptide mass 
mapping. Despite having a molecular weight o f  33KDa AsPcrAl runs at a lower 
apparent molecular weight than this by SDS-PAGE. Although the cleavage by the 
intein was more efficient with a methionine at the fusion point the SDS wash reveals 
that not all the cleaved AsPcrAl protein was soluble and insoluble AsPcrAl protein 
was pelleted with the chitin beads after intein cleavage (see figure 1.8 B).
90
A)
Mw 0°i v J  Cq
g>
175
8 3 .0 -
6 2 .0 - bsP  crA1 -Mxe GyrAi
47.5
3 2 .5 -
2 5 .0 -
B)
Mw
S '
175 -
8 3 .0 -
4 7 . 5 -
3 2 .5 -
2 5 . 0 -
bsPcrAI (S288M)-A4xeGyrAi
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Figure 3.8. Small scale purification tests of AsPcrAl
A) AsPcrA 1-MteGryAi. No AsPcrAl protein is eluted from the chitin beads because the AsPcrAl- 
MteGryAi fusion protein remains intact.
B) AsPcrA 1(S288M) -  MxeGryAi. The AsPcrAl is eluted from the chitin beads and intein cleavage occurs 
leaving no full-length fusion protein intact. Some of the AsPcrAl is insoluble and elutes only after 
washing the chitin beads in SDS.
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The foPcrAl protein was purified using a chitin column (see Figure 3.9). The main 
contaminant was identified by peptide mass mapping as the cleaved intein-CBD that 
was not staying bound to the column; this may be due to fact that the chitin beads are 
fragile and a small amount o f chitin may have dissociated from the beads during the 
elution.
✓  < /  
i s  ^  Fractions
83.0 -
6 2 .0 -
3 2 .5 -
2 5 .0 -
PsPcrAI
A/fxeGryAi
Figure 3.9. Purification of AsPcrAl
The AsPcrA 1 (S288M)-MreGryAi fusion protein was bound to a chitin column and intein cleavage was 
induced by the addition of the thiol MESNA. Fractions of the eluted AsPcrAl were collected after 
incubation overnight. The second band that runs at a slightly lower molecular weight than AsPcrAl is 
AfoeGryAi.
3.2.5 Cloning and expression of SspDnaBi-bsPcrA2
The sequence encoding for 6sPcrA2, amino acids T289C-724, was cloned into 
pTWIN 1 and expressed directly fused to the SspDnaBi intein via its N-terminus. 
Threonine 289 of foPcrA was mutated to a cysteine as required for IPL.
3.2.6 Purification of 6sPcrA2 from SspDnaB-bsPcrA2
The intein cleavage was efficient and the bs?crA2 was purified from the chitin 
column (see Figure 3.10).
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Figure 3.10. Purification of AsPcrA2
The S’.spDnaBi-Z>.sPcrA2 fusion protein was bound to a chitin column. The pH was lowered from 8.5 to 7.0 
and the temperature increased from 4°C to 22°C to induce intein cleavage. Fractions of eluted 6sPcrA2 
were collected after incubation overnight.
3.2.7 Ligation of bsPcrA 1 and bsPcrA2 to form bsPcrA
For successful ligation of short peptides one o f the peptides needs to be at a 
concentration of 1 mM. At this concentration most proteins would precipitate and 
become insoluble. The reports that 1 mM concentrations are needed come from the 
ligation of synthetic peptides, which can be concentrated to 1 mM, being ligated to 
proteins. Other reports have shown that concentrations of 0.8 mM are high enough 
for the ligation of two large proteins (Evans et al. 1999b). The high concentrations 
increase the chance o f the C-terminal thiol ester and the N-terminal cysteine being in 
close enough proximity to allow the ligation reaction to proceed.
Some AsPcrAl became insoluble after being cleaved from MxeGryAi suggesting that 
AsPcrAl in isolation may precipitate when concentrated. In order to stop AsPcrAl 
precipitating, AsPcrAl and AsPcrA2 were concentrated together as it was reasonable
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to assume this would lead to the two halves associating as they do in the wild type 
Z>sPcrA. It was reasoned that the association o f  foPcrAl and 6sPcrA2 would allow a 
high concentration o f ZwPcrA to be achieved, as wild-type foPcrA is soluble at high 
concentrations as shown when it was crystallised (Velankar et al. 1999). The 
association o f AsPcrAl and 6sPcrA2 would also have the added effect o f  bringing 
the C-terminal methionine o f  foPcrAl and the N-terminal cysteine o f foPcrA2 in 
close proximity increasing the chances o f  the ligation reaction. This would mean the 
overall concentration o f protein may not need to be as high as reported for ligation to 
occur.
The faPcrAl and foPcrA2 proteins were concentrated together. There was no need 
to buffer exchange because the reaction proceeds at neutral pH (Dawson et al. 1994; 
New England Biolabs) and both proteins were buffered at pH 7. A precipitate forms 
at around 0.1 mM o f bsPcrA so the ligation mixture was left at just below 0.1 mM of  
faPcrA overnight at 4 °C or at room temperature. Two faint bands, A and B, are seen 
by SDS-PAGE running at the same molecular weight as wild type foPcrA (see 
Figure 3.11). Band A was identified as foPcrA by peptide mass mapping. However, 
the ligation reaction is inefficient and produces very small amounts o f  full-length 
bsPcrA.
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Figure 3.11. Ligation of AsPcrAl and AsPcrA2 to form full length AsPcrA
The AsPcrAl and AsPcrA2 proteins were concentrated together and incubated overnight at 4°C or at room 
temperature.
a= 5ul reaction mixture loaded onto gel, b= lOul reaction mixture loaded onto gel.
3.2.8 Other bsPcrA N-terminal intein fusion proteins
Only small amounts o f soluble foPcrAl-MveGyrAi fusion protein could be made 
and the intein cleavage was inefficient. Only a very small amount of full length 
foPcrA could be formed from ligation. Different N-terminal fragments of foPcrA 
were fused to an intein in the hope that one of them would be soluble and the intein 
cleavage would, therefore, be more efficient. The crystal structure of foPcrA was 
used to help in selecting fragments that did not end in the middle of any secondary 
structure (see Figure 3.12).
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E314
Figure 3.12. Potential intein fusion points within AsPcrA
Only domains 1A and 2A are shown for clarity. Residues labelled in black were chosen to fuse the N- 
terminal bsPcrA fragment to MxeGiyAi.
The potential C-terminal amino acid o f the fragment was also considered as the 
intein cleavage efficiency is affected by the amino acid the intein is fused to. An 
appropriate mutation was made if  the fragment did not end in a suitable amino acid 
and the mutation was reasonable in terms o f how similar the amino acids were. None 
o f  the amino acids at potential fusion points were suitable for the Mf/zRIRli (New  
England Biolabs), neither was it reasonable to mutate any o f  the amino acids as this 
would result in a large change to the residue. The fragments chosen for fusion with 
MxeGyrAi are shown in Table 3.2 below.
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Table 3.2. The AsPcrA N-terminal fragments chosen to be fused via C-terminal to MxeGryAi
AsPcrA N-terminal 
fragment (amino acids)
C-terminal amino acid
1-302 Histidine
1-302 Histidine mutated to methionine
1-312 Tryptophan mutated to tyrosine
1-314 Glutamic acid mutated to methionine
1-327 Methionine
1-359 Arginine
The chosen AsPcrA N-terminal fragment (AsPcrA NTF) proteins were cloned into 
pTWIN 1. Table 3.3 below shows the expression trial conditions for the AsPcrA 
NTF-MreGyrAi fusion proteins. All apart from 1-E314M-A/xeGyrAi expressed, but 
none were soluble.
Table 3.3. Expression trials for AsPcrA N-terminal fragment MxeGyrAi fusion proteins
E.coli Strain Temperature (°C) 
and length of 
induction (hrs)
Concentration of 
IPTG (mM)
BL21 2+ 3 hrs, 37°C 1
12-18 hrs 18°C 1
0.2
Tuner 2+ 3 hrs, 37°C 1
12-18 hrs 18°C 1
0.2
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3.3 An attempt to make an 
PCNA dimer
3.3.1 Introduction
Proliferating cell nuclear antigen (PCNA) is a processivity factor for DNA  
polymerase (DNA pol). The PCNA acts as a sliding clamp on DNA to keep DNA  
pol tethered to the DNA. PCNA is loaded onto DNA by the Replication Factor C 
(RFC) complex. The crystal structures o f  Pyrococcus furiosus and human PCNA 
revealed that three PCNA monomers form a ring structure (Bruck and O'Donnell 
2001; Gulbis et al. 1996; Matsumiya et al. 2001). A trimeric ring model has also 
been proposed based on the crystal structure o f the Archaeoglobus fulgidus PCNA 
monomer (Chapados et al. 2004) (see Figure 3.13). Each monomer contains two 
structurally homologous domains joined by a flexible linker resulting in a trimeric 
ring with pseudo-six-fold symmetry (see Figure 3.13).
1 2
Figure 3.13. The crystal structure of a/PCNA
The ring is made of an a/PCNA homotrimer. The arrows point to flexible linkers that join the two 
homologous domains, 1 and 2, of one PCNA monomer together.
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The aim o f this part o f the thesis was to address the question o f  how PCNA is loaded 
onto DNA. There are several ways that PCNA could be loaded to form a trimeric 
ring around DNA. Two main theories are the assembly theory and the ring break 
theory. The assembly theory is based on PCNA monomers, or a PCNA monomer 
and dimer, being assembled by RFC into a PCNA trimeric ring on DNA. PCNA may 
also se lf assemble into a trimeric ring without the aid o f  RFC; this may happen with 
the trimeric ring assembling directly onto the DNA. The ring break theory suggests 
that RFC may take the pre-made trimer, break one or more interfaces, and then load 
the PCNA onto the DNA forming the final trimer configuration (see Figure 3.14).
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A)
i)
B)
PCNA
'  CX5
i)
RFi
PCNA
PCNA
PCNA
PCNA PCNA
PCNA
Figure 3.14. Possible ways for a PCNA trimer to be loaded onto DNA
A) Possible PCNA states, i) homotrimer, ii) monomers or dimer and monomer.
B) RFC may bind, i) a pre-formed PCNA trimer, ii) PCNA monomers, or dimer and monomer.
C) PCNA loading onto DNA by i) a RFC in a ring break mechanism, ii) RFC in a trimer assembly 
mechanism, iii) a PCNA trimer self assembly mechanism.
D) The PCNA homotrimer on DNA.
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The PCNA from the archaeon Pyrococcus furiosus (#/PCNA) appears to be 
assembled into a trimer on DNA from three monomers, or a dimer and monomer, 
that are loaded onto the DNA by RFC; whether this involves breaking open a pre­
made PCNA trimer is not clear (Cann et al. 1999; Matsumiya et al. 2001). The 
#/PCN A  can also se lf assemble into a trimer on DNA in the absence o f  RFC (Cann 
et al. 1999; Matsumiya et al. 2001), suggesting that both the ring break and 
assembly theories could happen in vivo in differing situations. The assembly theory 
seems to be the case in the PCNA in the archaeon Sulfolobus solfataricus as well 
(Dionne et al. 2003). In E.coli the PCNA homologue, the (3 clamp, which is a dimer 
not a trimer, has one monomer interface that is broken during loading onto DNA  
(Jeruzalmi et al. 2001a; Jeruzalmi et al. 2001b). The ring break theory is also 
proposed for the Saccharomyces cerevisiae  PCNA (Bowman et al. 2004).
The Archaeoglobus fulgidus PCNA and RFC complexes have been studied 
previously. The q/PCNA runs as a monomer on gel filtration and q/RFC is required 
for tf/PCNA loading onto DNA, suggesting that the se lf assembly theory does not 
apply in this case (Seybert et al. 2002; Seybert et al. 2006; Seybert and W igley 
2004). However this does not exclude the possibility that the q/PCNA trimer may be 
stable at 60-95 °C, the growth temperature o f  Archaeoglobus fulgidus.
The specific aim o f  this project was to create an q/PCNA dimer in order to 
investigate the loading properties using biochemical assays, and possibly for use in 
trying to crystallise an q/PCNA/RFC complex. A covalently linked q/PCNA dimer 
would allow investigations into whether three PCNA monomers are required by 
RFC in order to load a PCNA trimer on DNA, or whether RFC can load the linked 
dimer and monomer. This would provide information as to whether the RFC breaks
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open a PCNA trimer, or assembles three PCNA monomers, in order to load trimeric 
PCNA onto DNA.
Steric strains could be introduced by directly fusing two PCNA monomers together 
that could alter or prevent the final trimeric ring conformation (see Figure 3.15). To 
try and avoid this a flexible linker could be introduced in between the two monomers 
to allow one monomer to move relative to the other.
Figure 3.15. Fusing two PCNA monomers
A) A schematic of the PCNA trimer ring. Each PCNA monomer is coloured differently.
B) Directly fusing two PCNA monomers may alter or prevent the final trimer ring conformation.
C) Adding a flexible linker should allow relative movement between the fused PCNA monomers. The
arrow indicates the added linker.
PCNA itself provided an amino acid sequence for such a linker, as a PCNA 
monomer has two homologous domains joined by a flexible linker. The q/PCNA 
linker was not used because o f possible recombination events between the 
introduced linker and the original during cloning; instead the flexible linker o f  
/t/PCNA was used. Based on the crystal structure o f p/PCNA  the flexible linker was 
defined as amino acids 116-129 and could be introduced by PCR onto an q/PCNA 
monomer. The overall structure o f  the dimer would, therefore, resemble four 
homologous sub-domains all linked in a similar way, and should not produce any 
steric strains on the structure o f  the closed ring.
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An attempt was made to clone two q/PCNA genes next to one another, but this failed 
to work, probably due to recombination events within the cell between the two 
identical genes placed next to one another, despite the use o f  a RecAmut E.coli 
cloning strain. The IMPACT-TWIN system provided another way to create the 
dimer using intein-mediated protein ligation o f  two q/PCNA monomers, (see Figure 
3.16). It was decided to add the pJPCNA linker to the N-terminus o f the q/PCNA 
fused to SspDnaBi so that the cysteine required for IPL could be introduced to the N- 
terminus o f  the pJPCNA linker rather than the N-terminus o f  the q/PCNA.
A)
i) ii)
a/PCNA afP  CNA
MxeGryAi/MthRIRIi ( cbo C8D ) SspDnaBi
p/PCNA linker
Figure 3.16. Strategy for creating an a/PCNA dimer
Each q/PCNA monomer is coloured differently.
A) q/PCNA-intein fusion proteins to be made, i) The first q/PCNA monomer, comprising two 
homologous domains, 1 and 2, joined by a flexible linker is fused via its C-terminus to MceGryAi (or 
MARIRli). ii) The second q/PCNA monomer with the p/PCNA linker is fused via its N-terminus to 
■SspDnaBi.
B) Protein products after intein cleavage, i) q/PCNA with a C-terminal thiol group, ii) q/PCNA fused with 
the N terminal p/PCNA linker that has an N-terminal cysteine.
C) i) The final ligation product of two q/PCNA monomers joined by a flexible linker from pjPCNA.
ii)The q/PCNA trimer comprising of the ligated dimer and another monomer.
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3.3.2 Cloning and expression of a/PCNA-MxeGyrAi and 
a/PCNA-Mtf?RIR1i
The q/PCNA gene was cloned into pTWLNl and pTWIN2 to produce constructs 
with q/PCNA fused directly to the MreGyrAi or M thR lR li respectively. Previous 
work has shown that a C-terminal glutamate inhibits cleavage from MxeGyrAi and 
M /jR IR li fusions (New  England Biolabs). Sequence comparisons show that this 
glutamate residue, which is present in q/PCNA, is not conserved in other PCNA 
proteins and therefore could be mutated to glycine, which does not inhibit the 
cleavage reaction.
Expression trials were undertaken. The B834 2+ E.coli cell line was used to express 
wild type q/PCNA (Seybert et al. 2002) and was used for the fusion protein. The 
fusion proteins expressed in the 5ml expression trials (see Table 3.4 below), but did 
not express in 1 L cultures under the same conditions. Smaller cultures o f  200 ml 
were tried and the fusion proteins expressed. Table 3.4 below summarises the 
expression conditions tested.
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Table 3.4. Summary of expression trials of a/PCNA-A/jc^GyrAi and ayPCNA-A/f/iRIRli
E .coli Strain Induction
conditions
Culture 
volume (ml)
q/PCNA-
MxreGyrAi
q/PCNA- 
Aff/i RIRli
Expression 
and solubility
Expression 
and solubility
BL21 + ImM IPTG, 
3hrs, 37°C
5 -/+ -/+
ImM IPTG,
12-18hrs, 18°C
5 -/+ -/+
B L 2 1 3+ ImM IPTG, 
3hrs, 37°C
5 -/+ -/+
ImM IPTG, 
12-18hrs, 18°C
5 -/+ -/+
B834 2+ ImM IPTG, 
3hrs, 37°C
5
200
1000
+ +
+ +
- -
ImM IPTG, 
12-18hrs, 18°C
5
200
1000
+ +
+ +
- -
3.3.3 Purification of a/PCNA from a/PCNA-MxeGyrAi and
a/PCNA-Af f/iRIR1 i
Small-scale purification tests were tried, as described earlier in section 3.2.3, to see
i f  a/PCNA could be purified from either the q/PCNA-MreGryAi or q/PCNA-
Mf/tRIRli fusion proteins. The q/PCNA-Mf/zRIRli fusion protein cleaves w ell in the
small-scale tests, as expected with glycine at the fusion point, so q/PCNA was
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purified from q/PCNA-Mf/?RIRli using a chitin column (see Figure 3.17 A). The 
q/PCNA-MceGyrAi fusion protein does not cleave as well, but q/PCNA can also be 
purified from this fusion protein (see Figure 3.17 B).
A)
Mw ^
(KDa) ^
175 -
a/PCNA-/W/?RIR1i
83.0 -
62.0 -
47.5 -
3 2 .5 -
2 5 .0 -
a/PCNA
MthR\RY\
B)
✓  /  /<N° ^  <$> <§>’
8 3 .0 -
6 2 .0 -
1 3
3 2 .5 -
2 5 .0 -
a/PCNA-A/fxeGryAi
A/fxeGryAi
a/PCNA
Figure 3.17. Small-scale purification tests of a/PCNA fused to either MxeGryAi or Af/ARLRli
A) a/PCNA-A/r/jRIRli. B) q/PCNA-MreGryAi.
The q/PCNA-M/zRIRli fusion protein was chosen for a large-scale purification (see 
Figure 3.18) because A/z/tRIRli cleaved better than MreGyrAi.
106
< 9
Mw ^  ^
(KDa) ^  o  <<N°  Fractions
83.0 -
6 2 .0 -
4 7 . 5 -
3 2 . 5 -
2 5 . 0 -
a/PCNA
Figure 3.18. Purification of a/PCNA from a/PCNA-A/fARIRli
a/PCNA-MARIRli fusion protein was bound to a chitin column and intein cleavage was induced by the 
addition of the thiol MESNA. Fractions of the eluted a/PCNA were collected after incubation overnight.
3.3.4 Cloning and expression of SspDnaBi- a/PCNA
The a/PCNA gene was cloned into pTWINl so that the SspDnaBi was fused to the 
N-terminus of q/PCNA. The PCR primer for the 5 ’ end o f q/PCNA also contained 
the sequence for the flexible domain linker o f p/PCNA. A N-terminal cysteine was 
also added to the p/PCNA linker as required for intein-mediated protein ligation.
Two expression products can be seen by SDS-PAGE (see Figure 3.19). Peptide mass 
mapping identified the smaller band as a fragment o f q/PCNA and the larger band as 
the intein (see Figure 3.19).
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Mw A J?-dr
J
*
(KDa) ^  < f  c f
B)
a/PCNA
175 -
8 3 .0 -
6 2 .0 -
4 7 .5 -
3 2 .5 -
•SspDnaBi
2 5 .0 -
a/PCNA fragment
cao ) SspDnaBi
Asp70/Met71
C)
Figure 3.19. Expression of Ss/iDnaBi-q/PCNA
A) Expression of SspDnaBi-q/PCNA compared to purified a/PCNA.
B) A schematic of the fusion protein with residues at which proteolysis is occurring labelled in black.
C) Crystal Structure of q/PCNA with the residues at which proteolysis is occurring labelled in black.
Various expression conditions were tested (see Table 3.5), but all gave the same 
expression pattern. The N-terminus o f the qr/PCNA was sequenced and shows that 
the cleavage is taking place after aspartate 70 in the sequence TIGVD/MDR1F o f  the 
q/PCNA (see Figure 3.19).
Table 3.5 Expression trial conditions of ^ spDnaBi-q/PCNA.
E.coli Strain Temperature and length of induction
B834 2+ 3hrs, 37°C
12-18hrs, 18°C
BL21 2+ 3hrs, 37°C
12-18hrs, 18°C
BL21 + 3hrs, 37°C
12-18hrs, 18°C
BL21 3+ 3hrs, 37°C
12-18hrs, 18°C
All conditions used 1 mM IPTG
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Discussion
3.3.5 Bacillus stearothermophilus PcrA intein work
The bs?crA2  was successfully purified from a fusion with the SspDnaBi intein. This 
was the one case in all o f  the intein work where the fusion protein could be easily 
expressed and purified with no problems. This demonstrates that in certain cases the 
IMPACT-TWIN system can be used in a straightforward fashion to purify a protein 
using a self-cleavable affinity tag.
The lack o f  solubility o f  6sPcrAl-M reGyrAi and 6sPcrAl-A///zRIRli fusion proteins 
was a problem. There is no obvious reason why faPcrAl should be insoluble other 
than the high levels o f  expression, so it was decided to try and reduce the amount o f  
expression using Tuner cells. Tuner cells have a mutated lac permease (lacY) protein 
this means IPTG uptake is uniform in the cell culture and the amount o f  expression 
is dependant on the concentration o f IPTG. Tuner cells can therefore be induced to 
express high or low levels o f  protein by varying the concentration o f  IPTG used. 
This idea worked well and a small amount o f  protein was soluble when expressed in 
the Tuner E.coli cells using 0.2 mM IPTG.
Once soluble foPcrAl-M reGyrAi protein had been made little or no intein cleavage 
was observed this could not have been predicted, as there were no reports suggesting 
that a serine at the cleavage site would inhibit the cleavage reaction. Other studies 
have shown that having a methionine at the cleavage site lead to high levels o f  intein 
cleavage and muating serine 288 to methionine (S288M ) did indeed increase the 
amount o f  cleavage. There is not a lot o f work defining which amino acids at the
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cleavage point are better then others for allowing the cleavage reaction to work. The 
information available comes from individual reports o f  different proteins being 
cleaved from the inteins. It is reasonable to speculate that the protein fold and 
sequence context o f  the amino acid will play an important part in determining the 
cleavage efficiency. While some conclusions can be drawn as to which amino acids 
are best for the intein cleavage it seems that trial and error is the best approach when 
working with a protein that has not been used with inteins before.
Some 6sPcrAl became insoluble when cleaved from MxeGryAi reducing the yield. 
This suggests that the insolubility o f  the ZwPcrAl-MxeGryAi fusion protein was due 
to the ZwPcrAl being intrinsically insoluble rather than just the high levels o f  protein 
expression.
The ligation reaction between the foPcrAl and faPcrA2 was not very successful or 
reproducible. This meant that only a very small amount o f  full-length foPcrA was 
created in amongst lots o f  contaminants. The 6sPcrA halves could only be 
concentrated to around 0.1 mM before a precipitate formed. This may not be high 
enough for the ligation reaction to proceed. The precipitation is likely to be the 
faPcrAl forming insoluble aggregates as foPcrAl seemed intrinsically insoluble 
where as 6sPcrA2 did not; if  foPcrAl was forming aggregates then this would 
prevent Z>sPcrA2 associating with foPcrAl to allow the ligation reaction to occur.
During this time the RecD work (described in Chapters 4 and 5) had started to yield  
results and it was decided that the RecD project should be given priority because the 
foPcrA work had, to this date, not produced any firm data relating to the original 
question o f what 6sPcrA domains IB and 2B contribute to duplex DNA unwinding.
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If time had permitted the ZwPcrA work would have been revisited to try and purify 
full length 6sPcrA ligated from foPcrAl and foPcrA2.
Ligation o f  foPcrAl and ZwPcrA2 had not produced a positive control and it was 
decided not to try and make the domain deletion mutants. In retrospect, a bsPcrA  
mutant that contained the cysteine that would have been present from purification 
from the SspDnaBi- foPcrA fusion protein could have been made using site directed 
mutagenesis o f  the wild-type foPcrA gene and used as a pseudo positive control. 
How ever this would not have been ideal and any changes in activity o f  the domain 
deleted bsPcrA  could still be argued to have been a result o f  the method o f  making 
them.
3.3.6 Archaeoglobus fulgidus PCNA intein work
This part o f  the intein work provided a different set o f  problems to the 6sPcrA work. 
Firstly, in trying to express both the q/PCNA fusion proteins and secondly it was the 
SspDnaBi-q/PCNA fusion protein that could not be made, where as in the frsPcrA 
work 6sPcrA2 was successfully purified from the iSs/?DnaBi-foPcrA2 fusion protein. 
In the case o f  q/PCNA-MreGyrAi/Mf/zRIRli the fusion proteins expressed in 5 ml 
and 200 ml cultures, but not in 1 L cultures. There does not seem to be any good  
reason for this, the aeration o f  the culture may have some impact but it is hard to see 
how a 1 L culture could be so deficient in aeration as to stop expression o f  the 
protein especially as the 1 L culture grew at the same rate as the 200 ml culture.
As a tool for purifying q/PCNA the intein system works very well. The q/PCNA- 
Mf/zRIRli fusion protein allowed the purification o f  q/PCNA from a single column 
using the chitin-binding domain as an affinity tag instead o f  three columns as
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previously described (Seybert et al. 2002). The power o f  this method is that no tag is 
left attached to the protein. Using another reducing agent other than MESNA, which 
is required for the ligation reaction, could increase the cleavage efficiency o f  the 
intein. If the IMPACT-TWIN system was just being used to purify q/PCNA other 
reducing agents could be tried to see if  the yield o f  q/PCNA could be increased.
There was no attempt to ligate two q/PCNA monomers together. This is due to the 
fact that the q/PCNA monomer with an N-terminal cysteine and pJPCNA linker 
could not be purified, because the full-length SspDnaBi - q/PCNA fusion protein 
could not be expressed. The expression led to two products as described earlier. One 
product was a fragment o f  q/PCNA (amino acids 71-245) and the second was the 
SspDnaBi intein, presumably fused to the first 70 amino acids o f  q/PCNA, although 
this wasn’t detected in the peptide mass mapping. This proteolysis is unlikely to be 
caused by the SspDnaBi as it is reported to cleave best at cysteine, glycine and serine 
amino acids (N ew  England Biolabs); neither has the intein been reported to cleave 
anywhere else other then the fusion site between the intein and the target protein. 
The proteolysis occurred despite the use o f  the protease inhibitors PMSF, pepstatin, 
leupeptin and EDTA that inhibit the serine, acid, thiol and mettalo proteases 
respectively. The site o f  assumed proteolysis could have been mutated to try and 
stop the problem. This was not attempted due to time constraints and mutation might 
disturb the secondary structure o f  the protein especially in this case where 
proteolysis is occurring in between a |3 sheet and an a  helix.
In conclusion this work failed to create AsPcrA domain deletion mutants or a 
q/PCNA dimer. However, the project did demonstrate that the IMPACT-TWIN 
system is capable o f  purifying proteins using a self-cleavable affinity tag.
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4 Biochemical analysis of Deinococcus radiodurans  
RecD2 
4.1 Introduction
4.1.1 Summary
This part o f  the thesis describes the identification, purification and biochemical and 
mutational analysis o f  Deinococcus radiodurans RecD2 (drRecD2) in order to gain 
insights into the molecular mechanism o f  Superfamily IB a  (S F lB a ) helicase 
activity. The focus o f  this study was the molecular mechanism o f  a Superfamily IB a  
helicase and not the in vivo function o f  drRecD2. The main conclusions are, firstly, 
that a structurally conserved loop in the RecD2 family could be acting as a molecular 
pin for splitting open the duplex DNA ahead o f the motor domains. Secondly, that 
the N-terminal domain o f  drRecD2 may be acting as a regulatory domain that 
inhibits helicase activity. Lastly, that a conserved m otif (M otif A) may not be 
involved in the helicase activity o f  drRecD2.
4.1.2 The Superfamily 1Ba RecD helicase
There are two types o f  RecD helicases as described in the introduction to this thesis 
(see Chapter 1, section 1.10.3). The RecD enzymes that exist in organisms that have 
the RecB and RecC genes are classified as type 1 RecD (R ecD l) helicases and are 
likely to be part o f  the RecBCDl complex as a bona f id e  RecD. The RecD enzymes 
that exist in organisms that do not possess RecB or RecC genes are classified as type 
2 RecD (RecD2) helicases. A  RecD2 helicase, therefore, cannot be part o f  a
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RecBCDl complex and these are not therefore bona f id e  RecD enzymes, but are 
homologous S F lB a  helicases.
A histidine tagged construct o f  E.coli RecD l (E.coli R ecD lhls) has been shown to 
have ssDNA-dependent ATP hydrolysis and 5 ’ -  3 ’ helicase activities in vitro in 
isolation from the RecBCDl complex (Chen et al. 1997; Dillingham et al. 2003). 
The purification o f  E.coli R ecD lhls is not straightforward, because the protein is 
insoluble when expressed in the absence o f  the E.coli RecC and RecB proteins. The 
E.coli R ecD lhls protein was refolded from inclusion bodies and was not able to fully 
restore the wild-type Chi-speciflc cleavage activity o f  a reconstituted holoenzyme 
comprising E.coli RecBC and R ecD lhls (Dillingham et al. 2003). This indicates that 
not all o f  the protein was correctly folded. Further (unpublished) experiments 
suggest that only 10% o f the E.coli R ecD lhls is active (personal communication, 
Dillingham, M.).
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4.2 Identification and purification of  
radioduransR ecD 2
4.2.1 E.coliRecD1
In order to investigate the possibility o f using E.coli RecDl as a target for 
crystallisation it was cloned, expressed and purified based on previous work by 
Dillingham et al. (Dillingham et al. 2003) (see Figure 4.1).
- f
*  s
(KDa) ^  < £
175 -
8 3 .0 -
6 2 .0 -
4 7 .5 -
3 2 .5 -
2 5 .0 -
1 6 .0 -
Figure 4.1. Purified E.coli RecDlhi*
A 12% SDS-PAGE analysis showing the final purification product of E.coli RecDlhls
No ATP hydrolysis or helicase activities were observed from the protein despite 
several purification attempts (data not shown). Domain 1 o f E.coli RecDl interacts 
with RecC in the RecBCD complex, and it was reasoned that an E.coli RecDl 
protein missing this domain might be soluble. Two N-terminal truncations o f E.coli 
RecD 1 missing domain one were cloned into expression vectors missing amino acids 
1-109 and 1-126, E.coli RecD A1' 109 and E.coli RecD 1A1*126 in an attempt to make
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soluble protein. Both truncated proteins were insoluble. It was decided to concentrate 
on identifying a novel RecD target for crystallisation.
4.2.2 Identification of Deinococcus radiodurans RecD2
In order to avoid the problems associated with refolding insoluble proteins it was 
decided to screen for a RecD helicase from another organism that, when cloned into 
an expression vector, would provide a high yield o f  soluble protein. A strategy was 
devised in order to maximise the chances o f  finding a RecD gene that would provide 
large quantities o f  soluble protein.
The reason E.coli R ecD l is insoluble may be because it has a very large 
hydrophobic surface that interacts with RecC in the R ecBC Dl complex (Singleton et 
al. 2004). RecD2 helicases are more likely to be soluble than RecDl helicases 
because RecD2 proteins have no need for a large hydrophobic surface interface area 
to interact with RecC. For this reason RecD2 helicases were prioritised in the screen. 
Another factor in the screen was the availability o f  genomic DNA, so some RecD l 
helicases were also cloned. All the screened RecD helicases were cloned into 
expression vectors and underwent expression trials to determine if  the clone would 
express soluble protein. The results o f  the screen are shown in Table 4.1.
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Table 4.1. Screening for a soluble RecD helicase
Organism Name Size
(KDa)
Clones
made
Expression Solubility
Deinococcus
radiodurans
RecD2 76.4 Native + -
C-terminal 
histidine tag
-/+ +
Streptococcus
pneumoniae
RecD2 88.7 Native +
Bacillus cereus RecD2 87.4 Native - N/A
Lactobacillus
plantarum
RecD2 93.0 Native +
Desulfovibrio
vulgaris
RecD2 82.6 Native N/A
Methanococcus
jannaschii*
Y F 19M E
TAJ
138.6 Native N/A
Heamophilus
Influenzae
RecDl 72.8 Native N/A
Mycobacterium
smegmatis
RecDl 59.5 Native +
* This is an archaeon and not a bacterium like the rest of the organisms in this list. The gene cloned from 
this organism is not a RecD gene, but it does possess a RecD-like domain.
The RecD clones underwent expression trials and either the proteins did not appear 
to express or the protein produced was insoluble. Initially it appeared that 
Deinococcus radiodurans RecD2 protein was expressed in the BL21 2+ cell line, but 
was insoluble (see Figure 4.2).
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Figure 4.2. Initial expression trial of Deinococcus radiodurans RecD2
A 12% SDS-PAGE analysis showing the expression of insoluble Deinococcus radiodurans RecD2 
indicated by *. The E.coli BL21 2+ with the </rRecD2 expression vector was grown to 0.6 O.D6oonm and 
was induced with 1 mM IPTG for 3 hours. A control culture was not induced.
At the same time as this work was being performed data were published by Wang et 
al. that described a soluble C-terminal histidine tagged Deinococcus radiodurans 
RecD2 that had 5’ -  3 ’ helicase activity (Wang and Julin 2004). This study therefore 
cloned Deinococcus radiodurans RecD2 with a C-terminal histidine tag, (JrRecD2). 
Expression trials were performed, but no JrRecD2 protein was seen to be expressed 
(see Figure 4.3).
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Figure 43. Expression trial of </rRecD2 with a C-terminal histidine tag
A 12% SDS-PAGE analysis showing the expression trial of C-terminally histidine tagged Deinococcus 
radiodurans RecD2. The E.coli BL21 2+ with the c/rRecD2 expression vector was grown to 0.6 O.D^ oonm 
and was induced with 1 mM IPTG for 3 hours. A control culture was not induced.
It may have been the case that only very small amounts o f drRecD2 were expressed 
that could not be easily seen using SDS-PAGE analysis. In order to test for low 
levels of drRecD2, small scale purification tests were carried using nickel agarose 
beads to pull down JrRecD2 from different cell lines. The E.coli BL21 Rosetta 
strain appeared to produce the best yield of drRecD2 as analysed by SDS-PAGE 
(see Figure 4.4).
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A) BL21 rosetta B) BL21 3+
Figure 4.4. Purification trials of </rRecD2
12 % SDS-PAGE analysis showing the pull down of c/<rRecD2 using nickel agarose beads from A) BL21 
Rosetta E.coli and B) BL21 3+ E.coli. The E.coli expression strains with the <irRecD2 expression vector 
were grown to 0.6 O.Dsoonm and were induced with 1 mM IPTG for 3 hours. The soluble fraction was 
isolated and the drRecD2 was depleted from the fraction using nickel agarose beads. The beads were 
washed and then the drRecD2 was eluted from the beads using imizadole as a competitor for nickel 
binding.
4.2.3 Purification of Deinococcus radiodurans RecD2
Based on the method o f purification described by Wang et al. a high throughput and 
more stringent purification protocol was developed. Wang et al. utilised a nickel 
chelating column and a ssDNA cellulose column to purify drRecD2. A ssDNA 
cellulose column is not suitable for a high throughput purification o f large quantities 
o f protein because the medium is single-use, so a heparin column was used instead. 
An extra purification step using a MonoQ anion exchange column was included to 
remove the last remaining contaminants to ensure the protein was sufficiently pure 
for crystallisation. An outline of the purification protocol is described here (see 
Materials and Methods for specific details).
The protein was over-expressed in ten 1 L cultures of E.coli. In order to reduce the 
viscosity o f the resulting lysate the first step o f purification was a 65% ammonium
sulphate precipitation that removes lipids, DNA and some protein from the lysate. 
The resolublised pellet solution was now less viscous and could be applied to 
columns. The protein is histidine-tagged so a nickel chelating column was used as an 
affinity purification step (see Figure 4.5 A). The next step employed a heparin 
column as an affinity column for DNA binding proteins (see Figure 4.5 B). The 
heparin column step further purifies the protein and also helps to remove any trace 
amounts o f  DNA nucleases.
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Figure 4.5. Purification of </rRecD2 using nickel chelating and heparin columns
A) Nickel chelating column, i) Elution profile measuring A2 8 0nm from the column, ii) A 12 % SDS-PAGE 
analysis showing the load onto the column, the flow through from the column and the peak fractions. 
Fraction 2 was applied to the heparin column.
B) Heparin column, i) Elution profile measuring A2go nm from the column, ii) A 12 % SDS-PAGE analysis 
showing the load onto the column, the flowthrough from the column and the peak fractions. Fractions 7 
and 8 were applied to the MonoQ column.
As there are still some contaminating proteins seen eluting with drRecD2 from the 
heparin column a MonoQ column was used as an anion exchange purification step 
(see Figure 4.6).
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Figure 4.6. Purification of </rRecD2 , MonoQ column
A) Elution profile measuring A2go nm from the column. B) 12 % SDS-PAGE analysis showing the load 
onto the column, the flow through from the column and the peak fractions, r/rRecD2, a drRecD2 
fragment and E.coli RecB and RecC are indicated. Fractions 31 to 34 were selected.
A calculated pi o f  <7rRecD2 was determined as 6.2 using the ProtParam tool o f  
ExPASy (Gasteiger et al. 2003). The drRecD2 containing fractions from the heparin 
column were loaded onto the MonoQ column at pH 7.5, giving a net negative 
surface charge and allowing it to bind to the MonoQ column at low sodium chloride 
concentrations. The MonoQ step also had the added benefit o f  concentrating the 
<7rRecD2 as the protein is eluted as a sharp peak into a relatively small volume.
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A prominent contaminant that was purified away from drRecD2 on the MonoQ 
column (see Figure 4.6 B fraction 25) was identified by peptide mass mapping as 
being a fragment o f  drRecD2. As the histidine tag was attached to the C-terminus o f  
the protein any fragment o f  drRecD2 purified using the nickel chelating column 
must still have the C-terminus so the N-terminus must be truncated. The fragment 
was therefore N-terminally sequenced and the point o f  proteolysis was determined as 
the peptide bond between tryptophan 150 and serine 151. These data were used in 
designing an N-terminal truncation mutant o f  afrRecD2, drRecD2ANT (see section
4.4.3.2).
The purity o f  drRecD2 was assessed by gel filtration and dynamic light scattering 
(DLS) analysis (see Figure 4.7). The drRecD2 eluted from a Superdex 200 column 
at approximately 70 ml, corresponding to a molecular weight o f  around 70 KDa, 
indicating that drRecD2 is monomeric. DLS shows the JrRecD2 to be monodisperse 
as a single particle with a hydrodynamic radius o f  7.86 nm, corresponding to an 
estimated molecular weight o f  82 KDa, assuming a globular protein. These data 
suggest <7rRecD2 is monomeric and does not form dimers or larger order aggregates 
in 20 mM Tris pH 7.5, 100 mM sodium chloride, 1 mM DTT and 1 mM EDTA.
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Figure 4.7. Gel filtration and dynamic light scattering analysis of JrRecD2
A) i) Elution profile measuring A28 0 nmOf c/rRecD2 from a Superdex 200 column, ii) A 12 % SDS-PAGE 
analysis of the peak fractions eluted.
B) A plot of % volume against size of particle derived from DLS analysis of drRecD2. The % volume is a 
normalised value derived from the intensity of light scattered by the particles and the mass of the 
particles.
4.2.4 P o ss ib le  com plex formation betw een Deinococcus 
radiodurans RecD2 and E.coli RecBC
Other contaminants were sometimes observed during the Mono Q step, eluting at a
higher sodium chloride concentration than the main peak o f  drRecD2 (see Figure 4.6
B, fraction 48). These were identified as E.coli RecB and RecC by peptide mass
mapping, importantly a small amount o f drRecD2 was also confirmed by peptide
mass mapping to co-elute with the E.coli RecBC. This raised the possibility that
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drR scD l could be forming a complex with E.coli RecBC present in the E.coli 
expression host. In order to investigate this further drR zcD l was mixed with purified 
recombinant E.coli RecBC and complex formation was tested by gel filtration 
chromatography. However, the drRecD2 and E.coli RecBC did not co-elute from a 
gel filtration column indicating that no stable complex formation was occurring (see 
Figure 4.8).
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Figure 4.8. Complex formation of */rRecD2 and E.coli RecBC
A) Elution profile measuring A2go nm of pre-mixed E.coli RecBC and drKccDl from a Superdex 75 
column. B) 12 % SDS-PAGE analysis of the peak fractions eluted from the column.
E.coli RecBC and c7rRecD2 do not co-elute.
The RecD2 enzymes have an extended N-terminus compared to the RecDl enzymes. 
One o f the drRecD2 mutants described in this chapter is missing this N-terminal 
region (drRecD2ANT) and is therefore a comparable size to E.coli RecD (see section
4.4.3.2). The purification o f this mutant is the same as for the wild-type JrRecD2, 
and E.coli RecBCDl were seen to be contaminants that were removed on the
• VTT
MonoQ column with a small amount o f  co-eluting drRecD2 (see Figure 4.9) 
away from the main peak o f purified drRecD2ANT.
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Figure 4.9. Co-elution of E.coli RecBC and </rRecD2ANT from a MonoQ column
A 12 % SDS-PAGE analysis showing the co-elution of E.coli RecBCDl and c/rRecD2ANT from a MonoQ 
column during the purification of t/rRecD2ANT.
The drRecD2ANT was mixed with purified recombinant E.coli RecBC and complex 
formation was tested by gel filtration chromatography. Once again, the <7rRecD2ANT 
and E.coli RecBC did not co-elute from a gel filtration column indicating that no 
stable complex formation was occurring (see Figure 4.10).
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Figure 4.10. Complex formation of </rRecD2ANT and E.coli RecBC
A) Elution profile measuring A2go nm of pre-mixed E.coli RecBC and r/rRecD2ANT from a Superdex 75 
column. B)A 12 % SDS-PAGE analysis of the peak fractions eluted from the column. E.coli RecBC and 
drRecD2ANT do not co-elute.
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4.3 Biochemical analysis of wild-type Deinococcus 
radiodurans RecD2
In order to establish the effects any mutations o f  drRecD2  might have on its helicase 
activity, the wild-type enzyme was first characterised.
4.3.1 ATP hydrolysis activity
A pdT60 oligonucleotide was used for this assay in order to make sure that the DNA  
was o f sufficient length to cover the DNA binding sites required to stimulate 
activity. Isothermal calorimetry (ITC) data show that drRecD2 binds w ell to pdT 
substrates longer than 15 nucleotides (these data are described later in section 
4.3.2.1), suggesting that all the DNA binding sites o f  drRecD2 are occupied.
The concentration o f  ssDNA and ATP required to saturate drRecD2, i.e. the 
concentration required to obtain the maximum rate o f  ATP hydrolysis, were 
determined (see Figure 4.11). An apparent Km for ‘the ssDNA stimulation’ ( K Dn a ) ,  
and a Km for ATP ( K At p )  can then be calculated.
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Figure 4.11. ATP hydrolysis activity of </rRecD2
A) i) A plot of moles of ATP hydrolysed per mole of <7rRecD2 per second against pdT60 concentration in 
order to calculate ii) a kcal and KDNA for the reaction in the presence of saturating (4 mM) ATP.
B) i) A plot of moles of ATP hydrolysed per mole of c/rRecD2 per second against ATP concentration in 
order to calculate ii) kcat and KATP for the reaction in the presence of saturating (100 nM) pdT60.
A more accurate apparent Km for DNA (Kdna2) was calculated by determining and 
then plotting the apparent kcat (kcat app) for various concentrations o f  pdT60 (see 
Figure 4.12).
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Figure 4 .1 2 . Determination of K Dna2
A) A plot of moles of ATP hydrolysed per mole of c/rRecD2 per second against ATP concentration in 
order to calculate kcal app for the reactions at different pdT60 concentrations.
B) A plot of kcat app, as determined in A), against pdT60 concentration in order to calculate KDNA2.
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4.3.2 DNA binding activity
4.3.2.1 Isothermal calorimetry (ITC)
The binding o f  JrRecD2 to ssDNA was investigated in order to characterise the Kd 
o f  drRecD2 for ssDNA and the length o f  ssDNA that could be bound, indicating the 
length o f ssDNA required to fill all the ssDNA-binding pockets o f  JrRecD2.
ITC provides:
i) The stoichiometry o f  binding (AO, i.e. the number o f molecules o f  
drRecD2 bound to one DNA substrate molecule.
ii) A directly measured association constant o f  the protein for the DNA  
substrate (Ka), (where Ka = [drRecD2/DNA complex]/[JrRecD2][DNA]), 
that can be used to calculate its inverse, the dissociation constant, K<j.
ITC experiments were carried out using different length pdT ssDNA substrates. The 
minimum length o f  pdT that drRecD2 can bind to was determined (see Figure 4.13).
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Figure 4.13. ITC analysis of </rRecD2 with various pdT substrates
Isothermal calorimetry experiments. Varying lengths of pdT DNA substrates were injected into t/rRecD2 
and the heat of binding measured.
Values for N  and Kd were obtained by fitting curves calculated from the one- 
binding-event model and are summarised in Table 4.2.
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Table 4.2. Summary of ITC analysis of </rRecD2 binding to various pdT substrates
pdT length N Kd (nM) One-binding-event model 
Chi2/DoF (xlO5)
8 0.89 (± 0.05) 9900 (± 740) 0.09
1 0 1 . 0 0  (± 0 .0 1 ) 520 (± 77) 0 . 2 1
1 2 1 . 0 0  (± 0 .0 1 ) 56 (± 0.5) 2.84
15 1 . 0 0  (± 0 .0 1 ) 17 (± 3) 1.94
25 2.11 (± 0.03) 400 (± 40) 20.3
30 2 . 2 0  (± 0 .0 1 ) 48 (± 3) 2.70
The results show that one molecule o f  drRecD2 binds per molecule o f  pdT8 , pdT 10, 
pdT 12 or pdT 15, with higher affinity for pdT 15 and pdT 12 than for pdT 10 and 
pdT8 . Two molecules o f  drRecD2 bind per molecule o f  pdT25 or pdT30, suggesting 
that a 10-12 nucleotide length o f  ssDNA is required to fill all the ssDNA-binding 
pockets o f  <7rRecD2. Despite two molecules o f  JrRecD2 binding to pdT30, each 
drRecD2 molecule binds with the same affinity and so each binding event is 
indistinguishable. For example, if  there is no co-operative binding o f  the two 
drRecD2 molecules to the pdT30 molecule, two molecules o f  drRecD2 binding to 
one molecule o f  pdT30 will provide the same experimental ITC data as two 
molecules o f  drRecD2 binding to two molecules o f  pdT15 (see Figure 4.14). The 
only difference will be the stoichiometry o f  the number o f  drRecD2 molecules o f  
bound to one molecule o f  DNA substrate.
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Figure 4.14. Binding events that are indistinguishable by ITC
A) The binding of two drRecD2 molecules to one pdT30 molecule, with no cooperative effects. All the 
DNA-binding pockets of both c/rRecD2 molecules are filled.
B) The binding of two drRecD2 molecules to two molecules of pdT 15. All the DNA-binding pockets of 
both c/rRecD2 molecules are filled.
The heat measured by ITC will be similar for A) and B), only the stoichiometry of the number of 
molecules drRecDl bound to one molecule of DNA is different.
To investigate the length o f DNA that can accommodate two molecules o f  drRecD2, 
ITC experiments were performed using pdT20, pdT21, pdT22, pdT23 and pdT24 
ssDNA substrates. In theory this should lead to two binding events being observed 
(see Figure 4.15). The ITC experiment is carried out by injecting small amounts o f  
DNA substrate into a cell containing drRecD2 and measuring the heat o f  binding. In 
these experiments 30 injections were used. After the first injections o f  DNA, 
drRecD2 is in excess o f DNA. After the last injections o f the DNA substrate, the 
DNA is in excess o f  the drRecD2. When the drRecD2 is in excess o f  the DNA, two 
molecules o f  drRecD2 may bind to one DNA molecule with the dissociation 
constant, Kdi. When the DNA is in excess o f  the drRecD2 one o f  the two drRecD2 
molecules bound to one DNA molecule may dissociate, and then bind to another 
DNA molecule with the dissociation constant, Kd2 . This rearrangement will only 
occur if  the affinity o f one c/rRecD2 molecule for one DNA molecule is higher than
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the affinity o f  two drR ecD l molecules for one DNA molecule, i.e. if  K42  is lower 
than Kdi because either not all o f  the ssDNA-binding pockets o f  the two drRecD2 
molecules bound to one DNA molecule are filled, or the two drRecD2 molecules 
sterically hinder one another. Therefore, two binding events will be observed in a 
single ITC experiment (see Figure 4.15).
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Figure 4.15. Two equilibrium constants in one ITC experiment
A) After the first injections dlrRecD2 is in excess of the DNA substrate, i) A representation of an ITC 
binding curve of the equilibrium in ii) when iii) drRecD2 (red) is in excess of DNA (black) and iv) the 
DNA-binding pockets of one molecule of drRecD2 are not all filled and/or there is steric hindrance 
between the two drRecD2 molecules.
B) After the last injections the DNA substrate is in excess of drRecD2 i) A representation of an ITC 
binding curve of the equilibrium in ii) when iii) DNA (black) is in excess of drRecD2 (red) and iv) the 
DNA-binding pockets of c/rRecD2 are all filled.
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ITC experiments were performed using pdT20, pdT21, pdT22, pdT23 and pdT24 
ssDNA substrates. And both one-binding-event and two-binding-event models were 
used to calculate curves fitted to the experimental data (see Figure 4.16).
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Figure 4.16. ITC analysis of */rRecD2 with pdT20-24
Isothermal calorimetry experiments injecting pdT20, pdT21, pdT22, pdT23 or pdT24 into drRecD2.
As well as judging by eye whether the one-binding-event model or the two-binding- 
event model best fits the data, the fit of the curve to the data can be quantified using 
the statistical value o f Chi2/DoF. Chi2 is the sum of the squares of the deviations of 
the fitted curve from the experimental points and DoF (degree of freedom) is the 
total number of experimental points used in the fitting minus the total number of 
4adjustable parameters. A low Chi2/DoF value suggests a good fit o f the calculated
curve to the experimental data, a high Chi2/DoF value indicates a bad fit. The 
Chi2/DoF values o f  fitting the curves calculated from the either the one-binding- 
event or the two-binding-event models to the experimental data o f  drRecD2 binding 
to pdT20-24 are listed in Table 4.3.
Table 4.3. Chi2/DoF of fitting one-binding-event or two-binding-event models to the ITC data 
of rfrRecD2 binding to pdT20-24
pdT length One-binding-event model 
Chi2/DoF (x 10s)
Two-binding-event model 
Chi2/DoF (x 105)
2 0 19.3 5.30
2 1 63.6 6.36
2 2 54.7 10.9
23 2 1 . 0 1 2 . 6
24 20.5 4.31
The two-event binding model, judging either by eye or mathematically, best 
describes drRecD2 binding to pdT20-24. N  and IQ were calculated for both binding 
events with the first and second event denoted as Nj, IQi and N2, IQ2 respectively. 
The results are summarised in Table 4.4.
Table 4.4. Summary of ITC analysis of </rRecD2 with pdT20-25
pdT length N j Kdi (nM) n 2 IQ2 (nM)
2 0 2.0 (±0.09) 28 (±15) 1.0 (±0.03) 2.4 (±1.4)
2 1 1 .6  (±0 .0 1 ) 19 (±4) 1 . 0  (± 0 .0 1 ) 3.8 (±1.8)
2 2 1.7 (±0.01) 46 (±9) 1.0 (±0.05) 7.0 (±3.5)
23 2.3 (±0.15) 260 (± 1 0 0 ) 1.3 (±0.1) 19 (± 8 )
24 2 . 0  (±0.06) 98(± 31) 1.1 (±0.04) 8 . 6  (±2.5)
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As is necessary for the bipartite binding curve to be observed Kd2 is a lower value 
than K<n.
The two-binding-event model cannot be used to analyse the ITC data o f  drRecD2 
binding to pdT25 or pdT30 because no result is converged upon using iterative 
fitting o f the calculated curve.
4.3.2.2 DNA binding assays
For comparison o f  wild-type drRecD2 with mutant drRecD2 proteins a DNA  
binding assay was used. The binding o f  drRecD2 to a 5 ’-tailed duplex, ssDNA and 
dsDNA was investigated using this technique. The 5 ’-tailed duplex comprised 20bp 
duplex DNA with a 5 ’ pdT 12 tail. This was chosen for use in both the DNA binding 
and helicase assay so that the results could be compared. The ssDNA was pdT 15, 
this was chosen because the ITC data shows that one drRecD2 molecule binds to this 
length o f  DNA making the DNA binding assays easier to interpret. The dsDNA  
substrate comprised the duplex region o f the 5 ’-tailed duplex substrate so that the 
results could be compared. The Kd o f  drRecD2 for the DNA substrate was 
determined using DNA binding assays (see Figure 4.17).
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Figure 4.17. DNA binding activity of </rRecD2
A) Autoradiograph of a 9 % native PAGE analysis of the DNA binding assays of c/rRecD2 with i) the 5’- 
tailed duplex, ii) the ssDNA and iii) the dsDNA substrates. * indicates radio-labelled DNA substrate.
B) Plot of % DNA bound against </rRecD2 concentration in order to calculate ii) a of drRecD2 for the 
tailed duplex and ssDNA substrates.
The results show that JrRecD2 cannot bind dsDNA and binds to the 5’-tailed duplex 
substrate with a higher affinity than to the ssDNA substrate.
4.3.3 Helicase activity
Previous work has shown that drRecD2 and E.coli RecDl have 5’-3’ helicase 
directionality, i.e. the helicases unwind duplex DNA that has a 5’-ssDNA tail 
(Dillingham et al. 2003; Wang and Julin 2004). A helicase assay was performed in 
order to compare wild-type drRecD2 to the mutant drRecD2s. (see Figure 4.18). The 
substrate used was the same 5’-tailed duplex used in the DNA binding assays. The 
time taken to unwind 50% of the DNA substrate was determined (ti/2), as was the 
length of the 5’-tail required for activity. It is important to note that ti/2 is not a 
constant and will vary with the concentrations of both the enzyme and the DNA 
substrate used in the assay. However, all the helicase assays in this thesis use the
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same concentration o f  enzyme and substrate so 11/2 can be directly compared between
assays.
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Figure 4.18. Helicase activity of </rRecD2
A) Autoradiograph of a 10% SDS-PAGE analysis of the helicase assays of ofr-RecD2. The substrates were 
all 5’-tailed duplex DNA, the length of the 5’ tail varied from 8 to 12 nucleotides. ‘A’ indicates annealed 
substrate at time 0 min. ‘B’ indicates boiled substrate as marker for ssDNA. “"indicates radio-labelled 
DNA. B) Plot of % DNA unwound against time in order to calculate ii) a ti/2 for the substrates.
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4.4 Biochemical analysis of Deinococcus radiodurans 
RecD2 mutants
4.4.1 A new gene for the creation of Deinococcus 
radiodurans RecD2 mutants
The <7rRecD2 gene has a high GC content that causes problems for the polymerase 
chain reaction (PCR) o f  the gene. The cloning o f  the wild-type gene from 
Deinococcus radiodurans genomic DNA was not trivial (see Materials and 
Methods). Despite numerous attempts and conditions the mutants could not be 
cloned using the <7rRecD2 gene as a template because the replication o f  DNA step 
using PCR was unsuccessful. This problem was overcome by redesigning the wild- 
type gene sequence utilising codons recognised by the most abundant tRNAs present 
in E.coli whilst not changing the amino acid coding sequence. Changing the codons 
in this way had two consequences. Firstly, the gene sequence was less GC rich than 
the wild-type gene sequence allowing the replication o f  DNA using PCR. Secondly, 
the gene was better translated from mRNA to protein in E.coli leading to more 
protein being produced. The new sequence was designed and synthesised 
commercially. The new drRecD2 gene (drRecD2new) was cloned into an expression 
vector and underwent expression trials. The gene expressed soluble protein in 
various cell lines (data not shown). The amount o f  protein expressed from the 
drRecD2new gene was more than that from the drRecD2 gene. However, not all o f  
the protein expressed from the £/rRecD2new was soluble (see Figure 4.19). BL21 
E.coli was chosen as the expression strain as it grew the fastest, with cultures 
reaching an O.D6oonm o f  0.5 -  0.7 AU within three hours compared to six or seven 
hours for other E.coli expression strains.
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(1 mM ITPG)
Figure 4.19. Expression of </rRecD2 protein from the rfrRecD2new gene
A 12% SDS-PAGE analysis of the induced expression of soluble drRecD2 protein from the c/rRecD2new 
gene. The E.coli BL21 with the </rRecD2 expression vector was grown to 0.6 O.Dgoonm and was induced 
with ImM IPTG for 3 hours. A control culture was not induced. Purified drRecD2 as previously 
described was used as a marker for the molecular weight of t/rRecD2. *indicates soluble </rRecD2 protein 
expressed from the c/rRecD2new gene.
The drRecD2 protein expressed from drRecD2new gene was purified in the same way 
as drRecD2 protein expressed from the wild-type drRecD2 gene (see section 4.2.3).
The protein expressed from the drRecD2new gene had the same enzymatic activity as 
the protein expressed from the wild-type drRecD2 gene (see Figure 4.20 and Table 
4.5).
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Figure 4.20. ATP hydrolysis and helicase activity of rfrRecD2 protein from </rRecD2new gene
A) A plot of moles of ATP hydrolysed per mole of drRecD2 per second against pdT60 concentration in 
order to calculate a kcat and KDNA for the reaction in the presence of saturating (4 mM) ATP.
B) A helicase assay, a plot of % DNA substrate unwound against time.
Table 4.5. Summary of ATP hydrolysis and helicase activity of *frRecD2
ATP hydrolysis 
Kdna (nM)
ATP hydrolysis
kcat (S )
Helicase t\n  (min)
drRecD2 3.2 (± 0.3) 188 (± 3 ) 0.66 (± 0.04)
drRecD2new 4.5 (± 0.5) 203 (± 4) 0.75 (± 0.06)
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4.4.2 Motif A
4.4.2.1 Introduction
The helicase motifs la  and 3 play a role in the ssDNA translocation activity o f  the 
Bacillus stearothermophilus S F lA a  helicase, PcrA (foPcrA) (Dillingham et al. 
2001; Velankar et al. 1999). Phenylalanine 64 o f motif la  moves during the catalytic 
cycle o f ATP hydrolysis by foPcrA, opening and closing a hydrophobic DNA- 
binding pocket. The opening and closing o f the hydrophobic DNA-binding pocket 
forces the bases o f ssDNA bound to ZwPcrA to move (see Figure 4.21).
A ) i) S ubstra te  com plex ii) P roduct com p lex
A M P P M P  bound S u lpha te  ion bound
T3
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H587 Y257W259
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P3
.5’ -------
P4 P4
P2
5’-------  3'
ATP
Figure 4.21. Helicase motifs la  and 3 play a role in the ssDNA translocation by AsPcrA.
The DNA is coloured brown and the residues of binding pockets P2 and P4 are coloured red and blue 
respectively. F626 is coloured yellow. F64 of helicase motif la is shown as are Y257 and W259 of 
helicase motif 3.
A) Structural detail of the residues that comprise the ssDNA-binding sites of AsPcrA. i) The substrate 
complex with AMPPNP is bound, ii) The product complex with a sulphate ion bound that mimics a 
phosphate.
B) A schematic model of ssDNA-binding pockets of AsPcrA at different stages of the catalytic cycle of 
ATP hydrolysis. Upon ATP binding to PcrA F64 moves into pocket P2 displacing the base T2 into pocket 
PI, and T1 is pushed out of the protein and slides over domain 1A. This is accompanied by a closing of 
the cleft between domains 1A and 2A. Upon ATP hydrolysis F64 moves out of pocket 2 andT3 flips into 
the pocket. The movement of T3 forces T4 to flip into pocket P3, which in turn forces T5 to move and T6 
to flip into pocket P4. This is accompanied by a closing of the cleft between domains 1A and 2A.
This figure is based upon figures by Velankar et al. (Velankar et al. 1999).
H587
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The forced movement o f the DNA bases and the opening and closing o f  the cleft 
between domain 1A and domain 2A results in DNA translocation by an inchworm 
mechanism (see Figure 4.22)
Figure 4.22. Translocation of ssDNA by domain 1A and domain 2A of AsPcrA
Upon ATP binding to AsPcrA the affinity of domain 1A for ssDNA reduces while the affinity of domain 
of 2A for ssDNA increases, at the same time the cleft between the domains closes. Upon hydrolysis of the 
ATP by AsPcrA, the affinity of domain 1A for ssDNA increases and the affinity of domain 2A for ssDNA 
decreases, at the same time the cleft between the domains re-opens. The result of these steps is the 
translocation of ssDNA, with the 3’ tail end being moved out of AsPcrA while domain 1A and domain 
2A move in a 3’ to 5’ direction along the ssDNA.
Based upon sequence comparisons o f RecD and PcrA, the helicase motifs la  and 3 
in RecD do not have three key residues o f PcrA. F64, Y257 and W259 o f foPcrA are 
P205, S303 and E305 in E.coli RecDl.
Motif 1 a Motif 3
R e c D l
R e c D 2
E.coli
S .typhimurium 
V.cholerae 
H .Influenzea 
P.aeruginosa
D.radiodurans 
L.lactis 
S.pneumoniae 
B.cereus 
L.plantarum
Bs PcrA 
overall
LAAFTGKAAARLTESLG 
LAAPTGKAAARLTESLG 
LIAPTGKAAARLTESMG 
LVAPTGKAASRLEESIK 
LAAPTGKAAARLSESIG 
* ******* ; ** **• 
LCAPTGKAARRLGEVTG 
LAAPTGRASRRMNELTG 
LAAPTGRAARRMNELTG 
LTAPTGRAAKRMSESTG 
LAAPTGRAAKRMAETTG 
* * * * * . * . . * .  * * *
AITFTNKAAREMRERVQ 
* *
GDRDQLASVEAGAVLG 
GDRDQLASVEAGAVLG 
GDKDQLASVBSAGAVLG 
GDQAQLASVEAGAVLG 
GDRDQLASVEAGAVLG 
* * • * * * * ★ # ★ ★ * ★ * *
GDTDQLPPVDAGLPLL 
GDADQLPSVGPGQIFA 
GDSDQLPSVSPGQVLA 
GDE DQLP SVGPGQVLK 
GDKDQLPSVGAGQVFH
* *  * * * * ■ * ! *  j
GDADQSIYRWRGADIQ 
* *  *  *  .
Figure 4.23. A sequence comparison of the helicase motifs la  and 3 in RecD and AsPcrA
F64, Y257 and W259 of are indicated in grey, as are the residues in an equivalent position in the motifs of 
the RecD family of enzymes.
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An updated structure o f E.coli RecBCDl (personal communication, Wigley, D.) 
shows that a hydrophobic pocket is present in E.coli R ecD l, o f  which P205 is a part 
(see Figure 4.24).
A) i)BsPcrA B) i) E.coli RecDl
IR 2 5 8 F V  \  E305
T5 W 2 5 9 V ^ Y 2 5 7  JH587
Figure 4.24. T he ssDNA-binding pockets of AsPcrA and E.coli RecDl
A) i) Structural detail and ii) a schematic of the residues that comprise the ssDNA-binding sites of 
AsPcrA. The DNA is coloured brown and the residues of binding pockets P2 and P4 are coloured red and 
blue respectively. F64 of helicase motif la is shown as are Y257 and W259 of helicase motif 3.
B) Structural detail and ii) a schematic of the residues that comprise the only ssDNA-binding site of 
E.coli RecDl identified to date, P2’. The DNA is coloured brown and the residues of binding pocket P2’ 
are coloured red. P205 of helicase motif la is shown, as are S303 and E305 of helicase motif 3 (blue).
The hydrophobic pocket o f  E.coli RecDl does not appear to have any residues 
analogous to F64 o f foPcrA, which flips DNA bases in and out o f pocket P2.
The 5 ’-tail o f the substrate DNA in the E.coli RecBCDl structure appears to be
orientated in such a way that any ssDNA translocation activity by E.coli RecDl
would push the 5 ’ end o f the ssDNA toward domain 2B o f E.coli RecDl. However,
the 2B domain o f E.coli RecDl is disordered in the structure o f  E.coli RecBCDl, so
it is not possible to say if  domain 2B interacts with the ssDNA substrate. Sequence
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comparisons o f  RecD show a conserved m otif (m otif A) in domain 2B o f  types 1 and 
2 RecD proteins, that has also been reported to exist in the S F lB a  helicase Pifl 
(Zhang et al. 2006a)(see Figure 4.25).
Motif A Motif V
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RecDl
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S.pneumoniae 
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D.radiodurans
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S.typhimurium 
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H.Influenzea 
P.aeruginosa
H.sapiens_Pif1 
Overall
NVFNGDLGQIV 
HVFNGDLGAIT 
NVFNGDIGKIV 
QVFNGDIGEIV 
EIFNGTLGMVL
GLFNGDIGIAL
GLFNGDIGIAL
GLVNGDIGLCH
RLYNGDIGLCL
GLMNGDIGIAL
TLVNGARGWV
-DELVMDF--DGQELT----- YPRAEWYKITLAYAMSIHKSQGSEF
-DEIVIDF--DSNEVS----- YPRNEWYKIRLAYAMSIHKSQGSEF
-DQITIAF--DQNEVT----- YQRNEWNRLTLAYSMSIHKSQGSQF
— MI IVSF--DGI EVTYTKPDLNQITHAYCCSIHKSQGSEF
-ELIAAKYTDSKQ-----------
-DLIPGKYTESKQ-----------
IDLANDSHNESKK-----------
-SVFYAKENVEQQD----------
-KAE------- GA---------------- RLTVDF-- DGN-----WELTGAELFNLQLGYALTVHRAQGSEW
-------- DRGQG------------------TRVWFAMPDGN---- 1KSVQPSRLPEHETTWAMTVHKSQGSE F
-------- DRGQG------------------LRVWFVMPDGT---- IKSVQPSRLPEHDTTWAMTVHKSQGSEF
-R-----DRDDDQG---------------- RLKVYFELPDGS---- 1KAVLPSRVPQHETAYAMTI HKSQGSEF
-------- ANG-------------------- KVWF--- GN----- REVLTNRIPAHEPAFMMTIHKSQGSEF
-RLPERNDDGSLR---------------- FALRVAF-- PRNDGSGGVRFVLPSRLVEVDTVFAMTVHKSQGSEF
-GFE- - AEGRGLPQVRFLCGVTEVIHADRWTVQA TGG------ QLLSRQQLPLQLAWAMSIHKSQGMTL
Figure 4.25. Motif A
Sequence comparison of the RecDl and RecD2 proteins and Human Pifl. Motif A is outlined in black 
and motif V is shown for reference.
As there are no obvious candidate residues that could be involved in the ssDNA  
translocation activity o f  R ecD l and RecD2 enzymes, it was reasoned the 
phenylalanine in m otif A o f  the 2B domain might interact with ssDNA in a similar 
fashion to phenylalanine 64 in faPcrA. In order to investigate the role o f  the 
conserved m otif A, phenylalanine 635 was mutated to an alanine in drRecD2 to 
make drRecD2F635A.
4.4.2.2 Biochemical analysis of drRecD2F635A
Phenylalanine 635 o f  drRecD2 was mutated to an alanine to produce drRecD2F635A 
and the protein was expressed and purified (see Figure 4.26).
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iF635AFigure 4.26. Purified </rRecD2
A 12% SDS-PAGE analysis of the purity of </rRecD2F635A.
ATP hydrolysis and helicase assays o f <7rRecD2F635A were performed (see Figure 
4.27 and Table 4.6).
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Figure 4.27. ATP hydrolysis and helicase activity of </rRecD2F635A
A) ATP hydrolysis activity. A plot of moles of ATP hydrolysed per mole of c/rRecD2 or drRecD2F635A 
per second against pdT60 concentration in order to calculate a kcal and KDNA for the reaction in the 
presence of saturating (4 mM) ATP.
B) Helicase activity, i) A plot of % DNA substrate unwound against time, ii) Autoradiograph of a 10% 
SDS-PAGE analysis of a helicase assay of drRecD2F635A. ‘A’ indicates annealed substrate at time 0 min. 
‘B’ indicates boiled substrate as marker for ssDNA. *indicates radio-labelled DNA.
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Table 4.6. Summary of ATP hydrolysis and helicase activity of </rRecD2F635A
ATP hydrolysis 
Kdna (nM)
ATP hydrolysis 
kcat (S )
Helicase ti/2 (min)
<7rRecD2 3.2 (± 0.3) 188 (± 3) 0.66 (± 0.04)
drRecD2K6J5A 5.0 (± 0.6) 178 (± 4) 0.85 (± 0.08)
There is no significant difference between the K D n a , k c a t  and tm  o f  <7rRecD2F635A and 
those o f  c/rRecD2.
DNA binding assays were not performed in this instance. The ATP hydrolysis assay 
is also an indicator o f DNA binding and drRecD2F635A has the same ATP hydrolysis 
activity as <7rRecD2. The helicase activity was also not affected by the mutation. 
These data suggest that phenylalanine 635 has no significant role in the helicase 
activity o f  the JrRecD2 protein.
4.4.3 The N-terminal region
4.4.3.1 Introduction
The N-terminal region o f <irRecD2, here defined as being from the N-terminal amino 
acid through to, but not including, helicase m otif 1 and comprising amino acids 1- 
362, is larger than that o f  the N-terminal domain 1 o f  E.coli R ecD l that comprises 
amino acids 1-172. The type 2 RecD enzymes characteristically have a larger N- 
terminal region than the type 1 RecD helicases (see Figure 4.28).
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Figure 4.28. A comparison of the N-terminal domains of RecD2 and RecDl enzymes
A) The structure and a schematic of E.coli RecDl. The N-terminal domain 1 is coloured in brown and the 
rest of the protein in grey.
B) A schematic comparison of the N-terminal domain 1 of E.coli RecDl coloured in brown with the N- 
terminal of three examples of RecD2 enzymes also coloured in brown.
Domain 1 o f E.coli RecDl is responsible for binding to E.coli RecC in the E.coli 
RecBCDl complex. This cannot be the function o f the N-terminal region o f the 
RecD2 helicases because, by definition, there is no bona fid e  RecC, or RecC 
homologue available for RecD2 to bind to. It was reasoned that the N-terminal 
region o f  the RecD2 helicases could be responsible for disrupting the duplex DNA 
ahead o f  the helicase motor domains, similar to the function o f  the 2B domain o f  
PcrA or the N-terminal domain o f RecG (Singleton et al. 2001; Soultanas et al. 
2000; Velankar et a l  1999). During the purification o f JrRecD2 a distinct 
proteolysic fragment was isolated (see section 4.2.3). The fragment was N- 
terminally sequenced, which revealed drRecD2 had been proteolysed between 
tryptophan 150 and serine 151 indicating that this point could be between two 
distinct regions o f secondary structure. It was reasoned that this would be a good 
point to make an N-terminal truncation as the protein would be stable and soluble 
and would probably not undergo further proteolysis. A truncated drR scD l was 
produced from amino acid 151 to the C-terminal end amino acid, (drRecD2ANT). 
There is no obvious homology between the N-terminal regions o f the RecD2 family
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helicases, or between the N-terminal region o f the RecD2 and RecDl family 
helicases.
4.4.3.2 Biochemical analysis of c/rRecDANT
Amino acids 1-151 inclusive of drRecD2 were deleted to create t/rRecD2ANT and the 
protein was expressed and purified (see Figure 4.29).
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Figure 4.29. Purity of </rRecD2ANT
A 12% SDS-PAGE analysis of the purity of */rRecD2ANT.
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4.4.3.2.1 ATP hydrolysis activity
The ATP hydrolysis activity o f drRecD2ANT was investigated (see Figure 4.30).
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Figure 4.30. ATP hydrolysis activity of </rRecD2ANT
A) A plot of moles of ATP hydrolysed per mole of c/rRecD2ANT per second against pdT60 concentration 
in order to calculate a kcat and KDNA for the reaction in the presence of saturating (4 mM) ATP. The 
i/rRecD2 ATP hydrolysis assay is inset for comparison.
B) A plot of moles of ATP hydrolysed per mole of c/rRecD2ANT per second against ATP concentration in 
order to calculate KATP of the reaction in the presence of saturating (3.2 pM) pdT60 DNA substrate.
The results show drRecD2ANT has a significantly higher K d n a  than that o f  wild-type 
drRecD2, suggesting that drRecD2ANT has a higher IQ for ssDNA than that o f wild- 
type <7rRecD2. The K A t p  of drRecD2ANT was similar to that o f  wild-type drRecD2, 
suggesting that ATP binding was unaffected by the mutation (see Table 4.7).
Table 4.7. Summary of ATP hydrolysis activity of rfrRecD2ANT
K d n a  (nM) kcat (S ) K a tp  (mM)
<7rRecD2 3.2 (± 0.3) 188 (± 3 ) 0.57 (±0.03)
drRecD2aNT 230 (± 15) 1 9 9  (± 3) 0.78 (±0.13)
The kcat o f drRecD2ANT was comparable to that o f wild-type drRecD2 indicating the 
ATP hydrolysis activity was not affected by the mutation when enough ssDNA was 
present to overcome the defect in DNA binding and stimulate the ATP hydrolysis 
activity o f  drRecD2ANT (see Table 4.7).
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4.4.3.2.2 DNA binding activity
The ATP hydrolysis assay had indicated that drRecD2ANT has a higher Kd for ssDNA  
than that o f  wild-type drRecD2. These data suggested a role for the N-terminus o f  
c/rRecD2 in ssDNA binding. DNA binding assays were carried out to investigate the 
DNA binding activity o f drRecD2ANT to ssDNA, 5 ’-tailed duplex DNA and dsDNA  
(see Figure 4.31).
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Figure 4.31. DNA binding activity of </rRecD2ANT
A) Autoradiograph of a 9% native PAGE analysis of the DNA binding assay of drRecD2ANT with i) the 
5’-tailed duplex , ii) the ssDNA and, iii) dsDNA substrates. *indicates radio-labelled DNA substrate.
B) A plot of % DNA bound against </rRecD2ANT concentration in order to calculate a of drRecD2ANT 
for the 5’-tailed duplex and ssDNA substrates.
The Kd o f  JrRecD2ANT for the 5 ’-tailed duplex substrate is approximately 500 times 
greater than that o f wild-type drRecD2 (see Table 4.8).
Table 4.8. Summary of DNA binding activity of rfrRecD2ANT
Kd for the 5’-tailed 
duplex substrate (nM)
Kdfor the ssDNA 
substrate (nM)
Kdfor the dsDNA 
substrate (nM)
dr\R.ecD2 1.3 (±0.2) 20 (± 3) No binding
i*-RecD24NT 461 (±45) 160 (± 16) No binding
The Kd o f drRecD2ANT for the ssDNA substrate is approximately 5 times greater than
that o f JrRecD2, and no binding o f JrRecD2ANT to dsDNA is observed (see Table
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4.8). These data would suggest that the N-terminus o f drRecD2 plays a significant 
role in the binding duplex DNA in the context o f  a 5 ’-tailed duplex DNA structure.
4A.3.2.3 Isothermal calorimetry (ITC)
In order to confirm the defect in ssDNA binding, an ITC experiment was performed 
with drRecD2ANT and pdT15 (see Figure 4.32).
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Figure 4.32. Isothermal calorimetry of r/rRecD2ANT and pdT15
Isothermal calorimetry experiment. The ssDNA substrate, pdT15, was injected into c/rRecD2ANT.
The results as compared with wild-type drRecD2 are summarised in Table 4.9.
Table 4.9. Summary of ITC results of r/rRecD2ANT
N Kd (nM)
drRecD2 1.0 (±0.01) 17 (±3)
</rRecD2ANT 1.1 (±0.02) 1170 (±190)
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4.4.3.2.4 Helicase activity
The helicase activity o f <irRecD2ANT was investigated using helicase assays (see 
Figure 4.33). All the helicase assays contained 1 nM drRecD2 or JrRecD2ANT and 1 
nM DNA substrate.
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Figure 4.33. Helicase activity of </rRecD2ANT
A) Autoradiographs of 10% SDS-PAGE analysis of the helicases assays of i) drRecD2 and ii) 
drRecD2ANT. The substrates were all 5’-tailed duplex DNA, the length of the 5’ tail varied from 8 to 12 
nucleotide (nt). ‘A’ indicates annealed substrate at time 0 min. ‘B’ indicates boiled substrate as marker for 
ssDNA. * indicates radio-labelled DNA.
B) A plot of % DNA unwound against time.
There was no significant difference o f the Xm o f  <irRecD2ANT compared to wild-type 
drRecD2 (see Table 4.10). Neither was there a difference in the length o f  5 ’ tail 
required for activity.
155
Table 4.10. Summary of helicase activity of </rRecD2ANT
t , / 2  for pdT12 S’- 
tailed duplex DNA 
(min)
ti /2  for pdTIO 5’- 
tailed duplex DNA 
(min)
11/2 for pdT8 5’- 
tailed duplex DNA 
(min)
drRecD2 0.66 (± 0.04) 0.65 (± 0.13) No activity
^ R ecD 2 4NT 0.65 (± 0.02) 0.49 (± 0.03) No activity
This is a surprising result as drRecD2ANT appears to have the same helicase activity 
as that o f wild-type drRecD2 despite the fact that the IQ o f drRecD2ANT for the 5 ’- 
tailed duplex DNA substrate is approximately 500 times larger than that o f  wild-type 
drRecD2.
4.4.3.2.5 Helicase processivity
If drRecD2ANT is a more processive helicase than drRecD2 then this fact may help 
explain how the helicase activity o f drRecD2ANT is apparently the same as wild-type 
drRecD2, despite drRecD2ANT having a larger Kd for the 5 ’-tailed duplex substrate 
than that o f  wild-type drRecD2. In order to investigate the helicase processivity o f  
drRecD2ANT and drRecD2 a processivity assay was performed (see Figure 4.34). The 
assay measures the amount o f DNA substrate unwound by a helicase, which is pre­
bound to the DNA substrate, before the helicase dissociates from the DNA substrate. 
After dissociating from the DNA the helicase is bound by a trap that stops the re­
binding o f  the helicase to the DNA substrate.
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Figure 4.34. Processivity assay of </rRecD2ANT and </rRecD2
Autoradiograph of 10% SDS-PAGE analysis o f :
A) Processivity assays of i) drRecD2 and ii) drRecD2ANT with a 20bp or 40bp 5’-tailed duplex DNA 
substrate.
B) i) Positive control showing E.coli RecBCDl unwinding both substrates used in the assay, ii) Negative 
control showing no re-annealing of the DNA substrate during the time course of the assay after boiling.
‘A’ indicates annealed substrate at time 0 min. ‘B’ indicates boiled substrate as marker for ssDNA. 
indicates radio-labelled DNA.
The assay is dependent on all o f the DNA molecules present in the assay being 
bound to the helicase. In order to achieve this, 1 p,M drRecD2ANT was used meaning 
all the 5’-tailed duplex substrate should be bound (see Figure 4.31). The same 
concentrations were used for drRecD2 so that a direct comparison could be made. 
Neither drRecD2ANT nor JrRecD2 could unwind 20bp before dissociating from the 
DNA and no difference could be seen between them. E.coli RecBCDl is a very 
processive helicase and was therefore used as the positive control.
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4.4.3.3 Biochemical analysis of drRecD2NT
Amino acids 1-150 of drRecD2, part of the N-terminal region of <irRecD2, were 
cloned into an expression vector to create drRecD2NT and the protein was expressed 
and purified (see Figure 4.35).
A
Mw 
(KDa) ^  
175-
8 3 .0 -
6 2 .0 -
4 7 .5 -
3 2 .5 -
2 5 .0 -
16 .0-
6 .5 0 -
Figure 435. Purity of </rRecD2N
A 12% SDS-PAGE analysis of the purity of </rRecD2NT.
There were no grounds to suspect that the drRecD2NT would have ATP hydrolysis 
activity as drRecD2NT does not posses the Walker A and B motifs characteristic of 
such activity, nor were there any grounds to suspect helicase activity.
DNA binding assays were carried out to see if  drRecD2NT could bind to any of the
DNA substrates as suggested by the fact that £/rRecD2ANT, which is missing amino
acids 1-150, has significant defects in DNA binding compared to wild-type
drRecD2. The results show that drRecD2NT failed to bind to any of the DNA
substrates (see Figure 4.36), but there is no positive control to confirm that
drRecD2NT is correctly folded. No ITC analysis was performed because drRecD2NT
had failed to show any DNA binding properties.
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Figure 4.36. DNA binding activity of </rRecD2NT
Autoradiographs of 9% native PAGE analysis of the DNA binding assays of drRecD2NT with A) the 5’- 
tailed duplex. B) the ssDNA and C) the dsDNA substrates. * indicates radio-labelled DNA substrate.
During the purification o f t/rRecD2NT a gel-filtration chromatography step was used. 
drRecD2NT eluted at approximately 16 ml indicating a molecular weight o f  
approximately 20 KDa suggesting that <7rRecD2NT is running on the gel-filtration
column as a monomer (see Figure 4.37).
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Figure 4.37. Gel-filtration analysis of r/rRecDZ*7
A) The A2go (blue) and A260 (red) trace of the gel-filtration chromatography of drRecD2NT.
B) A 15% SDS-PAGE analysis of the gel-filtration chromatography showing the load on to the gel 
filtration column and the significant fractions eluted from the column.
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These data indicate that drRecD2NT is monomeric and does not form aggregates, but 
this does not prove JrRecD2NT is correctly folded. Crystallisation trials o f  
drRecD2NT were attempted, but drRecD2NT was not crystallised. If aHlecD2NT had 
been crystallised it would have shown that afrRecD2NT was uniformly folded. 
However, the failure o f drRecD2NT to crystallise does not prove that drRecD2NT is 
misfolded.
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4.4.4 The 1B domain
4.4.4.1 Introduction
Recent work on the E.coli RecBCDl structure revealed a loop that is inserted into 
domain 1A o f E.coli R ecD l, against which the 5 ’ tail o f the ssDNA, fed by E.coli 
RecC to E.coli R ecD l, appears to slide (personal communication, Wigley. D.). This 
loop (domain IB) might act as a molecular pin in the RecD2 family over which the 
DNA duplex is split as part o f the helicase mechanism (see Figure 4.3 8A).
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Figure 4.38. The IB domain loop of RecD
A) The structure of motor domains 1A (green) and 2A (red) of E.coli RecDl with the details of the IB 
domain loop (blue) shown. A sequence conserved region is coloured in orange.
B) A sequence comparison of RecDl and RecD2 between helicase motifs la and 2. The domain IB loop 
is outlined in blue. The conserved region as shown in A) is outlined in orange.
There does not appear to be any base stacking or hydrogen bond interactions 
between the amino acids o f  the loop and the DNA nucleotides, only Van der Waals 
forces are at play. This suggests that the DNA is not being bound tightly or moved 
by the loop, but rather it suggests that the loop is a mechanical feature over which 
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the base pair interactions o f  duplex DNA are broken apart. The loop could be 
structurally conserved in other RecD genes and the sequence N-terminal and C- 
terminal to the loop is conserved in the RecDl family and drRecD2. However, in 
those RecD2 helicases that are phylogenetically further away from the RecDl family 
(see Chapter 1) only the sequence N-terminal to the loop is conserved (see Figure 
4.38B). The RecDl helicases also have an extra insertion N-terminal to the loop 
compared to the RecD2 helicases. The loop may, therefore, be in different positions 
in the RecDl helicases compared to the RecD2 helicases (see Figure 4.38B).
There is a loop in the S F lB a  human RNA helicase U pfl that could also act as a 
molecular pin over which base pair interactions o f  duplex DNA are broken open. 
However, a molecular pin o f  this nature may not be needed in this case as human 
U pfl has a large 1C domain that may be analogous to domain 2B o f  foPcrA which 
disrupts the base pair interactions o f duplex DNA (see Figure 4.39).
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Figure 4.39. A comparison of RecDl and Upfl
A) A sequence comparison of the RecDl family and human Upfl. The conserved regions (orange) and 
loop (blue) of RecDl are outlined, as is a loop (blue) in Upfl. The 1C domain of human Upfl is outlined 
in yellow.
B) A structural comparison of domain 1A and domain IB of i) E.coli RecDl and ii) Upfl, showing 
domain 2A (red), 1A (green), 1C (yellow), with the IB domain loop of E.coli RecDl and a loop in a 
similar position in Upfl both coloured blue.
It was reasoned that amino acids 244 to 253 inclusive o f  E.coli RecDl could be 
replaced with a glycine in order to remove the DNA interacting part o f the loop 
without disturbing the secondary structure or folding o f  E.coli RecDl. A glycine 
would be able to span the distance between leucine 243 and arginine 254 in E.coli 
RecDl (see Figure 4.40).
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Glycine
Figure 4.40. Deleting the IB loop of E.coli RecDl
A) Structure of the IB loop (blue) of E.coli RecDl (green) with L243 and R244 highlighted in orange.
B) A model of the structure of E.coli RecD with the loop replaced with a glycine (blue). L243 and R244 
highlighted in orange.
Based on the sequence comparisons o f E.coli RecDl and <7rRecD2, replacing amino 
acids 243-254 (inclusive) o f  E.coli RecDl with a glycine was reasoned to be 
analogous to replacing amino acids 412-419 (inclusive) o f  drRecD2 with a glycine 
(see Figure 4.38).
4.4.4.2 Biochemical analysis of drRecD2A,oop
Amino acids 412-419 (inclusive) o f drRecD2 were replaced with a glycine to 
produce drRecD2Aloop. The protein was expressed and purified (see Figure 4.41).
MW ^  &  (KDa) ^  &
175 -
8 3 . 0 -
6 2 . 0 -
3 2 . 5 -
2 5 . 0 -
Figure 4.41. Analysis of the purity of </rRecD2Aloop
A 12% SDS-PAGE analysis of the purity of drRecD2Aloop.
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4.4.4.2.1 ATP hydrolysis activity
The ATP hydrolysis activity o f  <7rRecD2Aloop was investigated and the K d n a  and 
K a t p  determined (see Figure 4.42).
d rR e c D 2 Ak>op
d rR e cD 2 Al00p
3  S 100"
0 10 20 30 40 90 to  70 90 90 100
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[pdT60] nM [ATP] mM
Figure 4.42. ATP hydrolysis activity of </rRecD2Aloop
A) A plot of moles of ATP hydrolysed per mole of c/rRecD2Aloop per second against pdT60 concentration 
in order to calculate the kcat and K d n a  for the reaction in the presence of saturating (4 mM) ATP. The 
drRecD2 ATP hydrolysis assay is inset for comparison.
B) A plot of moles of ATP hydrolysed per mole of < r^RecD2Aloop per second against ATP concentration in 
order to calculate the KATPof the reaction in the presence of saturating (400 nM) pdT60 DNA substrate.
The K d n a  o f <7rRecD2Aloop was approximately 10 times larger than the K d n a  o f  
drRecD2. There was no difference in the k c a t  and K A t p  o f drRecD2Aloop and drRecD2 
(see Table 4.11).
Table 4.11. Summary of ATP hydrolysis activity of */rRecD2A,oop
K d n a  (nM) kcat (S ) K Atp  (mM)
drRecD2 3.2 (± 0.3) 188 (± 3 ) 0.57 (±0.03)
£/rRecD24loop 32 (± 4 ) 185 (± 5 ) 0.52 (±0.07)
These data indicate the ATP hydrolysis activity was not affected by the mutation 
when enough ssDNA was present to overcome the defect in DNA binding and 
stimulate the ATP hydrolysis activity o f drRecD2Aloop.
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4.4.4.2.2 DNA binding activity
The yield o f drRecD2Aloop from the expression and purification o f the protein was 
approximately 0.1 mgs per litre o f  E.coli culture. This was much lower than the yield 
o f  ^ /rRecD2 and not enough drRecD2Aloop could be purified for an ITC analysis. 
The Kd o f drRecD2 for the 5 ’-tailed duplex, ssDNA and dsDNA substrates were 
determined using the DNA binding assays (see Figure 4.43).
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Figure 4.43. DNA binding activity of </rRecD2Aloop
A) Autoradiographs of 9% native PAGE analysis of the DNA binding assays of dirRecD2Aloop with i) the 
5’-tailed duplex, ii) the ssDNA, and iii) the dsDNA substrates. ""indicates radio-labelled DNA substrate.
B) Plot of % DNA bound against drRecD2Aloop concentration in order to calculate the IQ of drRecD2Aloop 
for the 5’-tailed duplex and ssDNA substrates.
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Table 4.12. Summary of the DNA binding activity of </rRecD2Aloop
K<jfor the 5’-tailed 
duplex substrate (nM)
Kdfor the ssDNA 
substrate (nM)
Kdfor the dsDNA 
substrate (nM)
<7rRecD2 1.3 (±0.2) 20 (± 3) No binding
<7rRecD2Aloop 120 (±12) 48 (± 5) No binding
The Kd o f drRecD2Aloop for the 5 ’-tailed duplex substrate is approximately 100 times 
larger than that o f wild-type drRecD2. The Kd o f drRecD2Aloop for the ssDNA  
substrate is 2.5 times than that o f wild-type drRecD2. No binding of drRecD2Aloop to 
the dsDNA substrate was observed.
4.4.4.2.3 Helicase activity
The helicase activity o f drRecD2Aloop was investigated. No unwinding o f the 5 ’- 
tailed substrate by drRecD2Aloop was observed (see Figure 4.44).
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Time (mins)
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Figure 4.44. Helicase activity of </rRecD2Aloop
A) Autoradiographs of 10% SDS-PAGE analysis of the helicase assays of i/rRecD2Aloop and drRecDl. 
‘A’ indicates annealed substrate at time 0 min. ‘B’ indicates boiled substrate as marker for ssDNA. 
*indicates radio-labelled DNA.
B) A plot of % DNA substrate unwound against time.
The lack o f helicase activity could have been a symptom o f drRecD2Aloop not being 
able to bind to the 5 ’-tailed duplex DNA substrate. Both the helicase and DNA
drRecD2
d/f?ecD2
1001
70-
■ drftecD2Aloop 
▼ drRecD2
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binding assays use 1 nM o f the 5 ’-tailed duplex DNA substrate. The DNA binding 
assays show that when 1 nM drRecD2Aloop is used the DNA substrate is not bound by 
drRecD2Aloop, but if  1 pM drRecD2Aloop is used then the DNA substrate is bound by 
drRecD2Aloop (see Figure 4.43 A). Therefore, a helicase assay was performed in 
which the concentration o f drRecD2Aloop was varied and the time was kept constant 
at 16 minutes (see Figure 4.45).
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Figure 4.45. Helicase assay varying the concentration of */rRecD2Aloop
A) Autoradiograph of a 10% SDS-PAGE analysis of a helicase assay of c/rRecD2Aloop with varying 
drRecD2Aloop concentration and 1 nM tailed duplex substrate over 16 minutes. ‘A’ indicates annealed 
substrate at time 0 min. ‘B’ indicates boiled substrate as marker for ssDNA. *indicates radio-labelled 
DNA.
B) A graph of % DNA unwound in 16 minutes against the concentration of JrRecD2 and c/rRecD2Aloop.
No helicase activity o f  £/rRecD2Aloop was observed, even when 1 - 2 pM 
drRecD2Aloop was used so that all the tailed duplex substrate present was bound by 
</rRecD2Aloop.
These data suggest that the defect in the helicase activity o f drRecD2Aloop is due to an 
intrinsic helicase defect and not due to ATP hydrolysis or DNA binding defects.
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4.5 Discussion
The aim o f this part o f the thesis was to gain insights into the helicase mechanism o f  
Deinococcus radiodurans RecD2 (drRecD2), a Superfamily IB a  helicase, using 
biochemical techniques. There is very little known about the S F lB a  helicase 
mechanism and only one structure o f  a DNA S F lB a  helicase is available, that o f  
E .coliR ecD l as part o f the E.coli RecBCDl complex (Singleton et al. 2004). More 
recently the structure o f an RNA S F lB a  helicase, human U p fl, was also solved 
(Cheng et al. 2007). Neither o f  these structures have nucleic acid bound to the 
helicase motor domains. The E.coli RecBCDl structure has recently been updated 
with a longer 5 ’-tail o f the DNA substrate, which interacts with E.coli RecDl 
(personal communication, Wigley, D.). The 5 ’ tail o f  the DNA substrate is seen to 
interact with domain 1A o f E.coli R ecD l, but does not reach the domain 2A o f the 
helicase, and the helicase mechanism cannot be elucidated.
4.5.1 Identification and purification of Deinococcus 
radiodurans RecD2
Deinococcus radiodurans RecD2 was chosen as the target for study as it was the 
only soluble RecD helicase identified in this thesis. It was decided to screen RecD2 
helicases because they might be more soluble than R ecD l helicases. The reasoning 
was that R ecD l enzymes exist as part o f  a RecBCDl complex and would be 
insoluble when separated from the complex, and because RecD2 proteins are not 
part o f  a RecBCDl complex they may be soluble. However, all but one o f  the 
RecD2 helicases cloned in this work were insoluble. Predicting whether a protein 
will be soluble is not an exact science and the reasons for the majority o f  the RecD2
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proteins tested in this work being insoluble are not clear. It is tempting to speculate 
that RecD2 helicases do exist as part o f  a larger order complex in the cell.
The classification o f RecD-like enzymes may need to be further developed. It seems 
illogical to refer to RecD2 enzymes as RecD because there is no evidence to suggest 
that RecD2 enzymes perform an analogous function to RecD l enzymes. There may 
be more RecD-like enzymes that do fit into the RecD l or RecD2 family, for 
example, the Y F19M ETJA  protein o f  the archaeon Methanococcus jannaschii. 
Eukaryotes and archaea do not use the RecBCDl reaction pathway so even if  RecD2 
helicases performed an analogous function to RecDl helicases, this cannot be the 
case for the Methanococcus jannaschii YF19 METJA protein.
The purification o f  drRecD2 was based upon work by Wang et al. (Wang and Julin 
2004). It was apparent that the purification described by Wang et al. was not 
designed to produce the high yields o f  protein required for crystallography. The first 
improvement on the protocol was the use o f  the E.coli BL21 Rosetta strain to 
express the protein, which yielded more drR ecD l protein than using BL21. The 
second improvement was the use o f  a heparin column rather than a ssDNA cellulose 
column. The ssDNA cellulose is a single use medium and would need to be replaced 
for every purification. Apart from being expensive, this does not lend itself to a high 
throughput purification protocol because the preparation o f  the medium is time 
consuming and the ssDNA can be stripped o ff the cellulose very easily. A heparin 
column served the same purpose and was readily available. The third improvement 
was to add a MonoQ column to the protocol, which further purified drRecD2 to the 
extent required to start crystallisation trials.
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Two interesting observations were made from the purification o f drRecD2. Firstly, a 
fragment o f  <7rRecD2 was identified as being an N-terminal truncation o f  drR scD l. 
The N-terminal truncated drRecD2 fragment was N-terminally sequenced. A 
consistent and well defined N-terminal sequence was identified suggesting the 
majority o f  the <7rRecD2 molecules were proteolysed at the same point between 
amino acids 150 and 151. This is a very specific proteolysis and suggested that 
amino acids 1-150 form a region o f  secondary structure that is linked to the rest o f  
the protein with a flexible linker that is open to proteolysis. The gene sequence o f  the 
<7rRecD2 fragment was cloned into an expression vector to create drRecD2ANT. The 
second observation was a possible interaction o f  drRecD2 with E.coli RecB and 
RecC, suggested by the fact that they all co-purified on the MonoQ column in a 
separate peak from the main peak o f  drR ecD l (see Figure 4.6 B). However, this 
interaction could not be reproduced using gel filtration analysis. This does not 
discount an interaction o f drRecD2 and E.coli RecB and C, indeed <7rRecD2ANT was 
also seen to co-purify with E.coli RecB and RecC on a MonoQ column. There could 
be in vivo factors within the E.coli expression strain that are aiding the complex 
formation o f  drRecD2 and E.coli RecBC , which are missing in the in vitro 
experiments
4.5.2 Biochemical analysis of wild-type Deinococcus 
radiodurans RecD2
Helicase activity is reliant on the co-ordination o f  several molecular processes. One
o f  these activities is ATP hydrolysis that provides the energy required to unwind
duplex DNA and to translocate ssDNA. Another is the DNA binding activity, in
order for the helicase to be able to unwind a substrate the helicase must be able to
bind to the substrate. In order to understand the effects o f  any mutations o f  drRecD2
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on the helicase activity, the ATP hydrolysis, DNA binding and helicase activities of
wild-type drRecD2 were characterised.
The kcat, K atp and K Dna were all determined for wild-type drRecD2. Other work has 
shown drRecD2 to be a ssDNA-stimulated ATPase, but no kinetic analysis was 
undertaken (Wang and Julin 2004) so these results cannot be compared to the kinetic 
analysis o f  this chapter. Many SF1 helicases are ssDNA-dependent ATPases and 
<7rRecD2 appears to be a better ssDNA stimulated ATPase than foPcrA. The kcat o f  
drR soD l is around two orders o f  magnitude higher than that o f  6sPcrA under ATP 
and DNA saturating conditions (Dillingham et al. 1999), although differences in the 
buffer conditions have not been controlled for.
In the DNA binding assays the Kd is taken as equal to the <7rRecD2 concentration 
required to bind 50% o f the total DNA substrate to <7rRecD2. This is not ideal and 
will not provide as accurate a Kd as isothermal calorimetry. This is because the 
assumption has to be made that the free DNA and protein/DNA complex is in 
equilibrium. However this equilibrium will be disturbed as the protein/DNA  
complex is separated away from the free DNA and free protein in the electrophoresis 
gel. However, the assay is very useful to compare the relative DNA binding activity 
o f  different proteins under identical conditions. These assays were ideally suited to 
comparing the wild-type <7rRecD2 to the <7rRecD2 mutants.
As expected the DNA binding assays show that wild-type drRecD2 binds to the 
ssDNA and the 5 ’-tailed duplex DNA substrates. Previous work by Wang et al. had 
used hairpin substrates to create pseudo 5 ’-tailed duplex DNA substrates (Wang and 
Julin 2004), but no Kd o f JrRecD2 for the DNA substrates is presented for
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comparison with those o f  this chapter. Details o f  ssDNA and dsDNA binding by 
drRecD2 have not previously been reported. This chapter shows that <7rRecD2 
prefers to bind to the 5 ’-tailed duplex substrate than to the ssDNA substrate and 
cannot bind dsDNA at all. Therefore, drRecD2 must be binding the structure o f  the 
tailed duplex junction between ssDNA and dsDNA with a higher affinity than 
simply the sum o f  the dsDNA and ssDNA binding affinities. It is highly likely that 
drRecD2 is unwinding base pairs at the junction o f  ssDNA and dsDNA. It is 
common for helicases to unwind a few base pairs o f  the substrate upon binding 
without the need for ATP hydrolysis (Singleton et al. 2004; Singleton et al. 2001; 
Velankar et al. 1999). The ITC data shows that as the length o f  ssDNA increases 
from 8 to 15 nucleotides JrRecD binds the substrate with higher affinity. The 
optimum length appears to be around 15 nucleotides indicating that this is sufficient 
for all the DNA-binding pockets o f drRecD2 to be bound to DNA. This is consistent 
with drRecD2 unwinding 3 base pairs o f  the 5 ’-tailed duplex DNA substrate upon 
binding, increasing the length o f the ssDNA tail from 12 to 15 nucleotides.
The ITC experiments show that 1 molecule o f  <7rRecD2 can bind to 1 molecule o f  
pdT 10, pdT 12 or pdT15 and that 2 molecules o f  JrRecD2 will bind to one 
molecule o f pdT25 or pdT30 with out any co-operative binding. The ITC data also 
shows that two binding events occur when JrRecD2 binding to pdT20, pdT21, 
pdT22, pdT 23 or pdT 24 is analysed. These two binding events fit with the theory 
that if  drRecD2 is in excess o f the DNA substrate, two molecules o f  drRecD2 can 
bind to one molecule o f  DNA with the equilibrium constant Kdi. Later in the ITC 
experiment when DNA is in excess o f drRecD2, one o f  the two JrRecD2 molecules 
bound to one DNA molecule dissociates and binds to a free DNA molecule with the 
equilibrium constant K^- The errors are very large when looking at the two events,
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because two curves are being fitted using the same amount o f  data as fitting one 
curve in other experiments. Despite the large errors the results show that although 
two molecules drRecD2 can bind to one DNA molecule when afrRecD2 is in excess, 
one molecule o f  drRecD2 still prefers to bind per DNA molecule when the DNA  is 
in excess. Once the DNA length increases from 20 to 25 (or more) nucleotides, two 
molecules o f drRecD2 will bind per DNA and only one binding event is observed. 
There is, therefore, a transition between binding one molecule o f <7rRecD2 per DNA  
molecule to binding two molecules o f  RecD per DNA molecule when the length o f  
DNA is increased from 20 to 25 nucleotides depending on the concentrations o f  
drRecD2 and DNA. These data also suggest that the binding o f one <7rRecD2 
molecule a pdT25 or pdT30 molecule does not aid nor hinder the binding o f  a 
second drR scD l molecule to the same DNA molecule, because a two-event-binding 
model cannot be fitted to the data. In the event o f  either co-operative or non co­
operative binding a two-site-binding model could be fitted because the first binding 
event would necessarily have a different equilibrium constant, Kdi, to the second 
binding event K^.
Previous work has shown E.coli R ecD l and <7rRecD2 to be 5 ’ -  3 ’ helicases 
(Dillingham et al. 2003; Wang and Julin 2004). This chapter did not characterise the 
helicase activity o f  wild-type drRecD2 in detail, only for comparison with drRecD2 
mutants. The activity described in this thesis appears to be lower than the activity o f  
<7rRecD2 in work done by Wang et al. (Wang and Julin 2004), despite the fact that 
this chapter used the same conditions and substrate. However, it is hard to compare 
the results o f  this chapter with the previous work because no initial rate o f  
unwinding or tm  is presented by Wang et al. Wang et al. show that 0.25 nM 
drRecD2 will unwind 80% o f  the DNA substrate in 2 minutes, but the reaction is not
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shown to go to completion. In this chapter 1 nM drRecD2 requires approximately 
2.5 minutes to unwind 80% o f the DNA substrate before the reaction reaches 
completion suggesting that the drRecD2 in this chapter is approximately 5 - 1 0  times 
less active than the drRecD2 previously described, and the difference in helicase 
activity was a concern. The only difference between this chapter and previous work 
was the purification o f <7rRecD2. In order to control for this <irRecD2 was purified as 
described by Wang et al. (Wang and Julin 2004) and the helicase activity measured 
(data not shown). The helicase activity was the same as previously described in this 
chapter. It was therefore reasoned that this chapter would be consistent within itself 
and the activity o f  <7rRecD2 mutants could be compared to the wild-type drRecD2 
activity described in this chapter.
A  major problem came from the fact that the drRecD2 mutants could not be cloned 
using the wild-type drRecD2 gene as a template. The cloning o f  the drRecD2 gene 
into an expression vector from Deinococcus radiodurans genomic DNA proved to 
be difficult because o f  the failure o f the standard PCR o f  the gene. The standard PCR 
o f  the drRecD2 gene required to make mutants o f  drRecD2 failed as did the 
modified PCR used in cloning o f  wild-type drRecD2. The reason for the failure o f  
the PCR was attributed to the high GC content o f  the wild-type drRecD2 gene, 
which is around 70 %  GC . For this reason a gene was synthesised that was less GC 
rich. The drRecD2 protein expressed from the synthetic gene had the same activity 
as the drRecD2 previously described.
4.5.3 The role of phenylalanine 635 of motif A
This chapter described the effects o f  mutating phenylalanine 635 in a newly 
identified m otif A that exists in both the RecD l and RecD2 families. The region in
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which the m otif is located is disordered and cannot be seen in the crystal structure o f  
the E.coli RecBCDl complex (Singleton et al. 2004). The reason phenylalanine 635 
was targeted as a priority was because the key phenylalanine 64 o f foPcrA m otif la  
is missing in the RecDl and RecD2 helicases. It was reasoned that phenylalanine 
635 o f m otif A may be interacting with ssDNA bases and contributing toward the 
helicase mechanism. However, when phenylalanine 635 was mutated to an alanine 
in drRecD2F635A there was no observable difference in ssDNA-dependent ATP 
hydrolysis or helicase activity as compared to wild-type drRecD2. This would 
suggest that phenylalanine 635 is not playing a role in helicase activity or that the 
experiments used are not sensitive enough to detect any defect. Either way the 
mutation is not having a major effect on the helicase activity o f  drRecD2. This does 
not discount m otif A from being involved in the helicase activity, but other roles o f  
m otif A need to be investigated.
4.5.4 The role of the N-terminal region
The N-terminal region o f type 2 RecD helicases is longer than that o f the N-terminal 
domain 1 o f  type IRecD helicases. Domain 1 o f  E.coli R ecD l is responsible for 
binding to E.coli RecC in the RecBCDl complex (Singleton et al. 2004). This 
however cannot be the role o f  the N-terminal region o f  the RecD2 helicases because, 
by definition, there is no RecC to bind to. The aim o f  this chapter was to gain some 
insight into the role o f the N-terminal region o f  drRecD2 by making a truncated 
drRecD2, missing part o f  the N-terminus, drRecD2ANT.
The K d n a  o f  drRecD2ANT was two orders o f  magnitude greater than the K d n a  o f  
wild-type drRecD2 suggesting that drRecD2ANT would have a higher IQ for ssDNA  
than c/rRecD2. However, the kcat was unaffected meaning that the ATP hydrolysis
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activity was not impaired once enough ssDNA was present to overcome any ssDNA  
binding defects and saturate the protein. The K a t p  was also unaffected, meaning the 
binding o f ATP to the protein was not affected by the loss o f  the N-terminal domain. 
These data suggest that the N-terminus o f drRecD2 plays no role in the ATP 
hydrolysis activity o f drRecD2.
The IQ o f drRecD2ANT for the 5 ’-tailed duplex substrate was two orders o f  
magnitude larger than that o f  drRecD2. The K<j o f  drRecD2ANT for the ssDNA  
substrate was shown to be at least two orders o f  magnitude larger than that o f  
drRecD2. These data suggest the N-terminus is playing a role in binding the 5 ’-tailed 
duplex junction o f  dsDNA and ssDNA. It is surprising, therefore, that the helicase 
activity appears to be unaffected by the truncation, as drRecD2ANT appears to have 
the same helicase activity as drRecD2. It would follow  that if  drRecD2ANT could not 
bind the substrate as well as <7rRecD2, the helicase activity o f  <7rRecD2ANT would be 
lower than that o f ^/rRecD2, but this is not the case. The helicase activity o f  
drRecD2ANT appears to be the same as that o f  wild-type drRecD2 despite the fact 
that the Kd o f drRecD2ANT for the 5 ’-tailed duplex DNA  substrate is approximately 
500 times greater than that o f  wild-type drRecD2. The only difference in the buffers 
used for the DNA binding assays and the helicase assays was the addition o f  ATP in 
the helicase assay. The ATP is probably not affecting the DNA binding activity o f  
JrRecD2ANT as the ATP hydrolysis assays also show a defect in DNA binding, the 
K d n a  o f  drRecD2ANT was two orders o f  magnitude larger than that o f  JrRecD2. 
Another explanation for the increase o f  helicase activity o f  drRecD2ANT could be that 
more drRecD2ANT molecules are bound per DNA substrate. However, the ITC data 
shows that only one molecule o f  drRecD2ANT binds per pdT15 molecule, the same as
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drRecD2. It is hard to see how more molecules o f  drRecD2ANT rather than drRecD2 
could bind to the 12 nucleotide long ssDNA portion o f  the 5 ’-tailed duplex substrate.
Another explanation for drRecD2ANT having the same helicase activity as wild-type 
drRecD2 could be that JrRecD2ANT is a more processive helicase than JrRecD2. 
This would mean that despite the fact <irRecD2ANT cannot bind the DNA substrate as 
well initially, once the helicase activity starts drRecD2ANT may stay bound and 
unwind more base pairs than drRecD2 can, before falling off. However, there 
appeared to be no obvious difference between the processivity o f drRecD2ANT and 
drRecD2. In hindsight this may have been expected as the KDna o f ATP hydrolysis 
is an indirect measure o f  ssDNA binding activity during ssDNA translocation by the 
helicase and the K d n a  o f  drRecD2ANT was around two orders o f  magnitude larger 
than that o f  drRecD2.
The N-terminus o f  drRecD2 may be acting as a regulatory domain that inhibits the 
helicase o f  the wild-type protein. When the N-terminal is removed the inhibition is 
lost, but the DNA binding activity is also reduced so the helicase activity o f  
drRecD2ANT observed using the helicase assay appears to be same as wild-type 
JrRecD2. A gain-of-function mutation has been observed in the Superfamily lA a  
helicase, E.coli Rep, where the 2B domain has been shown not to be required for the 
helicase activity o f Rep and to inhibit the helicase activity o f  Rep when present. 
(Brendza et al. 2005; Cheng et al. 2002). Brendza et al. speculate that the 2B domain 
o f  Rep may be mutually sequestered when Rep forms a dimer negating the inhibition 
and activating the helicase. It is interesting to speculate that a similar regulatory 
function may be occurring in the case o f  drRecD with a speculative binding partner
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sequestering the N-terminal region o f drRecD2 and also tethering drRecD2 to the 
DNA.
The aim o f  another part o f  this thesis (Chapter 3) was to investigate further the role 
o f  the 2B domain in the PcrA helicase that appears to contribute to the helicase 
activity and not inhibit it. (Ha et al. 2002; Soultanas et al. 2000; Velankar et al. 
1999).
In order to investigate further the role o f the N-terminal region o f drRecD2 in 
binding DNA amino acids 1-150 o f <7rRecD2, deleted in <7rRecD2ANT, were cloned 
separately to create drRecD2NT. drRecD2NT did not appear to bind any o f  the DNA  
substrates, but there is no positive control available to confirm that <7rRecD2NT is 
folded correctly, and so it is hard to draw conclusions from these data.
4.5.5 The role of the 1B domain
The final part o f this chapter was to investigate the role o f  a loop that is probably 
structurally conserved in the RecDl and RecD2 families. The sequence o f  the loop 
itself appears to vary, but the sequence N-terminal and C-terminal to the loop appear 
to be conserved. The E.coli RecBCDl structure had has recently been improved with 
a longer 5 ’-tailed duplex present in the crystals. This structure shows the ssDNA fed 
to R ecD l from RecC sliding against a loop in R ecD l. It was reasoned that this loop 
could act as a mechanical pin over which the RecD2 family can force open the 
duplex DNA, much in the same way as a pin present in E.coli RecC (Singleton et al. 
2004). Indeed this may be how E.coli RecDl is able to unwind a 5 ’-tailed duplex 
substrate in isolation (Dillingham et al. 2003) without E.coli RecC present to split 
the duplex DNA ahead o f  E.coli RecDl (Singleton et al. 2004). Based on the
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structure o f  E.coli RecDl and sequence comparisons o f  the RecDl and RecD2 
families, amino acids 412 to 419 o f  JrRecD2 were replaced with a glycine in order 
to investigate the role o f  the loop by removing it.
The K d n a  o f drRecD2Aloop was an order o f magnitude bigger than the K d n a  of wild- 
type drRecD2 suggesting that ^/rRecD2Aloop would have a higher Kd for ssDNA than 
drRecD2. However, the kcat was unaffected meaning that ATP hydrolysis activity 
was not impaired once the concentration o f  ssDNA was high enough to overcome 
any ssDNA binding defects and saturate drRecD2Aloop. The K a t p  was also 
unaffected, meaning the binding o f  ATP to the protein was not affected by the loss 
o f  the loop. These data suggest that removal o f  the loop does not affect the ATP 
binding or ATP hydrolysis activities o f drRecD2.
The Kd o f  drRecD2Aloop for the 5 ’-tailed duplex substrate was two orders o f  
magnitude larger than that o f drRecD2 and the Kd o f drRecD2Aloop for ssDNA was 
shown to be twice as large as that o f drRecD2. These data show that the ssDNA  
binding activity is not as affected as the 5 ’-tailed duplex binding activity by the 
mutation. As there are only three DNA structures to bind, the ssDNA, the dsDNA  
and the junction o f dsDNA and ssDNA, these data suggest that the loop binds the 5 ’- 
tailed duplex substrate at the junction o f the dsDNA with ssDNA, because no 
dsDNA binding was observed. Despite the reduced affinity for the 5 ’-tailed duplex 
substrate, if  an excess JrRecD2Aloop (1 pM) was added to InM 5 ’-tailed duplex 
substrate, then all the 5 ’-tailed duplex was bound by drRecD2Aloop.
There was no observable helicase activity by drRecD2Aloop. When 1 pM drRecD2Aloop
and 1 nM o f the 5 ’-tailed duplex are used, meaning the DNA binding defect has been
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overcome and all the DNA is bound by drRecD2Aloop and, as already discussed, there 
is no defect in ATP hydrolysis, the ^/rRecD2Aloop still cannot unwind the 5 ’-tailed 
substrate. These data show that the loop is essential for helicase activity. The ATP 
hydrolysis and DNA binding activities o f drRecD2 are affected when the loop is 
removed, however, the defects can be over come when enough DNA substrate is 
present in the assays. This means that the loss o f  helicase activity upon removal o f  
the loop from drRecD2 is not simply a result o f loss o f  ATP hydrolysis or DNA  
binding actives o f drRecD2, but rather the intrinsic helicase activity. These data 
indicate that JrRecD2 is an active helicase.
All these data support the hypothesis that the loop is acting as a mechanical pin over 
which dsDNA is split into separate strands, because the loop is required to bind the 
ssDNA - dsDNA junction o f a tailed duplex substrate and the loop is also essential 
for helicase activity. However, deleting the loop may have displaced the spatial 
orientation o f  the la  motif, which may play a significant role in ssDNA  
translocation. Translocation activity is assumed to be unaffected because the ATP 
hydrolysis activity is only slightly impaired. This assumption may not be true and it 
is very important that the translocation o f  ssDNA by drR ecD l be shown 
experimentally unaffected by the removal o f the loop.
4.5.6 Conclusions
The main conclusions o f  this chapter are: 1) A conserved phenylalanine located in 
M otif A o f  drRecD2 does not appear to be required for helicase activity. 2) The N- 
terminal region o f  drRecD2 plays a role in binding DNA and may act to inhibit the 
helicase activity o f the protein. 3) A conserved loop in drRecD2 is involved in the
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binding o f  the ssDNA -  dsDNA junction o f  5 ’ tailed duplex DNA and is essential 
for helicase activity.
4.6 Future Work
There are experiments that could have been performed to further investigate the 
helicase mechanism o f <7rRecD2 that were not done because o f  time constraints.
To further investigate if  m otif A has any role in the helicase activity other residues 
could be mutated and the ATP hydrolysis, DNA binding and helicase activities 
investigated. M otif 3 o f foPcrA has a tyrosine, Y257, that is important in creating a 
ssDNA-binding pocket involved in the translocation o f  ssDNA by AsPcrA. In the 
R ecDl family the W259 o f foPcrA is replaced by a glutamate residue and by an 
aspartic acid residue in drRecD2, D471. It would be interesting to see if  D471 o f  
drRecD2 is involved in the helicase activity o f  drRecD2 by mutating D471 to an 
alanine and observing the effects on the ATP hydrolysis, DNA binding and helicase 
activities o f  drRecD2
The role o f the N-terminal region o f  JrRecD2 can be investigated further firstly by 
determining a steady-state specific activity o f the helicase activity, a measure o f how 
many moles o f  a DNA substrate can be unwound per mole o f drRecD2, or 
<7rRecD2ANT, per second. This could be done by measuring the initial rate o f  
unwinding (while the substrate is in excess o f  the helicase) at low concentrations o f  
the helicase compared to the DNA substrate.
An attempt to restore drRecD2ANT DNA binding activity to wild-type drRecD2 
levels could be made by trying to complex drRecD2ANT with drRecD2NT. This could
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be done by mixing an excess o f  JrRecD2NT to drRecD2ANT under different 
conditions. Any resulting complex formed could be purified by gel-filtration 
chromatography. If this was successful DNA binding assays could be carried out to 
see if  DNA binding activity had been reconstituted to wild-type drRecD2 levels. 
This could be an indication o f  whether or not drRecD2NT is correctly folded 
depending on whether the complex is formed and its activity reconstituted.
This chapter only describes one truncation o f the N-terminus o f  drRecD2 and further 
truncations o f the N-terminus could be made until only the helicase domains 
(domain 1A and domain 2A) o f drRecD2 are left. It would be very interesting to see 
the effect o f  these mutants on helicase activity.
The conserved IB domain loop o f  drRecD2 has been shown to be essential for 
helicase activity in this chapter. The ATP hydrolysis assay suggests translocation o f  
ssDNA is unaffected, but direct experiments to show this could be done. There are 
several different ssDNA translocation assays available, the simplest being the 
observation o f  streptavidin being displaced from a 3 ’-biotinylated ssDNA substrate 
by the translocating enzyme. If the ssDNA-translocation activity o f  drRecD2 was 
unaffected by the removal o f the loop these data would support the hypothesis that 
the loop is required to bind and disrupt the dsDNA -  ssDNA junction o f  a 5’ tailed 
duplex substrate and not required for the ssDNA-translocation activity or drRecD2.
In order to further confirm that the loop is required for helicase activity, the loop 
could be deleted in either or both E.coli RecDl and U pfl and the ATP hydrolysis, 
DNA binding and helicase activities measured. In the case o f  E.coli RecDl this 
would have to be done with the E.coli RecD l in isolation and not as part o f  the
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complex as in the complex there is no requirement for RecDl to break open duplex 
DNA as this is done by E.coli RecC. This may prove difficult because the 
purification o f E.coli R ecD l, in isolation o f E.coli RecB and E.coli RecC, does not 
yield 100% active protein. Any variations in helicase activity between wild-type 
E.coli R ecD l and mutant E.coli RecDl may be due to the purification and not the 
mutation. The experiments on E.coli RecD l could be done in the context o f the 
E.coli RecBCDl complex if  the helicase activity o f RecB is knocked out. An ATP 
hydrolysis dead E.coli RecB mutant is available (Personal communication, Wigley, 
D.). However, there would be many complications in analysing the effects o f  any 
mutations o f  E.coli RecDl in this case because o f  the complex interactions between 
the proteins in the E.coli RecBCDl.
Binding partners for d/rRecD2 could be searched for. This could be done by mixing 
purified recombinant drRecD2 with Deinococcus radiodurans cell extract and then 
re-purifying drRecD2 which is histidine tagged along with any other proteins bound 
to drRecD2.
A more ambitious and speculative project could be to investigate the missing 
phenylalanine o f  m otif la  o f  S F lB a  helicases compared to S F lA a  helicases. It 
would be interesting to see what effect mutating proline 205 o f  drRecD2 to a 
phenylalanine would have on helicase activity o f  drRecD2, and if  this could possibly 
reverse 5 ’ -  3 ’ helicase polarity o f  c/rRecD2 to 3 ’ -  5 ’. However, the mechanism o f  
helicase polarity is probably far more complex than the role o f one residue and the 5 ’ 
-  3 ’ helicase activity o f drRecD2 needs to be understood before experiments trying 
to reverse the helicase polarity are undertaken.
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5 Crystallisation of Deinococcus radiodurans RecD2
5.1 Introduction
5.1.1 Summary
The aims o f  this part o f the thesis were to crystallise and solve the structure o f  the 
RecD helicase in complex with DNA substrates in order to gain insights into the 
molecular details o f the SF1 B a  helicase mechanism. The Deinococcus radiodurans 
RecD2 protein was crystallised with a 5 ’-tailed duplex DNA substrate. Crystals were 
o f the C2 spacegroup with unit cell dimensions a = 169.9 A, b = 59.6 A, c = 91.6 A, 
a  = 90.0 °, P = 98.6 ° y = 90.0 °, and diffracted to 3.5 A.
5.1.2 Current structural understanding of Superfamily 1Ba 
helicases
The only structure o f  a S F lB a  DNA helicase to date is that o f  E.coli R ecD l as part 
o f the E.coli RecBCDl complex (Singleton et al. 2004). More recently the structure 
o f the S F lB a  RNA helicase, U pfl, has been solved in the absence o f  nucleic acid. 
(Cheng et al. 2007). However, neither o f  these structures shows nucleic acid bound 
to the motor domains o f  the helicases and therefore very little information on the 
S F lB a  helicase mechanism can be extracted.
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5.2 Crystallisation of Deinococcus radiodurans RecD2
5.2.1 Original screening
The aim o f  this work was to crystallise JrRecD2 and its DNA complexes. The 
crystallisation trials required <7rRecD2 to be concentrated to 10 mg/ml. The 
concentration had to be done slowly from storage stock o f  1 mg/ml over 8-10 hours, 
as any sudden increase in the protein concentration would lead to the precipitation o f  
drRecD2. The concentration was done using a YM-50 centricon and the protein was 
buffered in 10 mM Tris HC1 pH 7.5 and 100 mM sodium chloride . Crystallisation 
trials using drRecD2 in the presence and absence o f AMPPNP were undertaken. 
Crystallisation trials o f <7rRecD2 in the presence o f ADP were carried out, but 
drRecD2 precipitated upon addition o f  ADP. Around a thousand conditions were 
examined, but no protein crystals were observed.
It is very common for DNA-binding proteins to become more soluble and tractable 
to work with when bound to a suitable DNA substrate. The DNA substrate used can, 
therefore, often be the key for growing protein/DNA co-crystals. In order to gain 
insights into the helicase mechanism it was reasoned that a 5 ’-tailed duplex substrate 
would be the best substrate to use because it would show <7rRecD2 bound to the 
ssDNA and dsDNA, analogous to the junction between duplex and unwound DNA.
A 5 ’-tailed duplex DNA substrate was designed (DNA SI) based on the DNA  
substrate used in the crystal structure o f  ZwPcrA. DNA SI consisted o f  10 bp duplex 
DNA with a pdT7 5’ tail (see Figure 5.1).
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A) B)
5 '  GCAGTGCTCGTTTTTTT 3 '  5 '  TTTTTTTGCAGTGCTCG 3 '
3 '  CGTCACGAGC 5 '  3 '  CGTCACGAGC 5 '
Figure 5.1. DNA SI
A) The DNA substrate used in the foPcrA/DNA complex crystals.
B) DNA SI modified from A) to have a 5’, rather than 3’, tail.
DNA SI was suitable for this work for several reasons. Firstly, drRecD2 specifically 
binds 5 ’-tailed duplex DNA (see Chapter 4, section 4.3.2.2), and will unwind 5’- 
tailed duplex DNA in the presence o f  ATP and magnesium chloride (see Chapter 4, 
section 4.3.1). Secondly, DNA SI would show how drRecD2 binds to ssDNA, 
dsDNA and the ssDNA-dsDNA junction giving insights into the helicase 
mechanism. The DNA substrate used in the foPcrA crystals formed pseudo 
homodimers as a result o f the crystal packing, with the dsDNA blunt end forming 
triple-base pair interactions, while foPcrA is bound to the dsDNA -  ssDNA junction. 
The triple-base pair phenomenon could be assisting in the formation o f  ordered 
crystal lattices by forming longer regions o f  duplex DNA and the same could happen 
to aid JrRecD2/DNA SI crystallisation. The ssDNA tail o f  7 nucleotides did not 
extend out o f  the bsPcrA RecA-like fold core domains and it was reasoned that the 
same would be the case for drRecD2 because it is very probable drRecD2 will have 
the same RecA-like fold core domains common to all helicases. If any nucleotides 
did extend out o f the helicase DNA-binding sites they could be disordered and might 
impair crystal growth.
DNA binding assays were carried out using 1 to 1000 nM JrRecD2 and 1 nM DNA
SI, but no binding was observed (data not shown). The concentrations at which
crystallisation trials were to be carried out (150 to 200 pM drRecD2 and DNA SI)
are much higher than 1 pM protein and 1 nM DNA. The binding o f drRecD2 to
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DNA SI was therefore tested at higher concentrations using 1 pM DNA and 1 to 10 
pM <7rRecD2. A <7rRecD2/DNA SI complex was formed with 100% DNA substrate 
bound by drRecD2 at stoichiometric concentrations (see Figure 5.2), suggesting the 
concentrations used for crystallisation trails a JrRecD2/DNA SI complex should 
form. However, this does not guarantee that under all the crystallisation trial 
conditions all the drRecD2 would be in complex with DNA S 1.
[drRecD2] pM
0 1 10
Figure 5.2. Complex formation of </rRecD2 and DNA substrate 1
Autoradiograph of a 9% native PAGE analysis of a DNA-binding assay of drRecD2 and DNA SI. 1 pM 
DNA SI was used, indicates radio-labelled DNA.
Crystallisation trials were performed with 150 pM drRecD2 with a 1.3 times molar 
excess o f DNA SI to try and ensure that all o f the drRecD2 was bound to DNA SI. 
Two crystals were observed in very different conditions. Condition 1 (0.15 M 
potassium thiocyanate, 0.1 M Tris pH 7.5 and 15% w/v polyethylene glycol 6000 
(PEG 6K)) produced clusters o f  very fine needles. Condition 2 (0.2 M calcium 
acetate, 0.1 M MES pH 6.5 and 10% w/v PEG 8K) produced clusters o f irregularly 
shaped thin plates with sharp edges. Both o f these conditions came from high- 
throughput screens using the Mosquito robot. Trials were also carried out with the 
complex in the presence o f AMPPNP and magnesium chloride but no crystals were 
observed. Trials o f aHlecD2/DNA SI complex in the presence o f  ADP were to be 
carried out, but, as had happened with c/rRecD2 protein alone, the complex 
precipitated.
188
5.2.2 Optimisation
Having identified two crystallisation conditions o f the t/rRecD2/DNA SI complex in 
100 nl sitting drops, attempts to reproduce the crystals in larger 2 pi drops were 
carried out. The 2 pi hanging drop crystallisation grid screens were carried out based 
on the conditions identified from the 100 nl sitting drop high-throughput screens. 
This involved varying the salt and precipitant concentrations o f  the two conditions.
No crystals were observed in the 2 pi hanging drops based on condition 1. 
Optimisation o f condition 2 produced very clustered needles, but these did not seem  
to resemble the crystals observed in the 100 nl sitting drops. The crystals grew in 
various conditions based on the original condition 2. Crystal clusters with the 
thickest needles grew in 0.1 M MES pH 6.5, 7.5 % PEG 8K and 0.175 M calcium 
acetate. The crystals typically grew within one week. The crystals were soft and 
broke easily when probed and were birefringent, suggesting that they were not salt. 
The clusters did not break into single, useable, crystals when probed, but shattered. 
The crystals were crudely cryoprotected in 35% glycerol and produced a very low  
quality diffraction pattern in-house, diffracting to around 8 A  (data not shown).
5.2.3 Growing discrete crystals
The next stage o f the optimisation was to grow discrete crystals. The crystallisation
process consists o f three fundamental stages; nucleation, crystal growth, and
cessation o f  crystal growth. Nucleation is the process by which the first ordered
aggregates are formed; these then grow into larger crystals in the crystal growth
phase. Nucleation requires greater saturation o f  the crystallisation target to a
thermodynamically unstable state than is required for crystal growth. This means
that there is a balance between slowing down crystal growth before stopping
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nucleation, and it may be the case that nucleation will be abolished before crystal 
growth is effected (see Figure 5.3).
Single molecules 
of crystallisation target
A) Solubility curve
★  Nucleation
Insoluble protein
i f  Crystal growth
w
Supersaturation curve 
Saturation curveSoluble protein
Precipitant concentration
Figure 5.3. Nucleation and crystal growth
A) A phase diagram showing a hypothetical saturation curve, supersaturation curve and region of 
crystallisation of the protein target (green). The red star indicates the region in which B) nucleation 
occurs. The blue star indicates the region where C) crystal growth occurs. If the target is above the 
supersaturation curve then it can nucleate and crystal formation can begin. If the target is above the 
saturation curve, but is not supersaturated, then no nucleation will occur so no crystals will form.
The different conditions tested are summarised in Table 5.1. These conditions were 
based around the idea o f trying to slow crystal growth. A reduction in temperature 
slows vapour diffusion between the hanging drop and the reservoir meaning the 
increase in protein concentration will be slower and therefore crystal growth might 
be slower. A reduction in the amount o f  PEG, or addition o f glycerol, should make 
the drRecD2/DNA S 1 complex more soluble and thereby slow down crystal growth.
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Table 5.1. Conditions tested to grow single </rRecD2/DNA SI crystals
All conditions contained 0.1M MES pH 6.5.
Precipitant
PEG 8K (%w/v)
Salt
Calcium acetate 
(M)
Additive 
Glycerol (% v/v)
Temperature
(°C)
Crystal type
8 .5 -5 .5  
(0.5 steps)
0 .125-0 .225  
(0.025 steps)
0 22 Clusters
12,4 None
10 22 Clusters
12,4 None
20 or 30 22 None
5 .0 -3 .0  
(0.5 steps)
0 .125-0 .225  
(0.025 steps)
10, 20 ,30 22, 12,4 None
No discrete crystals were grown using the above conditions. Where clusters grew, 
they did so within one week. Trays were checked weekly for two months. The 
thickest needles were observed in those crystal clusters grown in the presence o f  
0.175 M calcium acetate.
It appeared that lowering the precipitant (PEG 8K) concentration inhibited the 
spontaneous nucleation o f the crystals, as did reducing the temperature or adding 
glycerol. Micro-seeding into these conditions would supply nucleated seeds, 
therefore by-passing the need for spontaneous nucleation. The crystal growth o f the 
seeds might still occur, but at a slower rate and hence produce single crystals. Micro 
seeding was carried out into the conditions summarised in Table 5.2.
191
Table 5.2. Conditions tested in order to grow single </rRecD2/DNA SI crystals by micro- 
seeding
All conditions contained 0.1M MES pH 6.5
Precipitant
PEG 8K (% w/v)
Salt
Calcium acetate 
(M)
Additive 
Glycerol (% v/v)
Temperature
(°C)
Crystal type
5 .0 -  1.0 
(1.0 steps)
0.175 0, 10 22 Discrete and 
clustered
12,4 None
0 0.175 0 22 Discrete
12,4 None
10 22, 12,4 None
Discrete crystals were grown when the concentration o f PEG 8K was reduced. As 
the concentration reduced from 5 % to 0 % (w/v) discrete crystals were favoured. 
When no PEG 8K was present only discrete crystals grew. The biggest crystal (100 x 
200 x 2 pM) grew in 0.1 M MES pH 6.5 and 0.125 - 0.175 M calcium acetate (see 
Figure 5.4). All the discrete crystals were very thin plates, the thinnest dimension 
being 1-2 pM.
Figure 5.4. Discrete crystals of </rRecD2/DNA SI complex
A picture of discrete crystals grown by microseeding into 0.1M MES pH 6.5, 0.175 M calcium acetate. 
Crystal 1 is lying with the thin edge across the plane of the picture. Crystal 2 is lying with the thin edge at 
right angles to the plane of the picture.
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An attempt to capillary-mount these crystals in order to see if  they would diffract at 
room temperature was made, but the crystals were so thin it proved very difficult not 
to damage them in the process. Instead, a screen for suitable cryoprotectant 
conditions was carried out. The crystals dissolve in 20-30% glycerol, ethylene 
glycol, PEG 400, and MPD. However, the crystals could tolerate MPD if  the 
concentration o f MPD was increased from 5 % to 20 % in quick 5% steps. The 
frozen crystals diffracted to around 5A in-house.
2.2 A
9 A
Figure 5.5. X-ray diffraction pattern of a discrete crystal of </rRecD2/DNA substrate 1 
complex
X-ray diffraction pattern of a crystal grown by micro seeding into 0.1 M MES pH 6.5, 175 mM calcium 
acetate and cryoprotected in 20% MPD. The right-side panel shows the overall diffraction pattern and the 
square box is zoomed in on in the left-side panel. Resolution rings are shown with the resolution of each 
ring indicated.
The crystals were indexed using MOSFLM (CCP4 suite (CCP4 1994)). The space 
group was C2 and unit cell dimensions were a = 169.9 A, b = 59.6 A, c = 91.6 A, a  
= 90.0 °, p = 98.6 ° y = 90.0 °. Datasets were collected but the crystals were very 
anisotropic diffracting to around 4 A in one direction while diffracting to 6 or 7 A in 
the other direction. The resolution o f a complete processed dataset was 6-7 A. The
193
crystals were also highly mosaic, possibly as a result o f damage during manipulation 
and freezing.
5.2.4 Optimisation of discrete crystals
It was reasoned that thicker crystals could be less anisotropic and more tolerant to 
freezing and could, therefore, provide higher resolution diffraction. In an attempt to 
grow thicker crystals different buffers were tried, and the conditions into which the 
existing crystals were seeded are summarised in Table 5.3 below.
Table 5.3. Changes in buffer
Buffer
(0.1 M and pH 6.5)
Calcium acetate 
(M)
PEG 8K (% w/v) Crystals
PIPES 0.125-0 .225  
(0.025 steps)
0 Well-defined, thick 
discrete crystals.
4 Thick but rough 
crystals
Sodium cacodylate 0 .125-0 .225  
(0.025 steps)
0 Discrete plates
4 Clustered plates
Imizadole 0 .125-0 .225  
(0.025 steps)
0 Thin needles
4 Clustered needles
Bis Tris 0 .125-0 .225  
(0.025 steps)
0 None
4 None
Crystals grew with PIPES, sodium cacodylate and imizadole buffers when 
microseeding was used. The crystals with the sharpest edges and thickest dimensions 
were obtained from PIPES buffer (see Figure 5.6).
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A) PIPES B) Sodium cacodylate C) Imidazole
Figure 5.6. Crystals grown in PIPES, sodium cacodylate or imizadole
Crystals grown in 0.1 M A) PIPES, B) sodium cacodylate or C) imizadole, with 0.175 M calcium acetate 
using micro seeding.
The crystals grown in PIPES, sodium cacodylate and imizadole were thicker than 
those grown in MES and could be capillary mounted to test for diffraction at room 
temperature. The crystals grown in sodium cacodylate and imizadole did not diffract. 
However, the crystals grown in PIPES diffracted to around 4-5 A at room 
temperature in-house (see Figure 5.7). The intensity o f the X-ray diffraction spots 
from crystals grown in PIPES were much greater than those from the crystals grown 
in MES.
3 8
5.0 A,
5.0 A
7.5,
7.5 A
15 A
Figure 5.7. Room temperature X-ray diffraction of a discrete crystal of </rRecD2/DNA SI 
complex
Crystals were grown in 0.1 M PIPES pH 6.5, 0.175 M calcium acetate. The right-side panel shows the 
overall diffraction pattern and the square box is zoomed in on in the left-side panel. Resolution rings are 
shown with the resolution of each ring indicated.
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Suitable cryoprotectant conditions were screened, as described earlier, with the same 
results. The crystals were cryoprotected 20 % MPD added in 5 % steps. These 
crystals were less anisotropic and less mosaic than the crystals grown in MES.
Different salts o f  similar ionic strength to calcium acetate and containing calcium or 
acetate were tested including zinc acetate, magnesium acetate, sodium acetate, cobalt 
acetate, and calcium chloride. However, crystals did not grow in these salts with the 
MES or PIPES buffer whether or not microseeding was used. The length o f  the 
ssDNA tail was also varied from 6 to 12 nucleotides and crystals could be grown 
when longer tails o f 8, 9 and 10 nucleotides were used, with microseeding using 
crystals grown in PIPES as the seeding stock. The thickest and largest crystals grew 
using the original DNA SI with a 7 nucleotide tail, when longer tails were used the 
crystals were thinner and smaller (see Figure 5.8).
Figure 5.8. Crystals grown with varying lengths of the 5’ ssDNA tail
Crystals of drRecD2 DNA SI complexes grown from seeding with A) 8 B) 9 and C) 10 nucleotide 5’- 
tails
Finally the pH o f  the PIPES buffer was varied from pH 6.1 to 7.5 in 0.2 pH unit 
steps. Crystals only grew when seeded into solutions buffered at pH 6.3, 6.5 and 6.7, 
with 6.5 yielding the biggest crystals.
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The resulting crystals were inconsistent, with one in ten diffracting. Generally, 
bigger crystals diffracted to higher resolution and were more stable in the cryo- 
protectant used for freezing. The use o f  synchrotron facilities allowed rapid 
screening of, and data-collection from, smaller crystals.
5.2.5 Data collection
This section describes the collection o f  datasets that were used to try and solve the 
structure o f  the <7rRecD2/DNA substrate 1 complex. All data collections were done 
at 100 °K after freezing the crystals.
The c axis o f the unit cell sometimes doubled from around 90 A (short c-axis) to 
around 180 A (long c-axis). There was no obvious morphological difference between 
crystals with short and long c-axis. The data from crystals with the long c-axis could 
be processed by XDS.
Complete datasets from native crystals o f  both forms were collected. A native 
dataset from a crystal with the short c-axis was collected using beamline ID 10.1 at 
the SRS, Daresbury. A native dataset from a crystal with the long c-axis was 
collected in-house.
5.2.5.1 Seleno-methionine drRecD2
The drRecD2 protein contains 15 methionines, excluding N-terminal methionine, 
and seleno-methionine drRecD2 (se-met drRecD2) was expressed in the E.coli B834 
+ strain, which cannot synthesise methionine. The E.coli were grown in rich medium 
with seleno-methionine replacing methionine. The se-met drRecD2 was purified and 
crystallised using the same protocol as for the wild-type drRecD2. The peak (pk),
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remote (rm) and inflection (ip) wavelengths o f  the anomalous scattering were 
determined using a fluorescence wavelength scan o f the crystal (see Figure 5.9).
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Figure 5.9. Fluorescence wavelength scan of seleno-methionine </rRecD2/DNA SI crystal
Experimental fluorescence wavelength scan of seleno-methionine drRecD2/DNA SI crystal using 
beamline ID 10.1 at the SRS. The X-ray energy at the peak (pk), inflection (ip) and remote (rm) parts of 
the scan are indicated.
Three datasets were collected from the same crystal (with the short c-axis) at the 
peak, inflection and remote X-ray wavelengths using beamline ID 10.1 at the SRS 
Daresbury. Three datasets were also collected from the same crystal (with the long c- 
axis) at the peak, inflection and remote X-ray wavelengths using beamline ID 23.1 at 
the ESRF, Grenoble.
5.2.5.2 Heavy atom derivatives
In order to soak crystals with heavy atom compounds, stable harvest conditions for 
consistency between native crystals need to be found.
The majority o f  crystals did not survive for more than 4-6 hours when harvested out
o f the growth drop into new mother liquor, they either cracked or dissolved.
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Conditions could not be found where the majority o f  harvested crystals survived for 
long time periods when removed from the drop they had grown in. However, some 
o f  the larger crystals did survive for up to 4 or 5 hours and very occasionally for as 
long as 12 to 18 hours when harvested into 1.1 times concentration mother liquor. 
Therefore, heavy atom compounds that do not require very long soak times were 
screened. Table 5.4 lists the compounds screened, the mode o f action, reason for use, 
soaks tried and the results.
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Table 5.4. Summary of heavy atom screening
Heavy atom 
compound
Formula Mode of action Reason for use Soak Result of soaking
Concentration
(mM)
Time
(Hours)
Potassium
tetrachloroplatinate (II)
K2PtCl4 Reacts with methionine 
and histidine residues.
Reaction will proceed at pH 6.5, 
no phosphate is present to displace 
the chloride.
10,5,2.5, 1, 
0.5
6, 12, 18, 
24
The majority of crystals did not survive the soak. The surviving 
crystals diffracted to around 7-8 A, both in house and at the ESRF.
10, 5,2.5, 1 4,2, 1 The majority of crystals did not survive.
A dataset of 5 A resolution was collected.
Potassium
hexachloroplatinate
(IV)
K2PtCl6 As above As above 10,5,2.5, 1, 
0.5
6, 12, 18, 
24
The majority of crystals did not survive the soak. The surviving 
crystals diffracted to around 7-8 A, both in house and at the ESRF.
Sodium
tetrachloroaurate (III)
NaAuCU As above As above 10,5,2.5, 1, 
0.5
6, 12, 18, 
24
No crystals survived the soak.
Ethyl mercuric
phosphate
(EMP)
(C2H5HgO)HP02 Reacts with histidine 
and cysteine residues
Reaction will proceed at pH 6.5 
and is highly reactive meaning 
short soak times.
10,5,2.5, 4,2, 1 No crystals survived the soak.
1 4,2,1 The majority of crystals did not survive the soak. 
A dataset of 3.5 A resolution was collected.
Triethyl lead acetate (C2H5)3Pb(C2H30 2) As above Reaction will proceed at pH 6.5 50 mM 12, 18,24 The majority of crystals did not survive the soak. 
A dataset of 4.2 A resolution was collected.
2 0 0
A dataset was collected in-house from a crystal (o f the short c-axis) soaked in 50 
mM triethyl lead acetate. A dataset was collected from a crystal (o f the short c-axis) 
soaked in 1 mM ethyl mercuric phosphate for 2 hours using beamline ID 14.3 at the 
ESRF, Grenoble. The ethyl mercuric phosphate-soaked crystal gave the best quality 
diffraction o f all the crystals in the project and diffracted to 3.5 A resolution (see 
Figure 5.10).
U.8 A3.8 A
.6 A
A
3.8 A
5.6 A
Figure 5.10. X-ray diffraction of a crystal of </rRecD2/DNA SI complex soaked in ethyl 
mercuric phosphate
Crystals were grown in 0.1 M PIPES pH 6.5, 0.175 M calcium acetate and soaked in 1 mM ethyl 
mercuric phosphate for 2 hours. The right-side panel shows the overall diffraction pattern and the square 
box is zoomed in on in the left-side panel. Resolution rings are shown with the resolution of each ring 
indicated. A) Phi = 0 °. B) Phi = 90°.
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5.2.5.3 lodouridine DNA derivative
DNA can be modified to contain iodouridine bases inserted in place o f  thymines. All 
the thymines o f the duplex portion o f DNA SI and alternate thymines o f the pdT tail 
were substituted with 5-iodouridine to make iodouridine-substituted DNA SI (iodo 
DNA SI).
A )  B )
5 '  T T T T T T T G C A G T G C T C G  3 '  5 '  X T X T X T X G C A G X G C X C G  3 '
3 '  C G T C A C G A G C  5 '  3 '  C G X C A C G A G C  5 '
X = 5’-lodouridine
Figure 5.11. Iodouridine-substituted DNA SI
A) DNA SI as used in the native crystals. B) Iodouridine-substituted DNA SI. X = 5’ iodouridine.
The iodines in iodo DNA SI would probably not provide sufficient phasing power 
for phase determination if  used alone. They would, however, provide the register o f  
the DNA and may help to further improve phases gained from other techniques. As 
the 5 ’ tail comprises only thymines, trying to determine the position o f  the DNA  
bases in the electron density would be helped as every other thymine in the tail was 
replaced by the electron-dense iodouridine that could be easily identified.
The drRecD2/iodo DNA SI complex was crystallised as previously described. A 
dataset was collected in-house from a crystal with the long c-axis. No crystals with 
the short c-axis were identified.
5.2.6 Data processing
The processing statistics for the datasets o f  collected from crystals with the short c- 
axis are shown in Table 5. The processing statistics for the data sets collected from 
crystals with the long c-axis are shown in Table 5.6
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Table 5.5. Summary of datasets from crystals with a short c-axis, processed in MOSFLM
Crystal Unit cell 
(a, b, c (A)) 
(a .P .y O )
Resolution
(A)
Mosaicity Completeness
(%)
Multiplicity Meanl/sig
mal*
R
factor*
Anomalous
completeness
(%)
Source Wavelength
Native 172.5,59.9, 90.9 
90.0,97.8, 90.0
4 0.86 99.3 3.6 7.0 (3.5) 0.072
(0.298)
SRS 0.9800
Se-met pk 171.3,59.9,90.0 
90.0, 98.1,90.0
4 1.20 99.2 3.6 9.7 (3.4) 0.062
(0.211)
99.3 SRS 0.9800
IP 172.1,60.1,90.4 
90.0,98.0,90.0
4 1.12 99.2 3.5 8.2 (2.5) 0.070
(0.284)
99.1 SRS 0.98021
rm 171.8, 60.0, 90.0 
90.0 98.1,90.0
4 1.18 99.3 3.6 8.0 (2.3) 0.079
(0.321)
99.3 SRS 0.97235
Ethyl mercury phosphate 
soak (EMP)
171.2, 59.6, 89.9 
90.0, 99.0, 90.0
3.5 0.54 94.0 3.2 5.7 (2.3) 0.064
(0.257)
83.0 ESRF 
beam 14-3
0.93100
Lead Acetate soak 172.6, 59.6,90.4 
90.0, 98.7, 90.0
4.2 0.90 91.8 3.1 10.7 (3.0) 0.063
(0.263)
85.6 In house 1.5417
* Values in brackets indicate highest resolution shell.
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Table 5.6. Summary of datasets from crystals with a long c-axis, processed in XDS
Crystal Unit cell 
(a, b, c (A)) 
(a, p, Y O)
Resolution
(A)
Mosaicity
(XDS)
Completeness
(%)**
I/sigma* R factor* Source Wavelength
Native 168.2,58.6,190.0 
90.0,93.5,90.0
4.2 0.46 94.3 9.6 (2.8) 0.079 (0.350) In-house 1.5417
Se-
met
pk 168.3,58.7, 187.8 
90.0, 93.3,90.0
4.0 0.39 91.1 10.1 (3.5) 0.056 (0.260) ESRF 23-1 0.97915
ip 168.0.58.7, 188.1
90.0, 93.4, 90.0
4.0 0.39 94.1 11.8(4.9) 0.069 (0.269) ESRF 23-1 0.97940
rm 167.7,58.7, 188.0 
90.0, 93.4,90.0
4.0 0.38 94.2 10.3(5.4) 0.078(0.218) ESRF 23-1 0.97565
Iodo
SI
DNA 164.8,58.2,186.4 
90.0,93.7,90.0
4.2 0.37 97.5 10.3(4.0) 0.088 (0.304) In-house 1.5417
* Values in brackets indicate highest resolution shell.
** Includes anomalous completeness where appropriate.
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5.2.7 Phase determination
5.2.7.1 Native crystals
Matthews coefficients o f the native datasets were calculated using the Matthews coef 
programme (CCP4 suite (CCP4 1994)) (see Table 5.7).
Table S.7. Matthews coefficient of native datasets
C-axis Number of molecules 
per asymmetric unit
Matthews
coefficient
Solvent (%)
Short c-axis 1 2.7 53
2 1.3 7
Long c-axis 1 5.8 81
2 2.9 63
3 1.9 43
4 1.4 24
The short c-axis crystal is likely to contain 1 drRecD2/DNA S 1 per asymmetric unit, 
and the long c-axis crystal is likely to contain 2 JrRecD2/DNA SI per asymmetric 
unit.
5.2.7.2 Molecular replacement
It is very likely that <7rRecD2 will possess the two RecA-like fold motor domains 
common to all SF1 helicases. Attempts to determine the phases by molecular 
replacement, using the programme Phaser (McCoy et al. 2005), were undertaken 
using various search models based on the structure o f  the E.coli RecDl motor 
domains.
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There is no sequence homology between the N-terminal domain 1 o f E.coli RecDl 
and the N-terminal region o f <irRecD2, so this domain was not used in the search 
model; only the RecA like fold motor domains 1A and 2A were used. A search 
model was created from domains 1A and 2A by reducing the structure down to a -  
helices and p-strands only and removing any o f  these that may not be structurally 
conserved. This gave a core structure o f  the motor domains. Any amino acids that 
were not conserved between JrRecD2 and E.coli RecD l were changed to alanine 
using the CHAINSAW programme (CCP4 suite (CCP4 1994)). Three search models 
were then made: (a) domains 1A and 2A fixed relative to each other as in the E.coli 
R ecD l structure, (b) domain 1A alone and (c) domain 2A alone. Each model was 
used with the native dataset and the higher resolution EMP dataset. Domain 1A 
alone (b) and domain 2A (c) alone were also used at the same time, to allow for any 
relative movement between the two in drRecD2 compared to E.coli R ecD l. No  
solutions could be identified in this way.
5.2.7.3 Heavy atom derivatives
The possible derivative datasets obtained from crystals soaked in heavy atoms were 
scaled against the native dataset using SCALEIT (CCP4 suite (CCP4 1994)). This 
provides various statistical outputs that allow the assessment o f  whether or not a 
heavy atom is present. The most important o f  these is the R factor for isomorphous 
differences. Using these data, it appeared that only the dataset from the ethyl 
mercuric phosphate-soaked crystal was likely to be a real derivative.
All o f  the datasets listed in Table 5., except that from lead acetate soaked crystal, 
were scaled together using SCALEIT (CCP4 suite (CCP4 1994)). A summary o f the
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R-factor for isomorphous differences (RiSO) between the datasets is shown in Table 
5.8.
Table 5.8. Summary of Riso between datasets
Data set Native Ethyl mercury 
phosphate
Se-met (pk) Se-met (ip)
Native
Ethyl mercury 
phosphate
0.209
Se-met (pk) 0.110 0.198
Se-met (ip) 0.106 0.202 0.066
Se-met (rm) 0.122 0.128 0.066 0.075
SOLVE and auto. SHARP (Bricogne et a l  2003; Terwilliger and Berendzen 1999) 
were used to try and identify any heavy atom positions using the automatic 
techniques within the programmes. Corresponding peaks were looked for in 
difference and anomalous Patterson maps calculated using the FFT programme 
(CCP4 suite (CCP4 1994)). No heavy atom sites could be determined in this manner.
Another approach was taken, difference and anomalous Patterson maps were 
calculated at different resolution limits using the FFT programme (CCP4 suite 
(CCP4 1994)), and common peaks looked for. No large peaks (signal to noise ratio 
o f  greater than 3.5) were observed, but some peaks were common at all resolution 
limits. The positions were refined using SHARP, and the statistical outputs analysed. 
Two possible heavy atom sites were identified in this way, although the occupancy 
o f both were very low. SHARP (Bricogne et al. 2003) also calculated an electron 
density map o f  using the phases calculated from the sites, but no coherent or protein­
like electron density was observed. The phases calculated using these sites were then
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used to try and find the selenium positions from the se-met JrRecD2 derivative 
using SOLVE and SHARP (Bricogne et al. 2003; Terwilliger and Berendzen 1999). 
No selenium positions were identified. One would expect to identify the positions o f  
the seleniums if  the mercury sites were correct. It was reasoned that the mercury 
sites were either not correct or that the non-isomorphous difference between the 
datasets were too large and masking any isomorphous differences from the presence 
o f  the heavy atoms.
The same approaches as above were used to try and identify selenium positions 
using isomorphous replacement with anomalous scattering (SIRAS), and also by 
multiple wavelength anomalous diffraction (MAD). No selenium positions were 
identified in this manner.
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5.3 Discussion
No apo drRecD2 crystals could be grown; this could be for any number o f  reasons. 
One o f the reasons could be that the drRecD2 was not pure enough and the 
impurities were interfering with the crystallisation process. This does not seem  
plausible because the same impurities would be present when drRecD2/DNA SI 
crystals were grown. Another reason may be structural non-uniformity between the 
drRecD2 molecules. For example, the N-terminal amino acids 1 - 1 5 0  which may be 
a region o f secondary structure o f  the protein may not be positioned in the same 
orientation in each drRecD2 molecule. A uniformity maybe induced by the binding 
o f the protein to DNA and a drRecD2/DNA S 1 complex did indeed crystallise. The 
crystals were optimised from clustered crystals to thin plates to thick crystals. PIPES 
was chosen as a buffer to try during optimisation as it is similar to MES, and PIPES 
produced thicker crystals than MES.
An experimental electron density map o f  the drRecD2/DNA SI complex was not 
obtained because the phases were not determined. The major problem when trying to 
determine the phases was the inconsistency between crystals. The unit cell o f  
different crystals varied by between 0.5 and 2 A in each axis, this could be due to 
several reasons. The crystals may be inherently different as they grow, which could 
be caused by differing purities o f protein preparations or by differences in the 
microseeding stocks. The harvesting and manipulation o f  the crystals may be 
damaging. The cryoprotectant may also be damaging the crystals, indeed the crystals 
seem very sensitive to, and dissolve in, many different cryoprotectants. The freezing 
o f the crystal may also be damaging.
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The lack o f  consistent unit cell dimensions between crystals means the isomorphous 
differences due to the presence o f a heavy atom would be lost in noise caused by the 
differences in the unit cell. This is not a problem when using MAD to try and 
determine the phases using datasets collected from a se-met drRecD2 crystal as the 
three datasets at different wavelengths were collected from the same crystal. 
However, the 16 seleniums in a 86 KDa complex could not be located; the 
diffraction quality and resolution were probably not good enough.
The molecular replacement technique is not affected by the lack o f  consistent unit 
cells between crystals as only one dataset is used. There could be many reasons for 
the failure o f molecular replacement to determine the phases in this case. The 
success o f molecular replacement depends on the quality o f  the search model, i.e. 
how similar the search model structure is to the structure o f  the protein trying to be 
solved. The search model based on E.coli R ecD l may not be similar enough to the 
structure o f  drRecD2, or may be too small in comparison with the size o f  drRecD2 
to provide any solutions.
Another major obstacle in determining the phases, which applies to all the strategies 
tried, comes from the fact that 3.5 -  4 A resolution data may not good enough to 
solve the problem. Although many people recommend cutting the resolution o f  the 
data to 4 or 5 A when trying to determine phases, this derives from data that extends 
to greater than 3 A, meaning the quality o f the data at 4 -  5 A resolution is likely to 
be very good. In hindsight it may have been a better strategy to carry on optimising 
the crystals, or to try and find entirely new crystallisation conditions to obtain 
crystals that diffracted to 3 A or better and had a consistent unit cell, rather than 
trying to solve the structure with the crystals as they were.
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5.4 Future work
There are various ways forward with this project that could not be explored because 
o f  time constraints. The existing drRecD2/DNA SI complex crystals could be 
further optimised to gain better resolution and consistency o f unit cells between 
crystals. Stable harvest conditions that allow for long soaks o f  the crystals without 
damaging them need to identified. The cryoprotection conditions could also be 
improved, more cryoprotectants could be screened and different techniques o f  
freezing investigated. Further crystallisation trials o f  the drRecD2/DNA S 1 complex 
in the presence o f AMPPNP could be carried out.
It would be worthwhile taking a step backwards and trying again to crystallise 
drRecD2 in the absence o f DNA. If this structure could be solved then it could be 
used for as model for molecular replacement in the case o f the drRecD2/DNA SI 
complex crystals. The drRecD2ANT could also go undergo crystallisation trials in the 
presence and absence o f ADP or AMPPNP. Indeed at the time o f writing these 
recommendations have been followed and apo drRecD2ANT has been crystallised. 
The crystals grow in 100 mM Tris pH 8.5 and 13 -  18 % (v/v) ethanol and diffract to 
3 A in house (personal communication. W igley, D). Work is currently under way 
screening for heavy atom derivates to solve the structure, and good progress toward 
determining the phases has been made. If the structure o f  apo drRecD2ANT is solved 
then it could be used as a search model to solve the structure o f  the drRecD2/DNA  
S 1 complex by molecular replacement.
The drRecD2ANT protein is missing amino acids 1-150 o f  drRecD2. Further 
truncations o f  drRecD2 could be made in order to create drRecD2 mutants that
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comprise only the core helicase domains. Limited proteolysis digests and N-terminal 
sequencing could indicate the best place to truncate drRecD2. If these drRecD2 
truncation mutants could be crystallised and the structures solved they too would be 
very good search models to solve the structure o f  the drRecD2/DNA S 1 complex.
Another technique to crystallise drRecD2 or the drRecD2/DNA SI complex is based 
upon the fact that both apo drRecD2 and the JrRecD2/DNA S 1 complex precipitate 
when ADP is added to them. As crystallisation is an ordered precipitation then it is 
possible that a controlled addition o f  ADP to either apo oHlecD2 or to the 
drRecD2/DNA SI complex may induce them to crystallise. A similar way o f  
crystallising a protein, Bacillus stearothermophilus DNA Gyrase B, has been 
reported (Tsai 1996).
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7 Appendix
7.1 Sequence comparison of RecD
D . radiodurans MSAALPAEPFRVSGGVNKVRFRSDTGF-TV— MSATLRNEQ-GEDPDATVIGVMPPLDVG
L. lactis -----MIEKTYFTGSIEAIFFSNPSNFYKVLLIEIDETNAE-YDDFEIWNGTIGDWEG
S. pneumoniae-----------MEVYFSGTIERIIFENPSNFYRILLLEIDDTDAEDFDDFEIIVTGTMADVIEG
E.coli    — ---------    — ---------- — ----
D .radiodurans 
L.lactis
S.pneumoniae
E.coli
L.lactis 
S.pneumoniae
D.radiodurans
E.coli
DTFSAEVLMEEHREYGYQYRWNMVLEAMPADLSEEGVAAYFEA-RVGGVGKVLAGRIAK 
DSYTFYGQLTQHPKYGEQLQV-SQYEKAVPT— SGAGLVKYFSSDKFPGIGKKTAEKIVE 
EDYTFWGQIVQHSKYGEQLQI-SRYDRAKPT— S-KGLVKYFSSSHFKGIGLKTAQKIVD
d r R e cD2aNT
TFPENTVDSILEAPEKLDGLLTLARKN— SFIKRI RENHGMEKVLTKLAEYGLPSKITFQ 
TYGENTIDEILQHPEKLEGIAGLSAKNREAFVSTI RLNYGTEMVLAKLANYGIPNKLAFQ 
TFGAAAFDLLEDDPQKFLQVPGITESTLHKMVSSV SQQGLERRLLAGLQGLGLTINQAQR 
---------------------------------------MKLQKQLLEAVEHKQLRPLDVQF
D . radiodurans AVKHFGADALDRLEKDLFTLTE-VEGIGFLTADKLWQARGGALDDPRRLTAAAVYALQLA
L . lactis IYELYKEETIEKIEENPYQLVEDVKGVGFKTADKIASSLGIEADSPNRFRAALMHEVNTH
S. pneumoniae IQDFYKEETLDWENYPYQLVEDIKGLGFTIADQLAEELGIESQAPERFRAGLVHSLFQA
E . coli ALTVAG--------------------------------------- DEHPAVTLAAALLSHDA
D . radiodurans GTQAGHSFLP-RSRAEKGW----- HYTRVTPGQARLAVETAVELGRLSEDDSPLFAAEA
L . lactis SQSTGDTYIEAKNLLEMTIDLLEEARNVEVNPSAVAEEINGLIVDGKVQQEG---------
S . pneumoniae CMETGDTYVEARDLLEQTLTLLESSRPVELDPSQVAQELSYLIEEDKVQQID--------
E . coli GE— GHVCLP-LSRLENNEA----- SHP-------- LLATCVSEIGELQNWEECLLASQA
D.radiodurans 
L.lactis
S.pneumoniae
E.coli
D.radiodurans 
L.lactis
S.pneumoniae
E.coli
D.radiodurans 
L.lactis
S.pneumoniae
E.coli
D.radiodurans 
L.lactis
S.pneumoniae
E.coli
AATGE-------- GRIYLPHVLRAEKKLASLIR--- TLLATPPADGAG-NDDWAVPKKA
-------------- TKIFENSLYFAEDGIRKSLT---ALTNRSGKDFAD-EKLLTVLAEV
-------------- TKIFDNSLFFAEEGIRSHLI---RILEKGEQKRQDLETIQKHITTV
VSRGDEPTPMILCGDRLYLNRMWCNERTVARFFNEVNHAIEVDEALLAQ-TLDKLFPVSD 
::: s * : :
Motif 1
RKGL SEEQASVLDQLAGHRLWL'J'GGPGTGKSTjrTKAV------ADL------- AE
ERDLEIT YDDLQKQAIIGAMNQQFFIL '. 'GGPGTGKTTIINGFIETYARLHQLDLDPDHYN
EQELGIEYDNIQKQAICDAIQNKVFIL' 'GGPGTGKTT 7INGIIAVYALLEGLDF----RK
EINW------ QKVAAAVALTRRISVIJ GGPGTGKTT TVAKLLA— ALIQM------- AD
• * . • 3. : : ;  *******.* m m
Motif 1a Loop
SLGLEVd 'LCAPTGKAAIRLGEVTGR 
DDVFPIILAAPTGRAS IRMNELTGL
-TASTVHRILGY— GPQGF 
-PAATIHRHLGL— GQDEA
KSNLPIILAAPTGRAA IRMNELTGL------------------PSATIHRK LGM— TGDDD
GERCRIF LAAPTGKAA \RLTESLGKALRQLPLTDEQKKRIPEDASTLHRL LGAQPGSQRL
. * .  * *  * ★
Motif 2
RHNHLEPAP YDLL 3 VDEVSMJfcDALMLSLLAAVPPGARVLLVGDTDQLPPVDAGLPLLAL 
EDALGNELSGALLIVDEFSMV DTWLANKLFQAIPGSMKVLLVGDADQLPSVGPGQIFADL 
TSHLEDYLDAEFI3]VDEFSMV DTWLANQLFSNISSNSKILIVGDSDQLPSVSPGQVLADL
OLPMMSRLIDALPDHARVIFLGDRDQLASVEAGAVLGDI
223
L.lactis 
S.pneumoniae
D.radiodurans
E.coli
-----------------------LKIPEIPSVK----------- LDKIFRQGDDSTITDLAHH
-----------------------LHIPLIPQTR-----------LEKIYRQSKESTIVTLASQ
 AQAAPTIK--------------------------------- LTQVYRQAAKNP11QAAHG
CAYANAGFTAERARQLSRLTGTHVPAGTGTEAASLRDSLCLLQKSYRFGSDSGIGQLAAA
L.lactis 
S.pneumoniae
D.radiodurans
E.coli
M otif 4
IKE
IRC
GQLPSDFTAKKPDR - S YFEVSANFVPQMVEQIASA- — WQKRGNNPF---
GILPADFTQKKADR----- S YFE IASGHI PAT IEKILGA------ ALRNGI PAR--
LLE GEAPAWGDK-RLN] ,TEIEP---DGGARRVALMVRELGG----------------PG--
INF GDKTAVKTVFQQD] ‘TDIEKRLLQSGEDYIAMLEEALAGYGRYLDLLQARAEPDLIIQ
L.lactis 
S.pneumoniae
D.radiodurans
E.coli
 ELQILAPMYKGMAGINAMNVLLQNLFNP -LNDRLEFALGDMKFREGDKVLHLVNDAE
 DIQVLAPMYRGTAGIDAINQLMQDLLNPPQKDQLSFEAPQCHYRKRDKVIHLVNDAE
 AVQVLTPMRKGPLGMDHLNYHLQALFNP GEGGVRIAEGEARPGDTWQTKNDYN
AFNEYQLLCALREGPFGVAGLNERIEQFMQQ KRKIHRHPHSRWYEGRPVMIARNDSA
L.lactis 
S .pneumoniae
D.radiodurans
E.coli
L.lactis 
S.pneumoniae
D .radiodurans
E.coli
L.lactis 
S.pneumoniae
D .radiodurans
E.coli
Motif A Motif 5
AIVFNGDLG()IVELIAAKYTDSKQDELVMDF-DGQELTYPRAEWYKITL\YAMSIHKSQG 
II VFNGDLGJlITDLIPGKYTESKQDEIVIDF-DSNEVSYPRNEWYKIRL \YAMSIHKSQG
IFNGTLGI[VL-KAEGAR------- LTVDF-DGNWELTGAELFNLQL 3YALTVHRAQG
:ALDRGQGTR------- VWFAMPDGNIKSVQPSRLPEHET rWAMTVHKSQG
Motif 6
s e f s t v i v p m v s s y s r m l Fr n l l y t a i t r a Kq s l i l l g e e r a f a q a v a r e g a n r k t y l i e
SEFPWILPITS ASRRMLI!RNLIYTAITRA1 !SKL ILLGELQAFD YATQHIGTARKTYLIE 
SEWGTVLGVLHEAHMPML! IRNLVYTALTRAILDRFFSAGSASAWQIAAARQREARNTALLE 
SEFDHAALILPSQRTPWVRELVYTAVTRAHRRLSLYADERILSAAIATRTERRSGL— A
RFMGENPAAKNLSVEIVSEKVTDKKERSDKEKKPAAPVELQGQIRSVSKKMPAQVEEISL
RFSD-------------LLENVEEKQQ---------------------AVSETVTSSASEQSY
RIRA--------------------------------------------------------------
ALFS--------------------------------------------------------------
L .lactis FEDEEIETLDKGSLTEALILSGNFD--- PLIGLTQQDF-AlFNK
S . pneumoniae ILTEE-------- NWDRIPAMIGITDTDLKEIFGK
D .radiodurans — HLE-------------------------------------------
E.coli — SRE-------------------------------------------
Figure 7.1. Sequence comparison of RecD
A sequence comparison of three type 2 RecD proteins, including JrRecD2, and the E.coli type 1 RecD 
protein. The helicase motifs are indicated as is the point at which drRecD2 was truncated to create 
drRecD2ANT . The sequence that corresponds to the molecular loop as described in chapter 4.5.5, and 
motif A as described in chapter 4.5.3 are also indicated.
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